concept,concept_type,name
mdg_0000000001,measure,Infant mortality rate (probability of dying between birth and age 1 per 1000 live births)
mdg_0000000003,measure,Adolescent birth rate (per 1000 women aged 15-19 years)
mdg_0000000005,measure,Contraceptive prevalence (%)
mdg_0000000006,measure,Unmet need for family planning (%)
mdg_0000000007,measure,Under-five mortality rate (probability of dying by age 5 per 1000 live births)
mdg_0000000010,measure,Median availability of selected generic medicines (%) - Public
mdg_0000000011,measure,Median consumer price ratio of selected generic medicines - Public
mdg_0000000012,measure,Antiretroviral therapy coverage among people with advanced HIV infection (%)
mdg_0000000013,measure,Children aged <5 years sleeping under insecticide-treated nets (%)
mdg_0000000014,measure,Children aged <5 years with fever who received treatment with any antimalarial (%)
mdg_0000000015,measure,Prevalence of condom use by adults during higher-risk sex (15-49) (%)
mdg_0000000016,measure,Deaths due to malaria (per 100 000 population)
mdg_0000000017,measure,Deaths due to tuberculosis among HIV-negative people (per 100 000 population)
mdg_0000000018,measure,Deaths due to tuberculosis among HIV-positive people (per 100 000 population)
mdg_0000000019,measure,Prevalence of HIV among adults aged >=15 years (per 100 000 population)
mdg_0000000020,measure,Incidence of tuberculosis (per 100 000 population per year)
mdg_0000000021,measure,Population aged 15-24 years with comprehensive correct knowledge of HIV/AIDS (%)
mdg_0000000022,measure,Tuberculosis detection rate under DOTS (%)
mdg_0000000023,measure,Prevalence of tuberculosis (per 100 000 population)
mdg_0000000024,measure,Tuberculosis treatment success under DOTS (%)
mdg_0000000025,measure,Births attended by skilled health personnel (%)
mdg_0000000026,measure,Maternal mortality ratio (per 100 000 live births)
mdg_0000000027,measure,Children aged <5 years stunted (%)
mdg_0000000028,measure,Population below minimum level of dietary energy consumption
life_0000000029,measure,nMx - age-specific death rate between ages x and x+n
life_0000000030,measure,nqx - probability of dying between ages x and x+n
life_0000000031,measure,lx - number of people left alive at age x
life_0000000032,measure,ndx - number of people dying between ages x and x+n
life_0000000033,measure,nLx - person-years lived between ages x and x+n
life_0000000034,measure,Tx - person-years lived above age x
life_0000000035,measure,ex - expectation of life at age x
gbd_0000000036,measure,Number of deaths
gbd_0000000037,measure,GBD - population
gbd_0000000038,measure,GBD - crude death rate
whs3_40,measure,Cholera - number of reported cases
whs3_41,measure,Diphtheria - number of reported cases
whs3_42,measure,Japanese encephalitis - number of reported cases
whs3_43,measure,Pertussis - number of reported cases
whs3_45,measure,Leprosy - number of reported cases
whs3_46,measure,Total tetanus - number of reported cases
whs3_47,measure,Meningitis - number of reported cases
whs3_48,measure,Malaria - number of reported confirmed cases
whs3_49,measure,Poliomyelitis - number of reported cases
whs3_50,measure,Yellow fever - number of reported cases
whs3_51,measure,H5N1 influenza - number of reported cases
whs3_52,measure,Plague - number of reported cases
whs3_53,measure,Mumps - number of reported cases
whs3_54,measure,Number of reported cases of tuberculosis (DOTS)
whs3_55,measure,Congenital Rubella Syndrome - number of reported cases
whs3_56,measure,Neonatal tetanus - number of reported cases
whs3_57,measure,Rubella - number of reported cases
mort_58,measure,Mortality - deaths (country)
mort_59,measure,Mortality - population (country)
mort_61,measure,Mortality - crude death rate per 100 000 population
whs3_62,measure,Measles - number of reported cases
mort_63,measure,Mortality - live births (country)
whosis_000001,measure,Life expectancy at birth (years)
whosis_000002,measure,Healthy life expectancy (HALE) at birth (years)
whosis_000003,measure,Neonatal mortality rate (per 1000 live births)
whosis_000004,measure,Adult mortality rate (probability of dying between 15 and 60 years per 1000 population)
whosis_000005,measure,Low-birth-weight newborns (%)
whosis_000006,measure,Infants exclusively breastfed for the first six months of life (%)
gbd_76,measure,GBD - Disability-adjusted life years (DALYS)
gbd_77,measure,GBD - Years of life lost (YLL)
gbd_78,measure,GBD - Years lost due to disability (YLD)
whosis_000008,measure,Children aged <5 years underweight (%)
whosis_000013,measure,Prevalence of current tobacco use among adolescents (13-15 years) (%)
whosis_000009,measure,Children aged <5 years overweight (%)
whosis_000010,measure,Adults aged &#8805; 20 years who are obese (%)
whosis_000011,measure,Alcohol consumption among adults aged &#8805; 15 years (litres of pure alcohol per person per year)
whosis_000012,measure,Prevalence of smoking any tobacco product among adults (&#8805;15 years) (%)
whs9_85,measure,Literacy rate among adults aged >= 15 years (%)
whs9_86,measure,Population (in thousands) total
whs9_87,measure,Net primary school enrolment ratio (%)
whs9_88,measure,Population median age (years)
whs9_89,measure,Population proportion under 15 (%)
whs9_90,measure,Population living on <$1 (PPP int. $) a day (%)
whs9_91,measure,Civil registration coverage of births (%)
whs9_92,measure,Population proportion over 60 (%)
whs9_93,measure,Gross national income per capita (PPP int. $)
whs9_94,measure,Civil registration coverage of causes of deaths (%)
whs9_95,measure,Total fertility rate (per woman)
whs9_96,measure,Population living in urban areas (%)
whs9_97,measure,Annual population growth rate (%)
whs4_99,measure,Antiretroviral therapy coverage among HIV-infected pregnant women for PMTCT (%)
whs4_100,measure,Diphtheria tetanus toxoid and pertussis (DTP3) immunization coverage among 1-year-olds (%)
whs6_101,measure,Median availability of selected generic medicines (%) - Private
whs6_102,measure,Hospital beds (per 10 000 population)
whs7_103,measure,Private prepaid plans as a percentage of private expenditure on health
whs7_104,measure,Per capita government expenditure on health at average exchange rate (US$)
whs7_105,measure,Per capita total expenditure on health (PPP int. $)
whs4_106,measure,Children aged < 5 years with pneumonia symptoms taken to a healthcare provider (%)
whs4_107,measure,Children aged <5 years with diarrhoea receiving ORT (%)
whs7_108,measure,Per capita government expenditure on health (PPP int. $)
whs8_110,measure,Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%)
whs4_111,measure,Antenatal care coverage - at least one visit (%)
whs7_113,measure,General government expenditure on health as a percentage of total government expenditure
whs4_115,measure,Births by caesarean section (%)
whs6_116,measure,Median consumer price ratio of selected generic medicines - Private
whs4_117,measure,Hepatitis B (HepB3) immunization coverage among 1-year-olds (%)
whs7_120,measure,External resources for health as a percentage of total expenditure on health
whs5_122,measure,Population using improved drinking-water sources (%)
whs6_123,measure,Number of dentistry personnel
whs4_124,measure,Children aged 6-59 months who received vitamin A supplementation (%)
whs6_125,measure,Physicians density (per 10 000 population)
whs2_126,measure,Distribution of years of life lost by major cause group
whs6_127,measure,Number of nursing and midwifery personnel
whs4_128,measure,Neonates protected at birth against neonatal tetanus (PAB) (%)
whs4_129,measure,Hib (Hib3) immunization coverage among 1-year-olds (%)
whs2_131,measure,Age-standardized NCD mortality rate  (per 100 000 population)
whs7_134,measure,Social security expenditure on health as a percentage of general government expenditure on health
whs6_136,measure,Number of physicians
whs2_138,measure,Deaths due to HIV/AIDS (per 100 000 population)
whs7_139,measure,Out-of-pocket expenditure as a percentage of private expenditure on health
whs6_140,measure,Number of community health workers
whs7_143,measure,Total expenditure on health as a percentage of gross domestic product
whs6_144,measure,Dentistry personnel density (per 10 000 population)
whs7_147,measure,Private expenditure on health as a percentage of total expenditure on health
whs6_148,measure,Nursing and midwifery personnel density (per 10 000 population)
whs7_149,measure,General government expenditure on health as a percentage of total expenditure on health
whs6_150,measure,Community health workers density (per 10 000 population)
whs2_152,measure,Deaths due to malaria (per 100 000 population)
whs4_154,measure,Antenatal care coverage - at least four visits (%)
whs2_155,measure,Distribution of causes of death among children aged <5 years (%)
whs7_156,measure,Per capita total expenditure on health at average exchange rate (US$)
whs6_157,measure,Number of other health service providers
whs5_158,measure,Population using improved sanitation facilities (%)
whs6_159,measure,Other health service providers density (per 10 000 population)
whs2_160,measure,Age-standardized mortality rate by cause (per 100 000 population) - Cancer
whs2_161,measure,Age-standardized mortality rate by cause (per 100 000 population) - Cardiovascular
whs2_162,measure,Age-standardized mortality rate by cause (per 100 000 population) - Injuries
whs2_163,measure,Age-standardized mortality rate by cause (per 100 000 population) - Noncommunicable
whs2_164,measure,Distribution of causes of death among children aged <5 years (%) - Malaria
whs2_165,measure,Distribution of causes of death among children aged <5 years (%) - Pneumonia
whs2_166,measure,Distribution of causes of death among children aged <5 years (%) - Injuries
whs2_167,measure,Distribution of causes of death among children aged <5 years (%) - Diarrhoea
whs2_168,measure,Distribution of causes of death among children aged <5 years (%) - Measles
whs2_169,measure,Distribution of causes of death among children aged <5 years (%) - Causes arising in the perinatal period
whs2_170,measure,Distribution of causes of death among children aged <5 years (%) - HIV/AIDS
whs2_171,measure,Distribution of causes of death among children aged <5 years (%) - Other diseases
whs2_172,measure,Distribution of years of life lost by broader causes (%) - Communicable
whs2_173,measure,Distribution of years of life lost by broader causes (%) - Noncommunicable
whs2_174,measure,Distribution of years of life lost by broader causes (%) - Injuries
was_0000000001,measure,Access to improved drinking water sources
was_0000000002,measure,Access to improved sanitation
oda_1,measure,"Donor commitments (Million, constant 2009 US$)"
oda_2,measure,"Commitments to recipient countries (Million, constant 2009 US$)"
oda_3,measure,"Donor disbursements (Million, constant 2009 US$)"
oda_4,measure,"Disbursements to recipient countries (Million, constant 2009 US$)"
gbd_prev,measure,Prevalence (in thousands)
gbd_inc,measure,Incidence (in thousands)
gbd_dthrt,measure,"Death rates  (per 100,000)"
gbd_dalyrt,measure,"DALY rates (per 100,000)"
gbd_dalyrtage,measure,"Age-standardized DALYs (per 100,000)"
tobacco_0000000186,measure,Monitor
tobacco_0000000187,measure,Protect from tobacco smoke
tobacco_0000000188,measure,Offer help to quit tobacco use
tobacco_0000000189,measure,Warn about the dangers of tobacco
tobacco_0000000190,measure,Enforce bans on tobacco advertising
tobacco_0000000191,measure,Raise taxes on tobacco
tobacco_0000000192,measure,Prevalence of smoking any tobacco product among persons aged >= 15 years
tobacco_0000000193,measure,Daily smoking of any tobacco product (age-standardized rate)
tobacco_0000000194,measure,Current smoking of cigarettes (age-standardized rate)
tobacco_0000000195,measure,Daily smoking of cigarettes (age-standardized rate)
tobacco_0000000196,measure,Health-care facilities (national legislation)
tobacco_0000000197,measure,Education facilities except universities (national legislation)
tobacco_0000000198,measure,Universities (national legislation)
tobacco_0000000199,measure,Government facilities (national legislation)
tobacco_0000000200,measure,Indoor offices (national legislation)
tobacco_0000000201,measure,Restaurants (national legislation)
tobacco_0000000202,measure,Pubs and bars (national legislation)
tobacco_0000000203,measure,Public transport (national legislation)
tobacco_0000000204,measure,All other indoor public places (national legislation)
tobacco_0000000205,measure,Number of places smoke-free (national legislation)
tobacco_0000000206,measure,Compliance with regulations on smoke-free environments (national legislation)
tobacco_0000000207,measure,Subnational smoke-free legislation authority exists
tobacco_0000000208,measure,Comprehensive bans in place subnationally
tobacco_0000000209,measure,Fines for violations
tobacco_0000000210,measure,Fines on the establishment
tobacco_0000000211,measure,Fines on the patron
tobacco_0000000212,measure,Dedicated funds for enforcement
tobacco_0000000213,measure,Citizen complaints and investigations
cholera_0000000001,measure,Number of reported cases of cholera
cholera_0000000002,measure,Number of reported deaths from cholera
cholera_0000000003,measure,Cholera case fatality rate
malaria_15034,measure,Total microscopy examined
malaria_15035,measure,Total microscopy positive
malaria_15043,measure,Suspected malaria cases
malaria_15049,measure,Malaria outpatient cases
malaria_15065,measure,Number of reported presumed and confirmed malaria cases
malaria_16201,measure,Number of health facility reports received per year (Outpatient)
malaria_16202,measure,Number of health facilities (Outpatient)
malaria_16203,measure,Number of reports expected per health facility per year (Outpatient)
malaria_16205,measure,Number of Admin 2 reports received per year (Outpatient)
malaria_16206,measure,Number of Admin 2 units (Outpatient)
malaria_16207,measure,Number of reports expected per Admin 2 per year (Outpatient)
malaria_16210,measure,Cases at community level (presumed and confirmed)
malaria_16227,measure,Number of malaria cases treated with ACT in public facilities
malaria_16228,measure,Number of RDTs delivered (public facilities and community)
malaria_16263,measure,Number of malaria cases treated with ACT (Community level)
malaria_16270,measure,Number of health facility reports received per year (Inpatient)
malaria_16271,measure,Number of health facilities (Inpatient)
malaria_16272,measure,Number of reports expected per health facility per year (Inpatient)
malaria_16273,measure,Number of Admin 2 reports received per year (Inpatient)
malaria_16274,measure,Number of Admin 2 units (Inpatient)
malaria_16275,measure,Number of reports expected per Admin 2 per year (Inpatient)
malaria_40105,measure,Imported cases
malaria_15029,measure,All-cause outpatient cases
malaria_15030,measure,All-cause inpatient cases
malaria_15031,measure,All-cause inpatient deaths
malaria_15056,measure,Malaria inpatient cases
malaria_15059,measure,Malaria attributed deaths
malaria_16231,measure,All-cause deaths (including malaria death) (Vital registration)
malaria_16232,measure,Malaria deaths (including confirmed deaths) (Vital registration)
malaria_15032,measure,Total RDT examined
malaria_15033,measure,Total RDT positive
malaria_15036,measure,Number of P. falciparum
malaria_15037,measure,Number of P. vivax
malaria_15040,measure,Number of mixed infections
malaria_15063,measure,RDT Positive cases at community level
malaria_15095,measure,Microscopy slides/RDTs examined
malaria_15096,measure,Microscopy slides/RDTs positive
malaria_16209,measure,RDT tested at community level
malaria_16211,measure,Examined (by microscopy and RDT)(Active case detection)
malaria_16212,measure,Positive (by microscopy and RDT)(Active case detection)
malaria_16229,measure,Number of P. falciparum (RDT test)
malaria_16230,measure,Number of other plamodium species (RDT test)
malaria_15077,measure,ANC first attendance
malaria_15079,measure,IPT 1st dose
malaria_15080,measure,IPT 2nd dose
malaria_15116,measure,Total number of conventional Insecticide Treated Nets (ITNs) + LLINS sold or delivered
malaria_15117,measure,Total number of Long Lasting Insecticide Treated Nets (LLINs) sold or delivered
malaria_16223,measure,Number distributed through mass campaign
malaria_16224,measure,Number distributed through ANC
malaria_16225,measure,Number distributed through EPI
malaria_16226,measure,Number distributed through other channels
malaria_20126,measure,Number of conventional insecticide-treated nets (ITNs) sold or delivered
malaria_15130,measure,Spraying cycle
malaria_15136,measure,Number of households sprayed at least once
malaria_15137,measure,Number of households targeted for spraying
malaria_15138,measure,Number people targeted for protection by IRS
malaria_15139,measure,Number of people protected by IRS
malaria_16221,measure,Number of houses or structures targeted
malaria_16222,measure,Number of houses or structures sprayed at least once
malaria_20129,measure,Insecticide used
malaria_15150,measure,Number of ACT only treatment doses received (public facilities and community)
malaria_16261,measure,Number of ACT only treatment doses received (public facilities only)
malaria_16262,measure,Total number of ACT treatment courses distributed
malaria_20132,measure,Total number of 1st line treatment course distributed
malaria_16234,measure,Programme Management (PM)
malaria_16235,measure,"Entomology and vector control (ITN, IRS, others)"
malaria_16236,measure,"Surveillance, Monitoring and Evaluation (SME)"
malaria_16237,measure,Diagnosis and case manangement (incl. IPT)
malaria_16238,measure,Communications and Advocacy (CAD)
malaria_16239,measure,Training
malaria_15283,measure,Government health budget (USD)
malaria_15284,measure,Government budget for malaria (USD)
malaria_15287,measure,Contributions from the Global Fund (USD)
malaria_15288,measure,Contributions from the Wolrdbank (USD)
malaria_15309,measure,European Union (USD)
malaria_15310,measure,Gov. expenditure on malaria (USD)
malaria_16233,measure,"Other (NGOs, foundations,etc)"
malaria_16240,measure,Others
malaria_16264,measure,WHO
malaria_16265,measure,UNICEF
malaria_16266,measure,Other UN agencies
malaria_16267,measure,PMI
malaria_16268,measure,Other bilaterals
malaria_16252,measure,High endemic or risk areas ( RMI > 1)
malaria_16253,measure,Low endemic or epidemic-prone areas ( RMI < 1)
malaria_16254,measure,Malaria-free areas (no indigenous transmission)
malaria_30514,measure,Household Net Possession - Percentage with at least one (Any type of mosquito net )
malaria_30515,measure,Household Net Possession - Percentage with more than one (Any type of mosquito net )
malaria_30516,measure,Household Net Possession - Average number of nets per household (Any type of mosquito net )
malaria_30517,measure,Household Net Possession - Percentage with at least one (Ever treated mosquito net )
malaria_30518,measure,Household Net Possession - Percentage with more than one (Ever treated mosquito net )
malaria_30519,measure,Household Net Possession - Average number of ever treated nets per household (Ever treated mosquito net )
malaria_30520,measure,Household Net Possession - Percentage with at least one (Insecticide treated mosquito nets (ITNs) )
malaria_30521,measure,Household Net Possession - Percentage with more than one (Insecticide treated mosquito nets (ITNs) )
malaria_30522,measure,Household Net Possession - Average number of ITNs per household (Insecticide treated mosquito nets (ITNs) )
malaria_30523,measure,Household Net Possession - (Number of households )
malaria_30526,measure,IPT and Anti-malarial Treatment - Percentage who took 2+ doses SP/Fansidar
malaria_30532,measure,Prompt Treatment - Percentage who took antimalarial drugs (Among children under age five with fever)
malaria_30533,measure,Prompt Treatment - Percentage who took antimalarial drugs same or next day (Among children under age five with fever)
malaria_30535,measure,Children with fever - Percentage of children who took drug: SP/ Fansidar
malaria_30536,measure,Children with fever - Percentage of children who took drug: Chloroquine
malaria_30539,measure,Children with fever - Percentage of children who took drug: Combination with artemisinin
malaria_30541,measure,Children with fever - Percentage of children who took drug the same or next day: SP/ Fansidar
malaria_30542,measure,Children with fever - Percentage of children who took drug the same or next day: Chloroquine
malaria_30545,measure,Children with fever - Percentage of children who took drug the same or next day: Combination with artemisinin
malaria_30548,measure,Use of mosquito nets - Percentage of under 5 who slept under any net last night
malaria_30549,measure,Use of mosquito nets - Percentage of under 5 who slept under an ever treated net last night
malaria_30550,measure,Use of mosquito nets - Percentage of under 5 who slept under an ITN last night
malaria_30555,measure,Use of mosquito nets - Number of children under 5
malaria_30556,measure,Use of mosquito nets - Percentage of all women age 15-49 who Slept under any net last night
malaria_30557,measure,Use of mosquito nets - Percentage of all women age 15-49 who Slept under an ever treated net last night
malaria_30558,measure,Use of mosquito nets - Percentage of all women age 15-49 who Slept under an ITN last night
malaria_30559,measure,Use of mosquito nets - Number of pregnant women
malaria_30560,measure,Use of mosquito nets - Percentage of pregnant women age 15-49 who Slept under any net last night
malaria_30561,measure,Use of mosquito nets - Percentage of pregnant women age 15-49 who Slept under an ever treated net last night
malaria_30562,measure,Use of mosquito nets - Percentage of pregnant women age 15-49 who Slept under an ITN last night
malaria_15279,measure,Population
tb_c_tsr,measure,Treatment success rate (new smear-positive cases)
tb_e_mort_exc_tbhiv_100k,measure,"Mortality of TB cases (all forms, excluding HIV) per 100 000 population"
tb_e_mort_exc_tbhiv_num_save,measure,"Number of deaths from TB (all forms, excluding HIV)"
tobacco_0000000337,measure,Current smoking of any tobacco product (crude rate)
tobacco_0000000338,measure,Daily smoking of any tobacco product (crude rate)
tobacco_0000000339,measure,Current smoking of cigarettes (crude rate)
tobacco_0000000340,measure,Daily smoking of cigarettes (crude rate)
tobacco_0000000341,measure,Current users of any smokeless tobacco product (crude rate)
tobacco_0000000342,measure,Daily users of any smokeless tobacco product (crude rate)
tobacco_0000000343,measure,Ever users of any smokeless tobacco product (crude rate)
tobacco_0000000344,measure,Prevalence of current tobacco use among adolescents aged 13-15 years
tobacco_0000000345,measure,Current smokers of cigarettes (youth rate)
tobacco_0000000346,measure,Exposure to smoke at home
tobacco_0000000347,measure,Exposure to smoke outside home
tobacco_0000000348,measure,Jurisdiction name
tobacco_0000000349,measure,Number of people covered by subnational legislation
tobacco_0000000350,measure,Proportion of national population covered by subnational legislation
tobacco_0000000351,measure,Number of places smoke-free (subnational legislation)
tobacco_0000000352,measure,Health-care facilities (subnational legislation)
tobacco_0000000353,measure,"Education facilities, except universities (subnational legislation)"
tobacco_0000000354,measure,Universities (subnational legislation)
tobacco_0000000355,measure,Government facilities  (subnational legislation)
tobacco_0000000356,measure,Indoor offices (subnational legislation)
tobacco_0000000357,measure,Restaurants (subnational legislation)
tobacco_0000000358,measure,Pubs and bars (subnational legislation)
tobacco_0000000359,measure,Public transport (subnational legislation)
tobacco_0000000360,measure,All other indoor public places (subnational legislation)
tobacco_0000000361,measure,Access to a toll-free quit line
tobacco_0000000362,measure,Smoking cessation support is available in hospitals
tobacco_0000000363,measure,Smoking cessation support is available in health clinics or other primary care facilities
tobacco_0000000364,measure,Smoking cessation support is available in offices of health professionals
tobacco_0000000365,measure,Smoking cessation support is available in the community
tobacco_0000000366,measure,Smoking cessation support is available in other settings
tobacco_0000000367,measure,Nicotine replacement therapy - legally sold
tobacco_0000000368,measure,Nicotine replacement therapy - place available
tobacco_0000000369,measure,Bupropion - legally sold
tobacco_0000000370,measure,Bupropion - place available
tobacco_0000000371,measure,Varenicline - legally sold
tobacco_0000000372,measure,Varenicline - place available
tobacco_0000000373,measure,Ban on deceitful terms on cigarette packaging
tobacco_0000000374,measure,Percentage of principal display area mandated to be covered by health warnings - front and back of cigarette packaging
tobacco_0000000375,measure,Percentage of principal display area mandated to be covered by health warnings - front of cigarette packaging
tobacco_0000000376,measure,Percentage of principal display area mandated to be covered by health warnings - back of cigarette packaging
tobacco_0000000377,measure,Specific health warnings are mandated for cigarette packaging
tobacco_0000000378,measure,Number of health warnings approved by the law for cigarette packaging
tobacco_0000000379,measure,Health warnings appear on each cigarette package and any outside packaging and labelling used in the retail sale
tobacco_0000000380,measure,Health warnings on cigarette packaging describe the harmful effects of tobacco use on health
tobacco_0000000381,measure,"Font style, font size and colour of health warnings are mandated for cigarette packaging"
tobacco_0000000382,measure,Health warnings on cigarette packaging must be rotated
tobacco_0000000383,measure,Health warnings on cigarette packaging must be written in the principal language(s) of the country
tobacco_0000000384,measure,Health warnings on cigarette packaging must include a photograph or graphic
tobacco_0000000385,measure,Ban on deceitful terms on other smoked tobacco packaging
tobacco_0000000386,measure,Percentage of principal display area mandated to be covered by health warnings - front and back of other smoked tobacco packaging
tobacco_0000000387,measure,Percentage of principal display area mandated to be covered by health warnings - front of other smoked tobacco packaging
tobacco_0000000388,measure,Specific health warnings are mandated for other smoked tobacco packaging
tobacco_0000000389,measure,Number of health warnings approved by the law for other smoked tobacco packaging
tobacco_0000000390,measure,Health warnings on other smoked tobacco packaging must be rotated
tobacco_0000000391,measure,Percentage of principal display area mandated to be covered by health warnings - back of other smoked tobacco packaging
tobacco_0000000392,measure,Health warnings appear on each other smoked tobacco package and any outside packaging and labelling used in the retail sale
tobacco_0000000393,measure,Health warnings on other smoked tobacco packaging describe the harmful effects of tobacco use on health
tobacco_0000000394,measure,"Font style, font size and colour of health warnings are mandated for other smoked tobacco packaging"
tobacco_0000000395,measure,Health warnings on other smoked tobacco packaging must be written in the principal language(s) of the country
tobacco_0000000396,measure,Health warnings on other smoked tobacco packaging must include a photograph or graphic
tobacco_0000000397,measure,Ban on deceitful terms on smokeless tobacco packaging
tobacco_0000000398,measure,Percentage of principal display area mandated to be covered by health warnings - front and back of smokeless tobacco packaging
tobacco_0000000399,measure,Percentage of principal display area mandated to be covered by health warnings - front of smokeless tobacco packaging
tobacco_0000000400,measure,Percentage of principal display area mandated to be covered by health warnings - back of smokeless tobacco packaging
tobacco_0000000401,measure,Specific health warnings are mandated for smokeless tobacco packaging
tobacco_0000000402,measure,Number of health warnings approved by the law for smokeless tobacco packaging
tobacco_0000000403,measure,Health warnings appear on each smokeless tobacco package and any outside packaging and labelling used in the retail sale
tobacco_0000000404,measure,Health warnings on smokeless tobacco packaging describe the harmful effects of tobacco use on health
tobacco_0000000405,measure,"Font style, font size and colour of health warnings are mandated for smokeless tobacco packaging"
tobacco_0000000406,measure,Health warnings on smokeless tobacco packaging must be rotated
tobacco_0000000407,measure,Most sold brand of bidis - price in US$ at official exchange rates
tobacco_0000000408,measure,Cheapest brand of bidis - currency reported
tobacco_0000000409,measure,Cheapest brand of bidis - price in currency reported
tobacco_0000000410,measure,Cheapest brand of bidis - price in US$ at official exchange rates
tobacco_0000000411,measure,Health warnings on smokeless tobacco packaging must be written in the principal language(s) of the country
tobacco_0000000412,measure,Health warnings on smokeless tobacco packaging must include a photograph or graphic
tobacco_0000000413,measure,Billboard and outdoor advertising
tobacco_0000000414,measure,International magazines and newspapers
tobacco_0000000415,measure,International television and radio
tobacco_0000000416,measure,Internet
tobacco_0000000417,measure,Local magazines and newspapers
tobacco_0000000418,measure,National television and radio
tobacco_0000000419,measure,Point of sale
tobacco_0000000420,measure,"Subnational bans on tobacco advertising, promotion and sponsorship"
tobacco_0000000421,measure,Compliance with bans on direct advertising
tobacco_0000000422,measure,Appearance of tobacco products in TV and/or films
tobacco_0000000423,measure,Brand name of non-tobacco products used for tobacco product
tobacco_0000000424,measure,Free distribution in mail or through other means
tobacco_0000000425,measure,Non-tobacco products identified with tobacco brand names
tobacco_0000000426,measure,Promotional discounts
tobacco_0000000427,measure,Sponsored events
tobacco_0000000428,measure,Compliance with bans on promotion and sponsorship
tobacco_0000000429,measure,Most sold brand of cigarettes - currency reported
tobacco_0000000430,measure,Most sold brand of cigarettes - price in currency reported
tobacco_0000000431,measure,Most sold brand of cigarettes - price in US$ at official exchange rates
tobacco_0000000432,measure,Cheapest brand of cigarettes - currency reported
tobacco_0000000433,measure,Cheapest brand of cigarettes - price in currency reported
tobacco_0000000434,measure,Cheapest brand of cigarettes - price in US$ at official exchange rates
tobacco_0000000435,measure,Most sold brand of bidis - currency reported
tobacco_0000000436,measure,Most sold brand of bidis - price in currency reported
tobacco_0000000437,measure,Most sold brand of cigarettes - taxes as a % of price - ad valorem excise
tobacco_0000000438,measure,Most sold brand of cigarettes - taxes as a % of price - import duties
tobacco_0000000439,measure,Most sold brand of cigarettes - taxes as a % of price - specific excise
tobacco_0000000440,measure,Most sold brand of cigarettes - taxes as a % of price - total tax
tobacco_0000000441,measure,Cheapest brand of cigarettes - taxes as a % of price - ad valorem excise
tobacco_0000000442,measure,Cheapest brand of cigarettes - taxes as a % of price - import duties
tobacco_0000000443,measure,Cheapest brand of cigarettes - taxes as a % of price - specific excise
tobacco_0000000444,measure,Cheapest brand of cigarettes - taxes as a % of price - total tax
tobacco_0000000445,measure,Most sold brand of bidis - taxes as a % of price - ad valorem excise
tobacco_0000000446,measure,Most sold brand of bidis - taxes as a % of price - import duties
tobacco_0000000447,measure,Most sold brand of bidis - taxes as a % of price - specific excise
tobacco_0000000448,measure,Most sold brand of bidis - taxes as a % of price - total tax
tobacco_0000000449,measure,Cheapest brand of bidis - taxes as a % of price - ad valorem excise
tobacco_0000000450,measure,Cheapest brand of bidis - taxes as a % of price - import duties
tobacco_0000000451,measure,Cheapest brand of bidis - taxes as a % of price - specific excise
tobacco_0000000452,measure,Cheapest brand of bidis - taxes as a % of price - total tax
tobacco_0000000453,measure,Government objectives on tobacco control exist
tobacco_0000000454,measure,National agency for tobacco control exists
tobacco_0000000455,measure,Number of full-time equivalent staff in national agency
tobacco_0000000456,measure,Annual budget for tobacco control in currency reported
tobacco_0000000457,measure,Reported currency
tobacco_0000000458,measure,Annual budget for tobacco control in US$ at official exchange rate
tobacco_0000000459,measure,Budget year
rs_193,measure,Income level
rs_194,measure,Number of registered vehicles
rs_196,measure,Estimated number of road traffic deaths
rs_198,measure,Estimated road traffic death rate (per 100 000 population)
rs_204,measure,Existence of a national drink-driving law
rs_208,measure,Attribution of road traffic deaths to alcohol (%)
rs_209,measure,Existence of a national seat-belt law
rs_210,measure,Applicability of seat-belt law to all occupants
rs_213,measure,Existence of a national child-restraint law
rs_214,measure,Existence of national speed limits
rs_215,measure,Adaptation of national speed limit at a local level
rs_216,measure,Specification of national speed law by vehicle type
rs_218,measure,Existence of a national motorcycle helmet law
rs_221,measure,Applicability of national motorcycle helmet law to all road types
rs_222,measure,Applicability of national motorcycle helmet law to all engine types
rs_223,measure,Requirement of motorcycle helmet use to adhere to standard
rs_224,measure,Motorcycle helmet wearing rate (%)
rs_225,measure,Existence of a road safety lead agency
rs_228,measure,Existence of a national road safety strategy
rs_229,measure,Availability of funding for national road safety strategy
rs_231,measure,Existence of a national policy on walking and cycling
rs_232,measure,Existence of a national policy on public transport
rs_233,measure,Existence of road safety audit for all new roads
rs_234,measure,Existence of road safety audit for existing roads
rs_236,measure,Existence of mandatory vehicle insurance
rs_237,measure,Existence of a formal pre-hospital care system
rs_205,measure,Definition of drink-driving by BAC
rs_246,measure,Distribution of road traffic deaths by type of road user (%)
rs_207,measure,Blood Alcohol Concentration (BAC) limit for drivers
rs_212,measure,Seat-belt wearing rate (%)
rs_219,measure,Applicability of national motorcycle helmet law to all occupants
rs_235,measure,Type of driving tests for new drivers
rs_238,measure,Existence of a universal access telephone number for pre-hospital care
rs_217,measure,Maximum speed limits
atlas_su_0000000532,measure,Government unit for treatment
atlas_su_0000000533,measure,Government unit for alcohol and drugs: Location
atlas_su_0000000534,measure,Government unit for alcohol: Location
atlas_su_0000000535,measure,Government unit for drugs: Location
atlas_su_0000000536,measure,No government unit
atlas_su_0000000537,measure,Government unit for mental health/substance use: Location
rs_576,measure,Gross national income per capita (Atlas method)
mdg_0000000029,measure,Prevalence of HIV among adults aged 15 to 49 (%)
tobacco_0000000502,measure,Year of survey of adults
tobacco_0000000503,measure,Representativeness of survey of adults
tobacco_0000000504,measure,Repeating interval for survey of adults (years)
tobacco_0000000505,measure,Year of survey of youth
tobacco_0000000506,measure,Representativeness of youth survey
tobacco_0000000507,measure,Repeating interval for survey of youth (years)
tobacco_0000000508,measure,Most sold brand of cigarettes - taxes as a % of price - value added tax
tobacco_0000000509,measure,Most sold brand of cigarettes - taxes as a % of price - other taxes
mdg_0000000030,measure,Smear-positive tuberculosis case-detection rate (%)
mdg_0000000031,measure,Smear-positive tuberculosis treatment-success rate (%)
whs5_512,measure,Population using solid fuels (%)
whs2_513,measure,Age-standardized mortality rate by cause (per 100 000 population) - Communicable
whs2_514,measure,Distribution of causes of death among children aged <5 years (%) - Prematurity
whs2_515,measure,Distribution of causes of death among children aged <5 years (%) - Neonatal sepsis
whs2_516,measure,Distribution of causes of death among children aged <5 years (%) - Congenital anomalies
whs6_517,measure,Number of pharmaceutical personnel
whs6_518,measure,Number of environment and public health workers
whs6_519,measure,Density of pharmaceutical personnel (per 10 000 population)
whs6_520,measure,Density of environment and public health workers (per 10 000 population)
mdg_0000000032,measure,Maternal mortality ratio (per 100 000 live births) - Country reported estimates
whs3_522,measure,Number of reported cases of tuberculosis
whs2_523,measure,Distribution of causes of death among children aged <5 years (%) - Birth asphyxia
tobacco_0000000524,measure,Most sold brand of bidis - taxes as a % of price - value added tax
tobacco_0000000525,measure,Most sold brand of bidis - taxes as a % of price - other taxes
nutrition_564,measure,Children aged <5 years wasted for age (%)
nutrition_565,measure,Prevalence of adults aged &#8805; 15 years who are pre-obese (%) (BMI 25.0-29.99)
nutrition_566,measure,Prevalence of adults aged &#8805; 15 years who are overweight (%) (BMI ? 25.0)
nutrition_567,measure,Prevalence of adults aged &#8805; 15 years who are in normal range (%) (BMI 18.5-24.99)
nutrition_568,measure,Prevalence of adults aged &#8805; 15 years who are underweight (%) (BMI <18.5)
nutrition_569,measure,Continued breastfeeding at 1 year (%)
nutrition_570,measure,Early initiation of breastfeeding (%)
nutrition_571,measure,Exclusive breastfeeding under 4 months (%)
nutrition_573,measure,Children ever breastfed (%)
nutrition_572,measure,Continued breastfeeding at 2 years (%)
nutrition_574,measure,Duration of any breastfeeding
nutrition_575,measure,Duration of exclusive breastfeeding
nutrition_576,measure,"Introduction of solid, semi-solid or soft foods and breast milk (%)"
nutrition_577,measure,Bottle feeding rate 0-11.9 months (%)
nutrition_578,measure,Bottle feeding rate 0-23.9 months (%)
nutrition_579,measure,Exclusive breastfeeding under 6 months (%)
whs4_543,measure,BCG immunization coverage among 1-year-olds (%)
whs4_544,measure,Polio (Pol3) immunization coverage among 1-year-olds (%)
sa_0000001398,measure,"Alcohol, consumption of pure alcohol by type of beverage (%)"
sa_0000001399,measure,Consumption by type of alcoholic beverage - market share (%)
sa_0000001400,measure,"Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol)"
sa_0000001401,measure,"Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average"
sa_0000001402,measure,"Alcohol, estimate of five-year change in recorded per capita (15+) consumption 2006-2010"
sa_0000001403,measure,"Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol)"
sa_0000001404,measure,"Alcohol, drinkers only (recorded 3 year average + unrecorded) per capita (15+)consumption in litres of pure alcohol"
sa_0000001405,measure,"Alcohol, tourist consumption (in litres of pure alcohol)"
sa_0000001406,measure,"Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol)"
mdg_0000000033,measure,Antiretroviral therapy coverage among people with HIV infection eligible for ART according to 2010 guidelines (%)
mdg_0000000034,measure,"Antiretroviral therapy coverage among people with advanced HIV infection (%), WHO 2006 guidelines"
sa_0000001409,measure,"Alcohol, abstainers lifetime (%)"
sa_0000001410,measure,"Abstainers (15-19 years), lifetime (%)"
sa_0000001411,measure,"Alcohol, abstainers past 12 months (%)"
sa_0000001412,measure,"Abstainers (15-19 years), past 12 months (%)"
sa_0000001413,measure,"Alcohol, consumers past 12 months (%)"
sa_0000001414,measure,"Alcohol, former drinkers (%)"
sa_0000001415,measure,"Alcohol, heavy episodic drinking (population) past 30 days (%)"
sa_0000001416,measure,"Alcohol, heavy episodic drinking (drinkers only) past 30 days (%)"
sa_0000001417,measure,"Alcohol, patterns of drinking score"
sa_0000001418,measure,"Age-standardized DALYs, alcohol use disorders, per 100,000"
sa_0000001419,measure,"Age-standardized DALYs, breast cancer, per 100,000"
sa_0000001420,measure,"Age-standardized DALYs, colon and rectum cancers, per 100,000"
sa_0000001421,measure,"Age-standardized DALYs, diabetes mellitus, per 100,000"
sa_0000001422,measure,"Age-standardized DALYs, drownings, per 100,000"
sa_0000001423,measure,"Age-standardized DALYs, falls, per 100,000"
sa_0000001424,measure,"Age-standardized DALYs, fires, per 100,000"
sa_0000001425,measure,"Age-standardized DALYs, ischaemic heart disease, per 100,000"
sa_0000001426,measure,"Age-standardized DALYs, liver cancer, per 100,000"
sa_0000001427,measure,"Age-standardized DALYs, liver cirrhosis, per 100,000"
sa_0000001428,measure,"Age-standardized DALYs, maternal conditions, per 100,000"
sa_0000001429,measure,"Age-standardized DALYs, mouth and oropharynx cancer, per 100,000"
sa_0000001430,measure,"Age-standardized DALYs, oesophagus cancer, per 100,000"
sa_0000001431,measure,"Age-standardized DALYs, poisoning, per 100,000"
sa_0000001432,measure,"Age-standardized DALYs, prematurity and low birth rate, per 100,000"
sa_0000001433,measure,"Age-standardized DALYs, road traffic accidents, per 100,000"
sa_0000001434,measure,"Age-standardized DALYs, self-inflicted injury, per 100,000"
sa_0000001435,measure,"Age-standardized DALYs, other unintentional injuries, per 100,000"
sa_0000001436,measure,"Age-standardized DALYs, violence, per 100,000"
sa_0000001437,measure,"Age-standardized death rates, alcohol use disorders, per 100,000"
sa_0000001438,measure,"Age-standardized death rates, breast cancer, per 100,000"
sa_0000001439,measure,"Age-standardized death rates, colon and rectum cancers, per 100,000"
sa_0000001440,measure,"Age-standardized death rates, diabetes mellitus, per 100,000"
sa_0000001441,measure,"Age-standardized death rates, drownings, per 100,000"
sa_0000001442,measure,"Age-standardized death rates, falls, per 100,000"
sa_0000001443,measure,"Age-standardized death rates, fires, per 100,000"
sa_0000001444,measure,"Age-standardized death rates, ischaemic heart disease, per 100,000"
sa_0000001445,measure,"Age-standardized death rates, liver cancer, per 100,000"
sa_0000001446,measure,"Age-standardized death rates, liver cirrhosis, per 100,000"
sa_0000001447,measure,"Age-standardized death rates, maternal conditions, per 100,000"
sa_0000001448,measure,"Age-standardized death rates, mouth and oropharynx cancer, per 100,000"
sa_0000001449,measure,"Age-standardized death rates, oesophagus cancer, per 100,000"
sa_0000001450,measure,"Age-standardized death rates, poisoning, per 100,000"
sa_0000001451,measure,"Age-standardized death rates, prematurity and low birth rate, per 100,000"
sa_0000001452,measure,"Age-standardized death rates, road traffic accidents, per 100,000"
sa_0000001453,measure,"Age-standardized death rates, self-inflicted injury, per 100,000"
sa_0000001454,measure,"Age-standardized death rates, other unintentional injuries, per 100,000"
sa_0000001455,measure,"Age-standardized death rates, violence, per 100,000"
sa_0000001456,measure,"Age-standardized death rates (15+ years), alcoholic liver disease, per 100,000"
sa_0000001457,measure,"Liver cirrhosis, age-standardized death rates (15+), per 100,000 population"
sa_0000001458,measure,"Age-standardized death rates (15+ years), poisoning, per 100,000"
sa_0000001459,measure,"Road traffic crashes, age-standardized death rates (15+), per 100,000 population"
sa_0000001460,measure,"Age-standardized death rates (15+ years), violence, per 100,000"
sa_0000001461,measure,"Alcohol dependence (15+ ), 12-month prevalence (%) with 95%CI"
sa_0000001462,measure,"Alcohol use disorders (15+), 12 month prevalence (%) with 95%"
sa_0000001463,measure,"Alcoholic psychosis, incidence, per 100,000"
sa_0000001464,measure,"Cautions and arrests for drink-driving, per 100,000 population"
sa_0000001465,measure,"Hospital discharges, alcohol-related injuries and poisoning, per 100,000"
sa_0000001466,measure,"Hospital discharges, alcoholic liver disease, per 100,000"
sa_0000001467,measure,Perceived trend in alcohol-related harm and consequences
sa_0000001468,measure,"Treatment admissions (inpatient), alcohol dependence, per 100,000"
sa_0000001469,measure,"Treatment admissions (inpatient), alcoholic psychosis, per 100,000"
sa_0000001470,measure,"Alcohol-related road traffic crashes, per 100,000 population"
sa_0000001471,measure,Alcohol-related road traffic crashes (% of all traffic crashes)
sa_0000001472,measure,"Alcohol-related injury mortality, per 1,000"
sa_0000001473,measure,"Alcohol-related disease mortality, per 100,000 (15+ years)"
sa_0000001474,measure,Alcoholic excise tax revenue as a per cent of government revenue
sa_0000001475,measure,Annual revenues from alcohol excise tax in millions US$
sa_0000001476,measure,Alcohol expenditure as a per cent of total household expenditure
sa_0000001477,measure,Social costs of alcohol use in millions US$
hiv_0000000001,measure,Estimated number of people (all ages) living with HIV
hiv_0000000002,measure,Number of adults aged 15 and over living with HIV
hiv_0000000003,measure,Number of women aged 15 and over living with HIV
hiv_0000000004,measure,Number of children under 15 living with HIV
hiv_0000000005,measure,HIV prevalence rate among adults (15-49)
hiv_0000000006,measure,Number of deaths due to HIV/AIDS
hiv_0000000007,measure,"Testing and counselling facilities, reported number"
hiv_0000000008,measure,"Testing and counselling facilities, estimated number per 100 000 adult population"
hiv_0000000009,measure,Reported number of people receiving antiretroviral therapy
hiv_0000000010,measure,"Reported number of people receiving antiretroviral therapy, month and year of report"
hiv_0000000011,measure,Reported number of children receiving antiretroviral therapy
hiv_0000000012,measure,"Reported number of children receiving antiretroviral therapy, month and year of report"
hiv_0000000013,measure,"Pregnant women tested for HIV, reported number"
hiv_0000000014,measure,"Pregnant women tested for HIV, estimated coverage (%)"
hiv_0000000015,measure,Number of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission
hiv_0000000016,measure,"Number of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission, reporting period"
hiv_0000000017,measure,"Number of people aged 15 years and over who received HIV testing and counselling, reported number"
hiv_0000000018,measure,"People aged 15 years and over who received HIV testing and counselling, estimated number per 1000 adult population"
hiv_0000000019,measure,"Number of people aged 15 years and over who received HIV testing and counselling, reporting period"
hiv_0000000020,measure,Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission
hiv_0000000021,measure,Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods
hiv_0000000022,measure,Estimated number of people eligible for antiretroviral therapy according to 2010 guidelines
hiv_0000000023,measure,Estimated number of children needing antiretroviral therapy based on WHO methods
hiv_0000000024,measure,Estimated antiretroviral therapy coverage among children
sa_0000001502,measure,Adopted written national policy on alcohol
sa_0000001503,measure,Alcoholic beverage legally defined
sa_0000001504,measure,Alcohol use is banned
sa_0000001505,measure,Surrogate alcohol consumption is a problem
sa_0000001506,measure,National legislation to prevent illegal alcohol
nutrition_0,measure,Prevalence of adults aged &#8805; 15 years who are moderately and severely thin (BMI <17.0)
nutrition_1,measure,Prevalence of adults aged &#8805; 15 years who are severely thin (BMI <16.0)
nutrition_2,measure,Prevalence of adults aged &#8805; 15 years who are mildly thin (BMI 17.0-18.49)
nutrition_3,measure,Prevalence of adults aged &#8805; 15 years who are moderately thin (BMI 16.0-16.99)
lead_1,measure,Percentage of the children under 15 years with blood lead levels above 5ug/dl
lead_2,measure,Percentage of the children under 15 years with blood lead levels above 10ug/dl
lead_3,measure,Percentage of the adults (15+ years) with blood lead levels above 5ug/dl
lead_4,measure,Percentage of the adults (15+ years) with blood lead levels above 10ug/dl
lead_5,measure,Lead attributable deaths
lead_6,measure,Lead attributable DALYs ('000)
lead_7,measure,Lead attributable deaths per 100'000 capita
lead_8,measure,Lead attributable DALYs per 100'000 capita
lead_9,measure,Lead attributable DALYs ('000) in children under 5 years
lead_10,measure,Lead attributable DALYs per 100'000 children under 5 years
shs_1,measure,Percentage of children under 15 years exposed to second-hand smoke
shs_2,measure,Percentage of women (15+ years) exposed to second-hand smoke
shs_3,measure,Percentage of men (15+ years) exposed to second-hand smoke
shs_4,measure,Second-hand smoke attributable deaths
shs_5,measure,Second-hand smoke attributable DALYs ('000)
shs_6,measure,Second-hand smoke attributable deaths per 100'000 capita
shs_7,measure,Second-hand smoke attributable DALYs per 100'000 capita
shs_8,measure,Second-hand smoke attributable deaths ('000) in children under 5 years
shs_9,measure,Second-hand smoke  attributable deaths per 100'000 children under 5 years
shs_10,measure,Second-hand smoke attributable DALYs ('000) in children under 5 years
shs_11,measure,Second-hand smoke  attributable DALYs per 100'000 children under 5 years
wsh_1,measure,"Water, sanitation and hygiene attributable deaths"
wsh_2,measure,"Water, sanitation and hygiene attributable deaths ('000) in children under 5 years"
wsh_3,measure,"Water, sanitation and hygiene attributable deaths per 100'000 capita"
wsh_4,measure,"Water, sanitation and hygiene  attributable deaths per 100'000 children under 5 years"
wsh_5,measure,"Water, sanitation and hygiene attributable DALYs ('000)"
wsh_6,measure,"Water, sanitation and hygiene attributable DALYs ('000) in children under 5 years"
wsh_7,measure,"Water, sanitation and hygiene attributable DALYs per 100'000 capita"
wsh_8,measure,"Water, sanitation and hygiene  attributable DALYs per 100'000 children under 5 years"
air_1,measure,Ambient air pollution attributable deaths
air_2,measure,Ambient air pollution (Annual PM10 [ug/m3])
air_3,measure,Percentage of the total population living in cities > 100'000 inhabitants
air_4,measure,Ambient air pollution attributable deaths in children under 5 years
air_5,measure,Ambient air pollution attributable deaths (per 100 000 population)
air_6,measure,Ambient air pollution  attributable deaths per 100'000 children under 5 years
air_7,measure,Ambient air pollution attributable DALYs ('000)
air_8,measure,Ambient air pollution attributable DALYs  in children under 5 years
air_9,measure,Ambient air pollution attributable DALYs  (per 100 000 population)
air_10,measure,Ambient air pollution  attributable DALYs per 100'000 children under 5 years
air_11,measure,Household air pollution attributable deaths
air_12,measure,Household air pollution attributable deaths in children under 5 years
air_13,measure,Household air pollution attributable deaths per 100'000 capita
air_14,measure,Household air pollution  attributable deaths per 100'000 children under 5 years
air_15,measure,Household air pollution attributable DALYs
air_16,measure,Household air pollution attributable DALYs in children under 5 years
air_17,measure,Household air pollution attributable DALYs (per 100 000 population)
air_18,measure,Household air pollution  attributable DALYs per 100'000 children under 5 years
air_19,measure,Population using electricity as main cooking fuel (%)
tb_1,measure,Tuberculosis treatment coverage
mening_1,measure,Number of suspected meningitis deaths reported
mening_2,measure,Number of suspected meningitis cases reported
tb_e_mort_exc_tbhiv_num,measure,"Number of deaths due to tuberculosis, excluding HIV"
tb_e_prev_num,measure,Number of prevalent tuberculosis cases
tb_e_inc_num,measure,Number of incident tuberculosis cases
tb_e_inc_tbhiv_100k,measure,Incidence of tuberculosis (per 100 000 population) (HIV-positive cases)
tb_e_inc_tbhiv_num,measure,"Number of incident tuberculosis cases,  (HIV-positive cases)"
air_20,measure,Population using LPG as main cooking fuel (%)
air_21,measure,Population using natural gas as main cooking fuel (%)
air_22,measure,Population using biogas as main cooking fuel (%)
air_23,measure,Population using kerosene as main cooking fuel (%)
air_24,measure,Population using clean fuels and technologies (sum of)(%)
air_25,measure,Population using coal as main cooking fuel (%)
air_26,measure,Population using charcoal as main cooking fuel (%)
air_27,measure,Population using wood as main cooking fuel (%)
air_28,measure,Population using dung as main cooking fuel (%)
air_29,measure,Population using crop waste as main cooking fuel (%)
air_30,measure,Population using solid fuels (sum of) (%)
air_31,measure,Population using others (non listed items) as main cooking fuel (%)
air_32,measure,Population not cooking (%)
air_33,measure,Missing information on cooking fuels (%)
air_34,measure,Total survey respondents
tb_tot_newrel,measure,Tuberculosis - new and relapse cases
tb_8_c_cdr,measure,Case detection rate for all forms of tuberculosis
sa_0000001507,measure,Advertising restrictions on national television
sa_0000001508,measure,Advertising restrictions on cable television
sa_0000001509,measure,Advertising restrictions on national radio
sa_0000001510,measure,Advertising restrictions on local radio
sa_0000001511,measure,Advertising restrictions in print media
sa_0000001512,measure,Advertising restrictions at cinemas
sa_0000001513,measure,Advertising restrictions on billboards
sa_0000001514,measure,Advertising restrictions at point-of-sale
sa_0000001515,measure,Advertising restrictions on the internet
sa_0000001516,measure,Restrictions on product placement on national television
sa_0000001517,measure,Restrictions on product placement on cable television
sa_0000001518,measure,Age limits on-premise service
sa_0000001519,measure,Minimum legal drinking age
sa_0000001520,measure,Legal blood alcohol concentration (BAC) limits
sa_0000001521,measure,Random breath testing (RBT) use
sa_0000001522,measure,Mandatory driver education for habitual offenders
sa_0000001523,measure,"Prices for alcoholic beverages (average, US$)"
sa_0000001524,measure,Trend in real price of alcoholic beverages relative to CPI over the past five years
sa_0000001525,measure,Off-premise sales restrictions on days
sa_0000001526,measure,Off-premise sales restrictions on hours
sa_0000001527,measure,Off-premise sales restrictions on places
sa_0000001528,measure,Off-premise sales restrictions on outlet density
sa_0000001529,measure,Off-premise sales restrictions at specific events
sa_0000001530,measure,Off-premise sales restrictions at petrol stations
sa_0000001531,measure,On-premise sales restrictions on days
sa_0000001532,measure,On-premise sales restrictions on hours
sa_0000001533,measure,On-premise sales restrictions on places
sa_0000001534,measure,On-premise sales restrictions on outlet density
sa_0000001535,measure,On-premise sales restrictions at specific events
sa_0000001536,measure,On-premise sales restrictions to intoxicated persons
sa_0000001537,measure,Restrictions on sponsorship of sporting events
sa_0000001538,measure,Restrictions on sponsorship of youth events
sa_0000001539,measure,"Restrictions on sales promotion from producers (parties, events)"
sa_0000001540,measure,Restrictions on sales promotion from retailers (sales below cost)
sa_0000001541,measure,Restrictions on sales promotion from owners of pubs and bars (alcohol for free)
sa_0000001542,measure,Government monopoly on production
sa_0000001543,measure,Government monopoly on retail sales
sa_0000001544,measure,Licence required for production
sa_0000001545,measure,Licence required for retail sales
sa_0000001546,measure,Excise tax as a per cent of the retail price of alcoholic beverages
sa_0000001547,measure,Excise duty (average) per hectolitre in Euros
sa_0000001548,measure,Excise tax as a per cent of the total retail price for 1 litre of pure alcohol
sa_0000001549,measure,Duty paid or excise stamp on alcohol container
sa_0000001550,measure,Excise tax on alcoholic beverages
sa_0000001551,measure,Value-added tax (VAT) on alcohol (%)
sa_0000001552,measure,"Value-added tax (VAT), (%)"
sa_0000001553,measure,Restrictions on alcohol use in public places
sa_0000001554,measure,Health warning labels on alcohol advertising
sa_0000001555,measure,Health warning labels on alcohol containers
sa_0000001651,measure,Monitoring
sa_0000001653,measure,"Treatment, services"
sa_0000001652,measure,"Interventions, projects, training"
sa_0000001647,measure,Awareness activities
sa_0000001648,measure,"Information, education, prevention"
sa_0000001650,measure,"Standard drink measures, in grams per unit"
sa_0000001649,measure,National drinking guidelines
sa_0000001676,measure,Production in 1000s hectolitres
sa_0000001677,measure,Imports in 1000s hectolitres
sa_0000001678,measure,Sales of beer in 1000s hectolitres
sa_0000001679,measure,Exports of beer (barley) in 1000s hectolitres
sa_0000001680,measure,Perceived trend in production
sa_0000001681,measure,Perceived trend in imports
sa_0000001682,measure,Perceived trend in sales
sa_0000001683,measure,Perceived trend in exports
sa_0000001654,measure,"Surveys, research"
sa_0000001655,measure,Counselling
sa_0000001684,measure,Sales of wine in 1000s hectolitres
sa_0000001685,measure,Sales of spirits in 1000s hectolitres
sa_0000001686,measure,Exports of wine (grape) in 1000s hectolitres
sa_0000001687,measure,Exports of spirits in 1000s hectolitres
tb_new_sp,measure,"New cases: Pulmonary, smear-positive"
tb_new_sn,measure,New cases: pulmonary smear-negative
tb_new_su,measure,New cases: pulmonary smear unknown/not done
tb_new_ep,measure,New cases: extrapulmonary
tb_new_oth,measure,New cases: other
tb_ret_rel,measure,Relapse cases (pre-2013 definition)
tb_ret_taf,measure,Retreatment cases: treatment after failure (pulmonary smear and/or culture positive)
tb_ret_tad,measure,Retreatment cases: treatment after default (pulmonary smear and/or culture positive)
tb_ret_oth,measure,Retreatment cases: other
tb_newret_oth,measure,Treatment history unknown
mort_100,measure,Number of deaths
mort_200,measure,Deaths per 1 000 live births
mort_300,measure,Distribution of causes of death among children aged < 5 years (%)
tb_c_lab_sm_100k,measure,Laboratories providing tuberculosis diagnostic services using sputum smear microscopy (per 100 000 population)
tb_c_lab_cul_5m,measure,Laboratories providing tuberculosis diagnostic services using culture (per 5 million population)
tb_c_lab_dst_5m,measure,Laboratories providing drug susceptibility testing (DST) (per 5 million population)
tb_sldst_avail,measure,Second-line drug susceptibility testing (DST) available
tb_nrl,measure,National Reference Laboratory (NRL)
tb_r_rgmn_new_initcont,measure,Rifampicin used throughout treatment
tb_fdc_pcnt,measure,% of patients treated with fixed-dose combinations (FDCs)
tb_paed_form,measure,Paediatric formulations procured for TB patients
tb_c_new_snep_tsr,measure,Treatment success rate for new pulmonary smear-negative and extrapulmonary tuberculosis cases
tb_c_ret_tsr,measure,Treatment success rate: previously treated TB cases
ncd_bmi_25a,measure,"Prevalence of overweight among adults, BMI &GreaterEqual; 25 (age-standardized estimate) (%)"
ncd_bmi_25c,measure,"Prevalence of overweight among adults, BMI &GreaterEqual; 25 (crude estimate) (%)"
ncd_bmi_30a,measure,"Prevalence of obesity among adults, BMI &GreaterEqual; 30 (age-standardized estimate) (%)"
ncd_bmi_30c,measure,"Prevalence of obesity among adults, BMI &GreaterEqual; 30 (crude estimate) (%)"
ncd_bmi_mean,measure,Mean BMI (kg/m&#xb2;) (age-standardized estimate)
ncd_paa,measure,Insufficiently active (age-standardized estimate)
ncd_pac,measure,Insufficiently active (crude estimate)
cc_1,measure,Climate change attributable deaths
cc_2,measure,Climate change attributable DALYs ('000)
cc_3,measure,Climate change attributable deaths per 100'000 capita
cc_4,measure,Climate change attributable DALYs per 100'000 capita
cc_5,measure,Climate change attributable deaths ('000) in children under 5 years
cc_6,measure,Climate change  attributable deaths per 100'000 children under 5 years
cc_7,measure,Climate change attributable DALYs ('000) in children under 5 years
cc_8,measure,Climate change  attributable DALYs per 100'000 children under 5 years
occ_1,measure,Occupational risk factors attributable deaths
occ_2,measure,Occupational risk factors attributable DALYs ('000)
occ_3,measure,Occupational risk factors attributable deaths per 100'000 capita
occ_4,measure,Occupational risk factors attributable DALYs per 100'000 capita
totenv_1,measure,Deaths attributable to the environment
totenv_2,measure,Age-standardized deaths attributable to the environment (per 100 000 population)
totenv_3,measure,Disability-adjusted life years (DALYs) attributable to the environment
totenv_4,measure,Age-standardized DALYs attributable to the environment (per 100 000 population)
totenv_5,measure,Deaths attributable to the environment (%)
totenv_6,measure,Disability-adjusted life years (DALYs) attributable to the environment (%)
totenv_7,measure,Total environment attributable deaths ('000) in children under 5 years
totenv_8,measure,Total environment  attributable deaths per 100'000 children under 5 years
totenv_9,measure,Total environment attributable DALYs ('000) in children under 5 years
totenv_10,measure,Total environment  attributable DALYs per 100'000 children under 5 years
totenv_11,measure,Deaths attributable to the environment in children under 5 years (%)
totenv_12,measure,DALYs attributable to the environment in children under 5 years (%)
uv_1,measure,UV radiation
uv_2,measure,UV radiation attributable deaths
uv_3,measure,UV radiation attributable DALYs ('000)
uv_4,measure,UV radiation attributable deaths per 100'000 capita
uv_5,measure,UV radiation attributable DALYs per 100'000 capita
ncd_ccs_ncdunit,measure,"Existence of Unit, Branch, or Dept. in Ministry of Health with responsibility for NCDs"
ncd_ccs_cvdplan,measure,Existence of operational policy/strategy/action plan for cardiovascular diseases
ncd_ccs_cancerplan,measure,Existence of operational policy/strategy/action plan for cancer
ncd_ccs_diabplan,measure,Existence of operational policy/strategy/action plan for diabetes
ncd_ccs_crdplan,measure,Existence of operational policy/strategy/action plan for chronic respiratory diseases
ncd_ccs_alcplan,measure,Existence of operational policy/strategy/action plan to reduce the harmful use of alcohol
ncd_ccs_dietplan,measure,Existence of operational policy/strategy/action plan to reduce unhealthy diet related to NCDs
ncd_ccs_paplan,measure,Existence of operational policy/strategy/action plan to reduce physical inactivity
ncd_ccs_tobplan,measure,Existence of operational policy/strategy/action plan to decrease tobacco use
ncd_ccs_cancerreg,measure,Existence and scope of cancer registry
ncd_ccs_rfsurv,measure,"Existence of risk factor surveillance for selected risk factors (harmful alcohol use, diet, physical inactivity, and tobacco use)"
ncd_ccs_diabguide,measure,Availability and stage of implementation of guidelines/protocols/standards for the management of diabetes
ncd_ccs_hypguide,measure,Availability and stage of implementation of guidelines/protocols/standards for the management of raised blood pressure / hypertension
ncd_ccs_cervcy,measure,General availability of cervical cytology at the primary health care level
ncd_ccs_aceticacid,measure,General availability of acetic acid visualization at the primary health care level
ncd_ccs_bowelcancer,measure,General availability of colon cancer screening at the primary health care level
ncd_ccs_breastcancer,measure,General availability of breast cancer screening (by palpation or mammogram) at the primary health care level
ncd_ccs_diabetestest,measure,"General availability of diabetes testing (by blood glucose measurement, OGTT, or HbA1c) at the primary health care level"
ncd_ccs_electrocard,measure,General availability of electrocardiogram at the primary health care level
ncd_ccs_cholmsmt,measure,General availability of total cholesterol measurement at the primary health care level
ncd_ccs_spirom,measure,General availability of peak flow measurement spirometry at the primary health care level
ncd_ccs_insulin,measure,General availability of insulin in the public health sector
ncd_ccs_aspirin,measure,General availability of aspirin (100 mg) in the public health sector
ncd_ccs_metformin,measure,General availability of metformin in the public health sector
ncd_ccs_gliben,measure,General availability of glibenclamide in the public health sector
ncd_ccs_thiazide,measure,General availability of thiazide diuretics in the public health sector
ncd_ccs_ace,measure,General availability of ACE inhibitors in the public health sector
ncd_ccs_ccblkrs,measure,General availability of CC blockers in the public health sector
ncd_ccs_betablkrs,measure,General availability of beta blockers in the public health sector
ncd_ccs_tamox,measure,General availability of tamoxifen in the public health sector
ncd_ccs_statins,measure,General availability of statins in the public health sector
ncd_ccs_oralmorph,measure,General availability of oral morphine in the public health sector
ncd_ccs_nicotine,measure,General availability of nicotine replacement therapy in the public health sector
ncd_ccs_salb,measure,General availability of salbutamol in the public health sector
ncd_ccs_prednis,measure,General availability of prednisolone tabs in the public health sector
ncd_ccs_steroid,measure,General availability of steroid inhalers in the public health sector
ncd_ccs_hydrocort,measure,General availability of hydrocortisone injections in the public health sector
ncd_ccs_ipratro,measure,General availability of ipratropium bromide in the public health sector
ncd_ccs_retinalpho,measure,General availability of retinal photocoagulation in the public health system
ncd_ccs_renaltherapy,measure,General availability of renal replacement therapy (by dialysis or transplantation) in the public health system
ncd_ccs_radiotherapy,measure,General availability of radiotherapy in the public health system
ncd_ccs_chemo,measure,General availability of chemotherapy in the public health system
ncd_ccs_collab,measure,Existence of partnerships/collaborations for implementing key activities related to NCDs
ncd_ccs_taxes,measure,Implementation of fiscal interventions to influence behaviour change
ncd_ccs_earmarking,measure,Earmarking of taxes from fiscal interventions to influence behaviour change used to fund health promotion programmes or a health promotion foundation
occ_5,measure,Occupational airborne particulates attributable deaths
occ_6,measure,Occupational airborne particulates attributable DALYs ('000)
occ_7,measure,Occupational airborne particulates attributable deaths per 100'000 capita
occ_8,measure,Occupational airborne particulates attributable DALYs per 100'000 capita
occ_9,measure,Occupational carcinogens attributable deaths
occ_10,measure,Occupational carcinogens attributable DALYs ('000)
occ_11,measure,Occupational carcinogens attributable deaths per 100'000 capita
occ_12,measure,Occupational carcinogens attributable DALYs per 100'000 capita
occ_13,measure,Occupational noise attributable DALYs ('000)
occ_14,measure,Occupational noise attributable DALYs per 100'000 capita
occ_15,measure,Occupational ergonomic stressors attributable deaths
occ_16,measure,Occupational ergonomic stressors attributable DALYs ('000)
occ_17,measure,Occupational ergonomic stressors attributable deaths per 100'000 capita
occ_18,measure,Occupational ergonomic stressors attributable DALYs per 100'000 capita
occ_19,measure,Occupational injuries attributable deaths
occ_20,measure,Occupational injuries attributable DALYs ('000)
occ_21,measure,Occupational injuries attributable deaths per 100'000 capita
occ_22,measure,Occupational injuries attributable DALYs per 100'000 capita
hrh_01,measure,Number of nursing personnel
hrh_02,measure,Number of physicians
hrh_03,measure,Number of midwifery personnel
hrh_04,measure,Number of pharmacists
hrh_05,measure,Number of pharmaceutical technicians/assistants
hrh_06,measure,Number of community health workers
hrh_07,measure,Number of traditional birth attendants
hrh_08,measure,Number of radiographers
hrh_09,measure,Number of other health workers
hrh_10,measure,Number of dental technicians/assistants
hrh_11,measure,Number of health management & support workers
hrh_12,measure,Number of environment and public health workers
hrh_13,measure,Number of laboratory scientists
hrh_14,measure,Number of laboratory technicians/assistants
hrh_15,measure,Number of dentists
hrh_16,measure,Number of traditional medicine practitioners
hrh_17,measure,Number of medical assistants
hrh_18,measure,Number of personal care workers
hrh_19,measure,Number of pharmaceutical personnel
hrh_20,measure,Number of laboratory health workers
hrh_21,measure,Number of dentistry personnel
hrh_22,measure,Number of community and traditional health workers
hrh_23,measure,Number of other health workers
hrh_24,measure,Number of nursing and midwifery personnel
hrh_25,measure,Pharmaceutical personnel density (per 1000 population)
hrh_26,measure,Physicians density (per 1000 population)
hrh_27,measure,Laboratory health workers density (per 1000 population)
hrh_28,measure,Dentistry personnel density (per 1000 population)
hrh_29,measure,Community and traditional health workers density (per 1000 population)
hrh_30,measure,Other health workers density (per 1000 population)
hrh_31,measure,Environmental and public health workers density (per 1000 population)
hrh_32,measure,Health management & support workers density (per 1000 population)
hrh_33,measure,Nursing and midwifery personnel density (per 1000 population)
bp_01,measure,Raised blood pressure (SBP>=140 OR DBP>=90 OR on medication) (crude estimate)
bp_02,measure,Raised blood pressure (SBP>=140 OR DBP>=90 OR on medication) (age-standardized estimate)
bp_03,measure,Raised blood pressure (SBP>=140 OR DBP>=90) (crude estimate)
bp_04,measure,Raised blood pressure (SBP>=140 OR DBP>=90) (age-standardized estimate)
bp_05,measure,Mean systolic blood pressure (crude estimate)
bp_06,measure,Mean systolic blood pressure (age-standardized estimate)
chol_01,measure,Raised total cholesterol (>= 5.0 mmol/L) (crude estimate)
chol_02,measure,Raised total cholesterol (>= 5.0 mmol/L) (age-standardized estimate)
chol_03,measure,Mean Total Cholesterol (age-standardized estimate)
chol_04,measure,Mean Total Cholesterol (crude estimate)
rs_1845,measure,Population
ncd_dth_tot,measure,Total NCD Deaths (in thousands)
ncd_dth_per,measure,"All NCDs, deaths per 100,000 (age-standardized estimate)"
ncd_ca,measure,"Cancers, deaths per 100,000 (age-standardized estimate)"
ncd_chron,measure,"Chronic respiratory diseases, deaths per 100,000 (age-standardized estimate)"
ncd_cardio,measure,"Cardiovascular diseases and diabetes, deaths per 100,000 (age-standardized estimate)"
ncd_under70,measure,NCD deaths under age 70 (percent of all NCD deaths)
chol_05,measure,Raised total cholesterol (&#8805; 6.2 mmol/L) (age-standardized estimate)
chol_06,measure,Raised total cholesterol (&#8805; 6.2 mmol/L) (crude estimate)
whosis_000014,measure,Stillbirth rate (per 1000 total births)
ncd_gluc_01,measure,Mean fasting blood glucose (mmol/l) (age-standardized estimate)
ncd_gluc_02,measure,Mean fasting blood glucose (mmol/l) (crude estimate)
ncd_gluc_03,measure,Raised fasting blood glucose (>= 7.0 mmol/L or on medication) (crude estimate)
ncd_gluc_04,measure,Raised fasting blood glucose (>=7.0 mmol/L or on medication)(age-standardized estimate)
whs6_100,measure,Radiotherapy units (per 1 000 000 population)
ncd_bmi_meanc,measure,Mean BMI (kg/m&#xb2;) (crude estimate)
ntd_1,measure,Number of new reported cases of Buruli ulcer
ntd_2,measure,Dracunculiasis certification status of countries at the beginning of the year
ntd_3,measure,Annual incidence of dracunculiasis cases
ntd_4,measure,Number of new reported cases of human African trypanosomiasis (T.b. gambiense)
ntd_5,measure,Number of new reported cases of human African trypanosomiasis (T.b. rhodesiense)
eq_anc,measure,Coverage of antenatal care (4 visits)
eq_dtp3,measure,Coverage of DTP3 immunization
eq_knhiv,measure,Knowlege about sexual transmission of AIDS
eq_hivprev,measure,HIV prevalence
eq_infantmort,measure,Infant mortality per 1 000 live births
eq_meaimm,measure,Coverage of measles immunization
eq_bmi30,measure,Prevalence of obesity
eq_sba,measure,Coverage of skilled birth attendance
eq_stunt,measure,Prevalence of (moderate or severe) stunting in children
eq_tobacco,measure,Prevalence of current cigarette smoking
eq_u5mort,measure,Under-five mortality per 1 000 live births
eq_urbpop,measure,Population living in urban areas (%)
eq_water,measure,Population using improved drinking-water sources (%)
ntd_6,measure,Status of elimination of trachoma as a public health problem
ntd_7,measure,"Population in areas that warrant treatment with antibiotics, facial cleanliness and environmental improvement for elimination of trachoma as a public health problem"
ntd_8,measure,Number of people who received treatment with antibiotics for trachoma
mening_3,measure,Number of meningitis epidemic districts
sa_0000001688,measure,Total (recorded+unrecorded) alcohol per capita (15+) consumption
eq_urbslum,measure,Slum population in urban areas (% of total population)
mdg_0000000005_age1519,measure,"Contraceptive prevalence, among girls aged 15-19 (%)"
mdg_0000000006_age1519,measure,"Unmet need for family planning, among girls aged 15-19 (%)"
mdg_0000000025_age1519,measure,"Births attended by skilled health personnel, among girls aged 15-19 (%)"
whs4_111_age1519,measure,"Antenatal care coverage - at least one visit, among girls aged 15-19 (%)"
hwws_2,measure,Handwashing with soap after cleaning child's stool (%)
hwws_1,measure,Handwashing with soap after using the toilet (%)
rsud_1,measure,"Point prevalence (%), alcohol use disorders, 15+ years"
rsud_2,measure,"Point prevalence (%), drug use disorders, 15+ years"
rsud_3,measure,"Age-standardized death rates, alcohol and drug use disorders, per 100 000"
rsud_4,measure,"Age-standardized death rates, drug use disorders, per 100 000"
rsud_5,measure,"Age-standardized DALYs, alcohol and drug use disorders, per 100 000"
rsud_6,measure,"Age-standardized DALYs, drug use disorders, per 100 000"
rsud_7,measure,Psychoactive substance causing entry into treatment
sa_0000001689,measure,"Age-standardized DALYs, cerebrovascular disease, per 100,000"
sa_0000001690,measure,"Age-standardized death rates, cerebrovascular disease, per 100,000"
rsud_8,measure,Epidemiological data collection system for substance use disorders
rsud_9,measure,Service delivery data collection system for substance use disorders
rsud_10,measure,National survey on substance use among children and adolescents
rsud_11,measure,Data on substance use disorders disseminated in national annual reports
rsud_12,measure,Substance use policy at the national level
rsud_13,measure,"Substance use policy at the national level, level of integration"
rsud_14,measure,Policy documents on the pharmacological treatment of substance use disorders
rsud_15,measure,Guidelines on the pharmacological treatment of substance use disorders
rsud_16,measure,Legislative provision for treatment and rehabilitation of substance use disorders
rsud_17,measure,Legislative provision for compulsory treatment
rsud_18,measure,Drug courts
rsud_19,measure,Programmes diverting clients from the justice system towards treatment
rsud_20,measure,Confidentiality of health records on substance use disorders  protected by law
rsud_21,measure,Government unit for substance use disorder treatment
rsud_22,measure,Budget line for substance use disorder treatment
rsud_23,measure,Financing method for substance use disorder treatment
rsud_24,measure,"Treatment services for alcohol use disorders, free of charge"
rsud_25,measure,"Treatment services for drug use disorders, free of charge"
rsud_26,measure,Governement benefits for persons with substance use disorders
rsud_27,measure,"Government benefits for alcohol use disorders, subsidy or disability pension"
rsud_28,measure,"Government benefits for drug use disorders, subsidy or disability pension"
rsud_29,measure,Sector for inpatient detoxification of alcohol use disorders
rsud_30,measure,Sector for inpatient treatment of alcohol dependence
rsud_31,measure,Sector for outpatient treatment of alcohol dependence
rsud_32,measure,Sector for the treatment of alcohol-induced psychoses and other alcohol-induced psychiatric conditions
rsud_33,measure,Sector for residential long-term rehabilitation of alcohol use disorders
rsud_34,measure,Sector for inpatient detoxification of drug use disorders
rsud_35,measure,Sector for inpatient treatment of drug dependence
rsud_36,measure,Sector for outpatient treatment of drug dependence
rsud_37,measure,Sector for substitution maintenance therapy of opioid dependence
rsud_38,measure,Sector for residential long-term rehabilitation of drug use disorders
rsud_39,measure,Treatment system for substance use disorders
rsud_40,measure,"Treatment setting for substance use disorders, most common"
air_2_1,measure,Ambient air pollution in urban areas (Annual PM<sub>10</sub> [&#956;g/m<sup>3</sup>])
air_3_1,measure,Percent of urban inhabitants living in cities covered by PM measurements
rsud_41,measure,Specialized treatment services for drug use disoders and HIV/AIDS
rsud_42,measure,Specialized treatment services for substance use disorders and TB
rsud_43,measure,Open access services for substance use disorders
rsud_44,measure,"Treatment slots for alcohol and drug use disorders, outpatient, per 10 000"
rsud_45,measure,"Beds for the treatment of substance use disorders, per 100 000"
rsud_46,measure,"Length of stay for inpatient detoxification, days"
rsud_47,measure,"Length of stay for inpatient short-term treatment, days"
rsud_48,measure,"Length of stay for inpatient long-term residential treatment, days"
cm_01,measure,Number of under-five deaths (thousands)
cm_02,measure,Number of infant deaths (thousands)
cm_03,measure,Number of neonatal deaths (thousands)
ncd_under60,measure,NCD deaths under age 60 (percent of all NCD deaths)
rsud_49,measure,Opioid agonist pharmacotherapy for the treatment of opioid dependence (detoxification or maintenance)
rsud_50,measure,Timeframe of opioid agonist treatment
rsud_51,measure,Methadone used for the treatment of opioid dependence
rsud_52,measure,Methadone used for detoxification or maintenance
rsud_53,measure,Methadone formulation used for the treatment of opiod dependence
rsud_54,measure,Buprenorphine used for the treatment of opioid dependence
rsud_55,measure,Buprenorphine used for detoxification or maintenance
rsud_56,measure,Buprenorphine/naloxone used for the treatment of opioid dependence
rsud_57,measure,Buprenorphine/naloxone used for detoxification or maintenance
rsud_58,measure,Methadone provision in clinical and community-based settings
rsud_59,measure,Buprenorphine provision in clinical and community-based settings
rsud_60,measure,Buprenorphine/naloxone provision in clinical and community-based settings
rsud_61,measure,Supervision requirements for methadone administration
rsud_62,measure,Supervision requirements for buprenorphine administration
rsud_63,measure,Supervision requirements for buprenorphine/naloxone administration
rsud_64,measure,Prescription requirements for methadone
rsud_65,measure,Prescription requirements for buprenorphine
rsud_66,measure,Prescription requirements for buprenorphine/naloxone
rsud_67,measure,Commencement of treatment with opioid agonists
rsud_68,measure,Pharmacotherapy used for the management of alcohol withdrawal
rsud_69,measure,Pharmacotherapy used for the management of benzodiazepine withdrawal
rsud_70,measure,Pharmacotherapy used for the management of cannabis withdrawal
rsud_71,measure,Essential list of medicines
rsud_72,measure,"Essential list of medicines, pharmacotherapy for substance use disorders"
tobacco_0000000526,measure,Anti-tobacco mass media campaigns
tobacco_0000000527,measure,National tobacco control programmes
tobacco_0000000528,measure,Survey age range
tobacco_0000000529,measure,Law mandates that health warnings appear on tobacco packages
tobacco_0000000530,measure,Health warnings on cigarette packaging must be placed at the top of the principal display areas of the package
tobacco_0000000531,measure,Health warnings on cigarette packaging do not remove or diminish the liability of the tobacco industry
tobacco_0000000532,measure,Health warnings on cigarette packaging law applys to products whether manufactured domestically imported AND for duty-free sale
tobacco_0000000533,measure,Health warnings on cigarette packaging must not be obscured in any way including by required markings such as tax stamps
tobacco_0000000534,measure,Health warnings on cigarette packaging law requires or establishes fines for violations
tobacco_0000000535,measure,Cigarette packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors
tobacco_0000000536,measure,Cigarette packaging and labelling must not use descriptors depicting flavours
tobacco_0000000537,measure,Cigarette packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark
tobacco_0000000538,measure,The quit line number must appear on cigarette packaging or labelling
tobacco_0000000539,measure,Plain packaging of cigarettes is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited)
tobacco_0000000540,measure,Law mandates that health warnings appear on smokeless tobacco packages
tobacco_0000000541,measure,Health warnings on smokeless tobacco packaging must be placed at the top of the principal display areas of the package
tobacco_0000000542,measure,Health warnings on smokeless tobacco packaging do not remove or diminish the liability of the tobacco industry
tobacco_0000000543,measure,Health warnings on smokeless tobacco packaging law applys to products whether manufactured domestically imported AND for duty-free sale
tobacco_0000000544,measure,Health warnings on smokeless tobacco packaging must not be obscured in any way including by required markings such as tax stamps
tobacco_0000000545,measure,Health warnings on smokeless tobacco packaging law requires or establishes fines for violations
tobacco_0000000546,measure,Smokeless tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors
tobacco_0000000547,measure,Smokeless tobacco packaging and labelling must not use descriptors depicting flavours
tobacco_0000000548,measure,Smokeless tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark
tobacco_0000000549,measure,The quit line number must appear on smokeless tobacco packaging or labelling
tobacco_0000000550,measure,Plain packaging of smokeless tobacco products is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited)
tobacco_0000000551,measure,At least one national mass media campaign ran during the survey period
tobacco_0000000552,measure,Campaign was part of a comprehensive tobacco control programme
tobacco_0000000553,measure,Campaign was pre-tested
tobacco_0000000554,measure,Formative research was conducted
tobacco_0000000555,measure,Campaign utilized media planning
tobacco_0000000556,measure,Earned media/public relations were used to promote the campaign
tobacco_0000000557,measure,Process evaluation was employed to assess implementation
tobacco_0000000558,measure,Outcome evaluation was employed to assess effectiveness
tobacco_0000000559,measure,Ban on appearance of tobacco brands in TV and/or films (product placement)
nutrition_2005,measure,Proportion of children aged 6-23 months who receive a minimum acceptable diet
nutrition_2006,measure,Minimum dietary diversity (%)
nutrition_2007,measure,Minimum meal frequency (%)
tobacco_0000000560,measure,Most sold brand of cigarettes - price in international dollars
tobacco_0000000561,measure,Cheapest brand of cigarettes - price in international dollars
tobacco_0000000562,measure,Most sold brand of bidis - price in international dollars
tobacco_0000000563,measure,Tobacco excises increased over the survey period
rsud_73,measure,Government unit for substance use disorder prevention
rsud_74,measure,Budget line for substance use disorder prevention
rsud_75,measure,Funding method for substance use disorder prevention
rsud_76,measure,"Prevention activities for substance use disorders, main focus"
rsud_77,measure,Programmes for the prevention of substance use disorders for special populations
rsud_78,measure,Screening and brief interventions for substance use and substance use disorders
rsud_79,measure,Harm reduction programmes for IDUs
rsud_80,measure,Health professionals mostly involved in treatment of substance use disorders
rsud_81,measure,Clinical supervision of health care staff
rsud_82,measure,Standards of care for health professionals
rsud_83,measure,"Standards of care for health professionals, maintenance"
rsud_84,measure,"Standards of care for health professionals, human rights"
rsud_85,measure,NGOs for alcohol use disorders
rsud_86,measure,NGOs for drug use disorders
rsud_87,measure,Self-help groups for substance use disorders
rsud_88,measure,Groups and agencies for the prevention of substance use disorders
mh_1,measure,Mental health policy
mh_2,measure,Mental health plan
mh_3,measure,Stand-alone mental health legislation
mh_4,measure,Government expenditures on mental health as a percentage of total government expenditures on health (%)
mh_5,measure,Government expenditures on mental hospitals as a percentage of total government expenditures on mental health (%)
mh_6,measure,"Psychiatrists working in mental health sector (per 100,000)"
mh_7,measure,"Nurses working in mental health sector (per 100,000)"
mh_8,measure,"Social workers working in mental health sector (per 100,000)"
mh_9,measure,"Psychologists working in mental health sector (per 100,000)"
mh_10,measure,"Mental health outpatient facilities (per 100,000)"
mh_11,measure,"Mental health day treatment facilities (per 100,000)"
mh_12,measure,Age-standardized suicide rates (per 100 000 population)
mh_13,measure,"Beds for mental health in general hospitals (per 100,000)"
mh_14,measure,"Community residential facilities (per 100,000)"
mh_15,measure,"Beds in community residential facilities (per 100,000)"
mh_16,measure,"Beds in mental hospitals (per 100,000)"
rsud_89,measure,Opioid agonist pharmacotherapy for the treatment of opioid dependence (maintenance)
mh_17,measure,"Mental hospitals (per 100,000)"
mh_18,measure,"Mental health units in general hospitals (per 100,000)"
whs4_108,measure,Children aged <5 years with ARI symptoms who took antibiotic treatment (%)
whosis_000015,measure,Life expectancy at age 60 (years)
malaria001,measure,Malaria - number of reported deaths
malaria002,measure,Estimated number of malaria cases
malaria003,measure,Estimated number of malaria deaths
devices01,measure,Total density per 100 000 population: Health posts
devices02,measure,Total density per 100 000 population: Health centres
devices03,measure,Total density per 100 000 population: District/rural hospitals
devices04,measure,Total density per 100 000 population: Provincial hospitals
devices05,measure,Total density per 100 000 population: Specialized hospitals
devices06,measure,Availability of national standards or recommended lists of medical devices
devices07,measure,Types of lists recommending health technology for high burden diseases
devices08,measure,Total density per million population: Magnetic Resonance Imaging
devices09,measure,Total density per million population: Computed tomography units
devices10,measure,Total density per million population: Positron Emission tomography
devices11,measure,Total density per million population: Gamma camera or Nuclear medicine
devices12,measure,Total density per million population: Linear Accelerator
devices13,measure,Type of nomenclature system
devices14,measure,Use of nomenclature system
devices15,measure,Health technology (medical device) national policy
devices16,measure,Unit in the Ministry of Health responsible for the management of medical devices
devices17,measure,Procurement of medical devices carried out at the national level
devices18,measure,Availability of national list of approved medical devices for procurement or reimbursement
devices19,measure,"National guidelines, policies or recommendations on the procurement of medical devices"
devices20,measure,Availability of technical specifications of medical devices to support procurement or donations
devices21,measure,Total density per million population: Telecobalt Unit
devices22,measure,Total density per million population: Radiotherapy units
devices23,measure,Total density per million females aged from 50 to 69 years old: Mammography units
whs4_2530,measure,Postnatal care visit within two days of birth (%)
sa_0000001691,measure,Central coordinating entity for alcohol policy implementation
sa_0000001692,measure,Framework of national alcohol policy
sa_0000001693,measure,Level of adoption of national alcohol policy
sa_0000001694,measure,Sectors represented in national alcohol policy
sa_0000001695,measure,"Cautions and arrests for public drunkenness, per 100,000 population"
sa_0000001696,measure,Alcohol-related road traffic crashes with fatalities (% of all road traffic crashes with fatalities)
whs2_3070_all,measure,"Age-standardized mortality rate by cause (ages 30-70, per 100 000 population) - All causes"
whs2_3070_cancer,measure,"Age-standardized mortality rate by cause (ages 30-70, per 100 000 population) - Cancer"
whs2_3070_cdd,measure,"Age-standardized mortality rate by cause (ages 30-70, per 100 000 population) - Cardiovasular disease and diabetes"
whs2_3070_chronic,measure,"Age-standardized mortality rate by cause (ages 30-70, per 100 000 population) - Chronic respiratory conditions"
whs9_cbr,measure,Crude birth rate (per 1000 population)
whs9_cdr,measure,Crude death rate (per 1000 population)
whs9_cs,measure,Cellular subscribers (per 100 population)
whs10_1,measure,Most recent census (year)
whs10_2,measure,Number of cause-of-death registration years available
whs10_3,measure,Number of national population surveys - child anthropometry
whs10_4,measure,Number of national population surveys - child mortality
whs10_5,measure,Number of national population surveys - maternal mortality
whs10_6,measure,Number of national population surveys -  HIV prevalence
whs10_7,measure,Number of national population surveys -  adult health
whs10_8,measure,Civil registration coverage of cause-of-death (%)
whs10_9,measure,Ill-defined causes in cause-of-death registration (%)
whs10_10,measure,International Statistical Classification of Diseases and Related Health Problems (ICD)
hiv_0000000025,measure,"Testing and counselling facilities, reporting period"
malaria004,measure,Number of under-five deaths from malaria
anc1,measure,Antenatal care coverage - at least one visit (in the two or three years preceding the survey) (%
bcgv,measure,BCG immunization coverage among one-year-olds (%)
cpmo,measure,Contraceptive prevalence - modern methods (%)
cpmt,measure,Contraceptive prevalence - modern and traditional methods (%)
dptv,measure,DTP3 immunization coverage among one-year-olds (%)
ebreast,measure,Early initiation of breastfeeding (in the two or three years preceding the survey) (%)
famplan,measure,Family planning needs satisfied (%)
full,measure,Full immunization coverage among 1-year-olds (%)
itnchild,measure,Children aged <5 years sleeping under insecticide-treated nets (%)
measlesv,measure,Measles (MCV) immunization coverage among 1-year-olds (%)
ort,measure,Children aged < 5 years with diarrhoea receiving oral rehydration therapy and continued feeding (%)
pneumcare,measure,Children aged <5 years with ARI symptoms taken to facility (%)
poliov,measure,Polio immunization coverage among one-year-olds (%)
sba,measure,Births attended by skilled health personnel (in the two or three years preceding the survey) (%)
stunt,measure,Children aged <5 years stunted (%)
uweight,measure,Children aged <5 years underweight (%)
vita,measure,Children aged 6-59 months who received vitamin A supplementation (%)
anc13,measure,Antenatal care coverage - at least one visit (in the three years preceding the survey) (%)
anc15,measure,Antenatal care coverage - at least one visit (in the five years preceding the survey) (%)
anc43,measure,Antenatal care coverage - at least four visits (in the three years preceding the survey) (%)
anc45,measure,Antenatal care coverage - at least four visits (in the five years preceding the survey) (%)
csection3,measure,Births by caesarean section (in the three years preceding the survey) (%)
csection5,measure,Births by caesarean section (in the five years preceding the survey) (%)
ebreast3,measure,Early initiation of breastfeeding (in the three years preceding the survey) (%)
ebreast5,measure,Early initiation of breastfeeding (in the five years preceding the survey) (%)
itnpreg,measure,Pregnant women sleeping under insecticide-treated nets (%)
obese,measure,"Prevalence of obesity in non-pregnant women aged 15 - 49 years, BMI >=  30 (%)"
pncall3,measure,Postnatal care visit within two days of birth (in the three years preceding the survey) (%)
pncall5,measure,Postnatal care visit within two days of birth (in the five years preceding the survey) (%)
pnchome3,measure,Postnatal care visit within two days of birth - born outside a health facility (in the three years preceding the survey) (%)
pnchome5,measure,Postnatal care visit within two days of birth - born outside a health facility (in the five years preceding the survey) (%)
sba3,measure,Births attended by skilled health personnel (in the three years preceding the survey) (%)
sba5,measure,Births attended by skilled health personnel (in the five years preceding the survey) (%)
stunt3,measure,Stunting prevalence in children aged < 3 years (%)
stunt5,measure,Stunting prevalence in children aged < 5 years (%)
uweight3,measure,Underweight prevalence in children aged < 3 years (%)
uweight5,measure,Underweight prevalence in children aged < 5 years (%)
asfr1,measure,Adolescent fertility rate (per 1000 women aged 15-19 years)
tfr,measure,Total fertility rate (per woman)
cmr,measure,Child mortality rate (probability of dying between age 1 and age 5 per 1000 live births)
imr,measure,Infant mortality rate (deaths per 1000 live births)
nmr,measure,Neonatal mortality rate (deaths per 1000 live births)
pnmr,measure,Postneonatal mortality rate (probability of dying between age 30 days and 11 months per 1000 live births)
u5mr,measure,Under-five mortality rate (deaths per 1000 live births)
sa_0000001697,measure,"Adopted written national policy on alcohol, year adopted"
sa_0000001698,measure,"Adopted written national policy on alcohol, year revised"
sa_0000001699,measure,Age limits off-premise sales
sa_0000001700,measure,Consumer information on alcohol and health at points of sale
sa_0000001701,measure,Educational programmes involving target groups in school curriculum
sa_0000001702,measure,Brief interventions as health promotion/disease prevention
sa_0000001703,measure,Server training on a regular basis
sa_0000001704,measure,Data collection on alcohol-related health indicators
sa_0000001705,measure,System for monitoring alcohol-related harm
sa_0000001706,measure,National treatment policy for alcohol use disorders
sa_0000001707,measure,Persons with alcohol use disorders receiving treatment (%)
sa_0000001708,measure,Designation of alcohol tax revenues to health services
sa_0000001709,measure,National surveys on drink-driving
sa_0000001710,measure,Public-funded alcohol research/monitoring programmes
sa_0000001711,measure,"Public funds designated for alcohol research/monitoring programmes, in Euros"
sa_0000001712,measure,Community-based interventions/projects involving stakeholders
sa_0000001713,measure,Interventions/projects actively involving young people and civil society
sa_0000001714,measure,Training in screening and brief interventions for alcohol problems
sa_0000001715,measure,Counselling to children in families with alcohol problems
sa_0000001716,measure,Counselling to pregnant women with alcohol problems
sa_0000001717,measure,Prevention/counselling at workplaces for those with alcohol problems
meds201110200,measure,Total Pharmaceutical Expenditure (millions US$)
meds201120200c,measure,Total Pharmaceutical Expenditure per capita (US$)rate)
meds2011400c,measure,Share of Total Pharmaceutical Expenditure in Total Health Expenditure (%)
meds2011600c,measure,Share of Public Pharmaceutical Expenditure in Total Pharmaceutical Expenditure (%)
meds201170200c,measure,Public Pharmaceutical Expenditure per capita (US$)
meds2020200c,measure,Density of pharmacists (per 10 000 population)
meds3010400,measure,Presence of National Medicines Policy
meds3010700,measure,Presence of National Medicines Policy implementation plan
meds3011000,measure,Right of access to essential medicines
meds5010200,measure,Existence of formal Medicines Regulatory Authority
meds5010700,measure,Website of the formal Medicines Regulatory Authority
meds5020100,measure,Market Authorization for all pharmaceutical products required
meds5021700s,measure,Registration Fee pharmaceutical containing New Chemical Entity
meds5021800s,measure,Registration Fee generic pharmaceutical product
meds5030200,measure,Inspectors are allowed to inspect premises where pharmaceutical activities are performed
meds5050200,measure,Pharmaceutical manufacturers must comply with Good Manufacturing Practices
meds5050900,measure,Licensing private pharmacies obligatory
meds5060200,measure,National Quality Control Laboratory exists
meds5070100,measure,Legal provisions control promoting and advertising of prescription medicine
meds5070300,measure,Ban on Direct to Consumer Pharmaceutical Advertising
meds5080100,measure,Legal provisions exist requiring authorization for conducting Clinical Trials by the MRA
meds5090300,measure,Annual consumption of Morphine (mg/capita)
meds5100400,measure,National pharmacovigilance centre linked to the MRA exists
meds6010102,measure,Children <5 years receive free medicines
meds6010103,measure,Pregnant women receive free medicines
meds6010201,measure,All medicines included in the EML
meds6010300,measure,Social (health) fund is providing at least partial medicine coverage
meds6030100,measure,System in place to monitor prices of medicines
meds6060100,measure,Duties on imported active pharmaceutical ingredients
meds6060200,measure,Duties on imported finished pharmaceutical products
meds6060300,measure,Value Added Tax is levied on finished pharmaceuticals products
meds7010400,measure,Public sector tender awards are publicly available
meds7020900s,measure,Availability of key medicines at the Central Medical Store in percentage (%)
meds8010100,measure,National Essential Medicine List exists
meds8010200,measure,Standard Treatment Guidelines for common illnesses are made by Ministry of Health
meds8010500,measure,National Standard Treatment Guidelines specific to paediatric conditions exist
meds8010800,measure,National Medicines Information Center provides information on medicines
meds8011200,measure,Existence of National strategy to contain antimicrobial resistance
meds8021201,measure,Public sector
meds8021202,measure,Private sector
meds8030400,measure,Substitution of generic equivalents at the point of dispensing in public sector facilities is allowed
meds8030500,measure,Substitution of generic equivalents at the point of dispensing in private sector facilities is allowed
meds3011302,measure,For the pharmaceutical sector
meds5020600,measure,Number of registered pharmaceutical products
meds5100800,measure,Number of reports submitted in the last two year by the pharmacovigilance centre
meds4020300,measure,Market share of domestic manufacturers (%)
meds2012100s,measure,Market share of generic pharmaceuticals by value (%)
nhabasis,measure,Basis for NHA estimate
perctestedanc,measure,Women accessing antenatal care (ANC) services who were tested for syphilis (%)
percposanc,measure,Antenatal care attendees who were positive for syphilis (%)
percpossw,measure,Sex workers with active syphilis (%)
percposmsm,measure,Men who have sex with men (MSM) with active syphilis (%)
hiv_0000000026,measure,Number of new HIV infections
ncdmort3070,measure,"Probability (%) of dying between age 30 and exact age 70 from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease"
rs_239,measure,Reported % of seriously injured patients transported by ambulance
rs_240,measure,Training in medical emergency - available for doctors
rs_241,measure,Training in medical emergency - available for nurses
malaria005,measure,Malaria incidence per 100 000 population
whs_pbr,measure,Preterm birth rate (per 100 live births)
gbd_asdr,measure,Age-standardized death rates (per 100 000 population)
meds1_01_01,measure,Population
meds1_02_01,measure,Life Expectancy M
meds1_02_02,measure,Life Expectancy F
meds1_02_04,measure,Under 5 Mortality
meds1_02_03,measure,Infant mortality
meds1_01_03,measure,GDP
meds1_01_05,measure,Gross domestic product per capita
meds1_02_11,measure,NCD mortality rate
meds1_02_12,measure,CVD and Diabetes  mortality rate
meds1_02_13,measure,Cancer  mortality rate
meds1_02_15,measure,TB mortality rate
meds1_02_16,measure,Malaria mortality rate
meds1_02_14,measure,HIV mortality rate
meds2_01_01_02,measure,THE
meds2_01_03_02,measure,THE per capita
meds2_01_04_02,measure,Public Health Expenditure
meds2_01_07_02,measure,Public Health Expenditure per capita
meds2_01_05,measure,Public Health Expenditure as a % of Government Expenditure
meds2_01_06,measure,Public Health Expenditure of a % of THE
meds,measure,OOP as a % of THE
meds2_01_08,measure,Private Health Expenditure % of THE
meds2_01_24,measure,OOP as a % of Private Health Expenditure
meds2_01_26,measure,Premiums for private health plans as a % of private health expenditure
meds2_01_10,measure,Population covered by private health insurance
meds2_01_09,measure,Population covered by a public health service orr insurance plan
meds2_01_11_02,measure,Total pharmaceutical expenditure
meds2_01_14,measure,Share of total pharmaceutical expenditure in total health expenditure (%)
meds2_01_13,measure,Share of total pharmaceutical expenditure in gross domestic product (%)
meds2_01_12_02,measure,Total pharmaceutical expenditure per capita
meds2_01_15_02,measure,Share of public pharmaceutical expenditures in total pharmaceutical expenditures (US$)
meds2_01_18_02,measure,Private TPE
meds2_01_21,measure,Market share of generic pharmaceuticals by value (%)
meds2_02_01,measure,Pharmacists
meds2_02_02,measure,Density of pharmacist (per 10.000)
meds3_01_01,measure,Presence of National Health Policy
meds3_01_02,measure,NHP Implementation plan exists
meds3_01_04,measure,Presence of national medicines policy
meds3_01_07,measure,Presence of national medicines policy implementation plan
meds3_01_12_01,measure,Pharmaceutical policy implementation is regularly monitored
meds3_01_08,measure,Presence of National Clinical Laboratory Policy
meds3_01_09,measure,NCLP implementation plan exists
meds3_01_10,measure,Right of access to essential medicines
meds3_01_13,measure,Presence of national good governance policy
meds3_01_11,measure,Official guidelines on medicine donations exist
meds3_01_14,measure,Policy to manage conflict of interest issues
meds3_01_15,measure,Formal code of conduct for public officials
meds3_01_16,measure,Whistle Blowing mechanism
meds4_01_02_01,measure,Legal provision for granting patents on: Pharmaceuticals
meds4_01_02_02,measure,Legal provision for granting patents on: Laboratory Supplies
meds4_01_02_03,measure,Legal provision for granting patents on: Medical Supplies
meds4_01_02_04,measure,Legal provision for granting patents on: Medical Equipment
meds4_01_04,measure,TRIPS legislated through national legislation
meds4_01_06,measure,Trasitional period eligibility
meds4_01_07_01,measure,Compulsory Licensing
meds4_01_07_02,measure,Bolar exemption
meds4_01_08,measure,Parallel importing
meds4_01_10,measure,Legal provisions related to: Data exclusivity
meds4_01_11,measure,Legal provisions related to: Patent Extension
meds4_01_12,measure,Legal provisions for the linkage between patent status and market authorization
meds4_02_01,measure,Number of licensed pharmaceutical manufacturers
meds4_02_02_01,measure,Manufacturing capacity: R&D new API
meds4_02_02_02,measure,Manufacturing capacity: Production API
meds4_02_02_03,measure,Manufacturing capacity: Production formulations
meds4_02_02_04,measure,Manufacturing capacity: Repackaging of finished dose forms
meds4_02_03,measure,Market share of domestic manufacturers by value (%)
meds4_02_05,measure,Market share of domestic manufactures by volume (%)
meds5_01_01,measure,Legal provisions for establishing MRA
meds5_01_02,measure,Formal medicines regulatory authority exists
meds5_01_04_01,measure,MRA part of MoH
meds5_01_04_02,measure,MRA semi-autonomous
meds5_01_07,measure,Medicines regulatory authority has it own website
meds5_01_08,measure,MRA receives external technical assistance
meds5_01_09,measure,MRA involved in harmonization / collaboration activities
meds5_01_10,measure,Assessment of medicines regulatory system conducted in last 5 years
meds5_01_15,measure,RA uses computerized information management system
meds5_01_05_01,measure,Function of MRA: Market Authorization
meds5_01_05_02,measure,Function of MRA: Inspection
meds5_01_05_03,measure,Function of MRA: Import Control
meds5_01_05_04,measure,Function of MRA: Licensing
meds5_01_05_05,measure,Function of MRA: Market control
meds5_01_05_06,measure,Function of MRA: Quality control
meds5_01_05_07,measure,Function of MRA: Advertising
meds5_01_05_08,measure,Function of MRA: Clinical trials
meds5_01_05_09,measure,Function of MRA: Pharmacovigilance
meds5_01_11,measure,Funding of MRA: Government
meds5_01_12,measure,Funding of MRA: Fees for service
meds5_01_13,measure,Funding of MRA: Other funding
meds5_01_14,measure,Funding of MRA: Revenues derived from RA kept in RA
meds5_02_01,measure,Market authorization for all pharmaceutical products is required
meds5_02_02,measure,Mechnaisms for exceptions / waiver of registration
meds5_02_03,measure,Mutual recognition
meds5_02_04,measure,Public transparency of criteria for MA application assessment
meds5_02_05,measure,WHO prequalification programme information used for product registration
meds5_02_06,measure,Number of registered pharmaceuticals
meds5_02_07,measure,List of pharmaceuticals with defined periodicity required to be publicly available
meds5_02_08,measure,Medicines registration includes INN
meds5_02_09,measure,Fee required for Marketing Authorization applications
meds5_02_17,measure,Fee for pharmaceuticals containing new chemical entity
meds5_02_18,measure,Registration fee generic pharmaceutical product
meds5_03_01,measure,Legal provisions for the appointment of government pharmaceutical officials
meds5_03_02,measure,Inspectors are allowed to inspect premises where pharmaceutical activities are performed
meds5_03_03_01,measure,Inspection a pre-requisite for licensing of: Public
meds5_03_03_02,measure,Inspection a pre-requisite for licensing of: Private
meds5_03_04,measure,Inspection requirements the same for public and private facilities
meds5_03_05_01,measure,Local manufacturers - GMP compliance
meds5_03_05_02,measure,Private Wholesalers
meds5_03_05_03,measure,Retail distributors
meds5_03_05_04,measure,Public pharmacies and stores
meds5_03_05_05,measure,Pharmacies and dispensing points of health facilities
meds5_04_01,measure,Authorization to import medicines required
meds5_04_02,measure,Sampling of imported products for testing permitted
meds5_04_03,measure,Importation of medicines through authorized ports of entry
meds5_04_04,measure,Inspection of pharmaceutical products at authorized ports of entry permitted
meds5_05_02,measure,Pharmaceutical manufacturers must comply good manufacturing practices
meds5_05_01,measure,Licensing required for: Manufacturers
meds5_05_04,measure,Licensing required for: Importers
meds5_05_05,measure,Licensing required for: Wholesalers
meds5_05_09,measure,Licensing private pharmacies obligatory
meds5_05_10,measure,Licensing required for: public pharmacies
meds5_05_06,measure,Wholesalers and distributors to comply with Good Distribution Practices
meds5_05_08,measure,Pharmacists to be registered
meds5_05_03,measure,Good Manufacturing Practices (GMP) published
meds5_05_07,measure,National Good Distribution Practice requirements published
meds5_05_11,measure,National Good Pharmacy Practice Guidelines published
meds5_05_12,measure,List of all licensed pharmaceutical facilities (publication legally required)
meds5_06_01,measure,Legislation supports Pharmaceutical market regulation
meds5_06_02,measure,Quality control testing laboratory is available
meds5_06_02_01,measure,Quality control laboratory is part of medication regulatory authority
meds5_06_02_02,measure,Testing services contracted out by regulatory authority
meds5_06_04_01,measure,For quality monitoring in public sector (pharmacy stores and health facilities)
meds5_06_04_02,measure,For quality monitoring in private sector (retail outlets)
meds5_06_04_03,measure,When there are complaints / problems
meds5_06_04_04,measure,For product registration
meds5_06_04_05,measure,For public procurement prequalification
meds5_06_04_06,measure,For public program products prior to acceptance and/or distribution
meds5_06_06,measure,Number of quality control samples tested in past two years
meds5_06_07,measure,Number of samples that failed the testing in two years
meds5_07_01,measure,Legal provisions control promoting and advertising of prescription medicine
meds5_07_03,measure,Ban on direct to consumer pharmaceutical advertising
meds5_07_04,measure,Pre-approval for medicines advertisements and promotional materials  required
meds5_07_05,measure,Guidelines for advertising and promotion of non-prescription medicines
meds5_07_06,measure,Code of conduct for advertising by MA holders exists and is publicly available
meds5_07_06_01,measure,Code of conduct applies to: Both
meds5_07_06_02,measure,Voluntary adherence to code
meds5_07_06_03,measure,Code contains formal process for complaints and sanctions
meds5_07_06_04,measure,Up to date list of complaints and sanctions publicly available
meds5_08_01,measure,Legal provisions exist requiring authorization for conducting clinical trials by the medical regulatory authority
meds5_08_02,measure,Clinical Trials require ethics committee/institutional review board approval
meds5_08_03,measure,Registration of clinical trials in international/national/regional registry
meds5_09_01_01,measure,"Single convention on narcotic drugs, 1961"
meds5_09_01_02,measure,"The 1972 protocol amending the single convention on narcotic drugs, 1961"
meds5_09_01_03,measure,"Convention on psychotropic substances, 1971"
meds5_09_01_04,measure,"United nations convention against the illicit traffic in narcotic drugs and psychotropic substances, 1988"
meds5_09_02,measure,"Laws for the control of narcotic and psychotropic substances, and precursors exist"
meds5_09_03,measure,Annual morphine consumption (mg/capita)
meds5_10_01,measure,PV activities legally established within MRA mandate
meds5_10_02,measure,MA holders required to continuously monitor safety of products and report to MRA
meds5_10_03,measure,Legal provisions for monitoring of ADR exist
meds5_10_04,measure,National pharmacovigilance center linked to the medicines regulatory authority
meds5_10_04_02,measure,Number of reports submitted in the last two years by the national pharmacovigilance center
meds5_10_04_03,measure,NPC publishes ADR bulletin
meds5_10_07,measure,No. of ADRs on database
meds5_10_08,measure,Number of reports of adverse drug reactions submitted in the last two years by the national pharmacovigilance center
meds5_10_09_01,measure,No. of ADRs submitted to Uppsala database
meds6_01_01_01,measure,Patients who cannot afford them received free medicines
meds6_01_01_02,measure,Children under 5 receive free medicines
meds6_01_01_03,measure,Pregnant women receive free medicines
meds6_01_01_04,measure,Elderly  received free medicines
meds6_01_02_01,measure,All essential medicines are free
meds6_01_02_02,measure,Free medicines for any non communicable diseases
meds6_01_02_03,measure,Free medicines for Malaria
meds6_01_02_04,measure,Free medicines for TB
meds6_01_02_05,measure,Free medicines for STD
meds6_01_02_06,measure,Free medicines for HIV
meds6_01_02_07,measure,Free vaccines for EPI
meds6_01_03,measure,National or social health insurance providing at least partial medicines coverage
meds6_01_03_01,measure,Providing medicines that are on the Essential Medicines List for inpatients
meds6_01_03_02,measure,Providing medicines that are on the Essential Medicines List for outpatients
meds6_01_04,measure,Private health insurance schemes provide medicines coverage
meds6_01_04_01,measure,Private health insurance provides coverage for medicines which are on the EML
meds6_02_01,measure,Co-payments/ fee requirements for consultations
meds6_02_02,measure,Co-payments/ fee requirements for medicines
meds6_03_01,measure,Medicine pricing regulations
meds6_03_01_01,measure,Pricing provisions aimed at: Manufacturers
meds6_03_01_02,measure,Pricing provisions aimed at: Wholesalers
meds6_03_01_03,measure,Pricing provisions aimed at: Retailers
meds6_06_01,measure,Duties on active pharmaceutical ingredients
meds6_06_02,measure,Duties on finished pharmaceutical products
meds6_06_03,measure,Value added taxes on pharmaceutical products
meds6_06_07,measure,Duty rate on active pharmaceutical ingredients
meds6_06_08,measure,Duty rate on finished pharmaceutical products
meds6_06_09,measure,Value added taxes rate
meds6_02_03,measure,Revenues from fees used to pay salaries of health workers
meds7_01_01_01,measure,Public sector procurement is decentralized
meds7_01_01_02,measure,Public sector procurement is decentralized and centralized
meds7_01_02_01,measure,Public sector procurement is the reponsibility of procurement agency that is part of MOH
meds7_01_02_02,measure,Public sector procurement is the reponsibility of procurement agency that is semi autonomous
meds7_01_02_03,measure,Public sector procurement is the reponsibility of procurement agency that is  autonomous
meds7_01_02_04,measure,A government procurement agency procures all public goods
meds7_01_03,measure,Public sector requests for tender documents are publicly available
meds7_01_04,measure,Public sector awards are publicly available
meds7_01_05,measure,Procurement is based on prequalification of suppliers
meds7_02_01,measure,The government supply system department has a central medical store
meds7_02_03,measure,There are national guidelines on Good Distribution Practices
meds7_02_04,measure,There is a licensing authority that issues GDP licenses
meds7_02_04_01,measure,The licensing authority accredits public distribution facilities
meds7_02_05,measure,A list of GDP certified warehouses in the public sector exists
meds7_02_06,measure,A list of GDP certified distributors in the public sector exists
meds7_02_09,measure,Availability of key medicines at the central medical store
meds7_03_01,measure,Legal provisions exist for licensing wholesales in private sector
meds7_03_02,measure,Legal provisions exist for licensing distributors in private sector
meds7_03_03,measure,A list of GDP certified wholsesalers in the private sector exists
meds7_03_04,measure,A list of GDP certified distributors in the private sector exists
meds8_02_08_01,measure,Core medical training includes: concept of EML
meds8_02_08_02,measure,Core medical training includes: Use for STGS
meds8_02_08_03,measure,Core medical training includes: Pharmacovigilance
meds8_02_08_04,measure,Core medical training includes: Problem based pharmacotherapy
meds8_02_09,measure,Mandatory continuing education that includes pharmaceutical issues is required for doctors
meds8_02_10,measure,Mandatory continuing education that includes pharmaceutical issues is required for nurses
meds8_02_11,measure,Mandatory continuing education that includes pharmaceutical issues is required for paramedical staff
meds8_02_12_01,measure,Public sector generic prescribing is obligatory
meds8_02_12_02,measure,Private sector generic prescribing is obligatory
meds8_03_02_01,measure,Core pharmacist training includes: EML
meds8_03_02_02,measure,Core pharmacist training includes: Use of  STG
meds8_03_02_03,measure,Core pharmacist training includes: drug information
meds8_03_02_04,measure,Core pharmacist training includes: clinical pharmacology
meds8_03_02_05,measure,Core pharmacist training includes: medicines supply management
meds8_03_04,measure,Generic substitution permitted in public sector
meds8_03_05,measure,Generic substitution permitted in private sector
meds8_03_06,measure,Antibiotics are sometimes sold OTC without prescription
meds8_03_07,measure,Injectables are sometimes sold OTC without prescription
meds8_01_08,measure,National medicines information center exists
meds8_01_09,measure,Public education campaigns on rational medicine use topics have been conducted in previous two years
meds8_01_10,measure,A survey on rational medicine use has been conducted in the previous two years
meds8_01_11,measure,A national committee exists to monitor and promote rational use of medicines
meds8_01_12,measure,National strategy to contain antimicrobial resistance exists
meds8_01_18,measure,Existence of a funded national intersectoral taskforce to coordinate the promotion of appropriate use of antimicrobials
meds8_01_19,measure,A national reference lab has responsibility for coordinating epidemiological surveillance of AMR
meds8_02_01,measure,Legal provisions exist to govern the licensing and prescribing practices of prescriber
meds8_02_02,measure,Legal provisions exist to restrict dispensing by prescribers
meds8_02_03,measure,Prescribers in the private sector dispense medicine
meds8_02_04,measure,Regulations require hospitals to organize/develop DTCs
meds8_02_05,measure,More than half of referral hospital have a DTC
meds8_02_06,measure,More than half of general hospitals have a DTC
meds8_02_07,measure,More than half of regions/provinces have a DTC
meds8_02_13,measure,Average number of medicines prescribed per patient contact in public health facilities
meds8_02_15,measure,Percentage of medicines in outpatient public health care facilities that are prescribed by INN name
meds8_02_16,measure,Percentage of patients in outpatient public health care facilities receiving antibiotics
meds8_02_17,measure,Percentage of patients in outpatient public health care facilities receiving injections
meds8_02_19,measure,Percentage of medicines adequately labelled in public health facilities
meds8_02_23,measure,Diarrhoea in children treated with ORS
meds8_03_10_01,measure,Nurses sometimes prescribe prescription-only medicines
meds8_03_10_02,measure,Pharmacists sometimes prescribe prescription-only medicines
meds8_03_10_03,measure,Paramedics sometimes prescribe prescription-only medicines
meds8_03_10_04,measure,Personnel with less than one month training sometimes prescribe prescription-only medicines
meds8_03_01,measure,Legal provisions exist to govern dispensing practices of pharmaceutical personnel
meds8_01_01_01,measure,Number of medicines on essential medicines list
meds8_01_01_02,measure,Written process for selecting medicines on the EML
meds8_01_01_03,measure,Written process is publicly available
meds8_01_01_04,measure,Mechanism to align EML and STG
meds8_01_02,measure,Standard treatment guidelines for common illnesses produced by the ministry of health
meds8_01_03,measure,STG specific to primary care exists
meds8_01_04,measure,STG specific to secondary care exists
meds8_01_05,measure,National standard treatment guidelines for children
meds8_01_06,measure,% of public health facilities with copy EML (mean)
meds8_01_07,measure,% of public health facilities with copy STG (mean)
meds8_01_14,measure,EML includes formulations specific for children
meds8_01_15,measure,There are explicitly documented criteria for the selection of medicines on the EML
meds8_01_16,measure,There is a formal committee for the selection of products on the EML
meds8_01_16_01,measure,Conflict of interest declarations are required from members of national EML committee
meds8_01_17,measure,National medicines formulary exists
meds8_02_14,measure,% of medicines prescribed in outpatient public health care facilities that are on the EML
meds8_03_03,measure,Mandatory continuing education that includes rational use of medicines is required for pharmacists
mort_500,measure,Number of deaths
mort_400,measure,Deaths per 100 000 population
cco_1,measure,Poverty headcount ratio at $1.25 a day (PPP) (% of population)
cco_2,measure,Human development index rank
cco_3,measure,Gender inequality index rank
meds2_01_15_02_01,measure,Share of public pharmaceutical expenditures in total pharmaceutical expenditures (%)
meds0_0_0,measure,Generic
meds8_01_12_01,measure,AMR strategy has been updated in 2010 or later
meds8_01_01,measure,Essential medicines list exists
nutoverweightprev,measure,Overweight prevalence
nutoverweightnum,measure,Overweight numbers (in millions)
nutsevwastingprev,measure,Wasting prevalence
nutsevwastingnum,measure,Wasting  numbers (in thousands)
nutstuntingprev,measure,Stunting prevalence
nutstuntingnum,measure,Stunting  numbers (in millions)
nutunderweightprev,measure,Underweight prevalence
nutunderweightnum,measure,Underweight  numbers (in millions)
nutwastingprev,measure,Wasting prevalence
nutwastingnum,measure,Wasting  numbers (in millions)
rhr_ipv,measure,Intimate partner violence prevalence among ever partnered women (%)
rhr_npsv,measure,Non-partner sexual violence prevalence (%)
organpop,measure,Population (millions)
organkidneynum,measure,Kidney transplants (absolute number)
organkidneyrate,measure,Kidney transplants (per million)
organlivernum,measure,Liver transplants (absolute number)
organliverrate,measure,Liver transplants (per million)
organtotalnum,measure,Total organs transplanted (absolute number)
organtotalrate,measure,Total organs transplanted (per million)
organtotaldecnum,measure,Total actual deceased donors (absolute number)
organtotaldecrate,measure,Total actual deceased donors (per million)
m_group,measure,Monitor
p_group,measure,P_Group
o_group,measure,Offer help to quit tobacco use
w_group,measure,Warn about the dangers of tobacco
w-mm_group,measure,Anti-tobacco mass media campaigns
e_group,measure,E Group
r_group,measure,Raise taxes on tobacco
m_est_tob_curr,measure,"Current tobacco smoking, age-standardised"
m_est_tob_daily,measure,"Daily tobacco smoking, age-standardised"
m_est_cig_curr,measure,"Current cigarette smoking, age-standardised"
m_est_cig_daily,measure,"Daily cigarette smoking, age-standardised"
m_svy_yr_adult,measure,Year of latest adult prevalence survey
m_survey_title_adult,measure,Name of survey of adults
m_svy_national_adult,measure,Representativeness of survey of adults
m_svy_age_adult,measure,Adult survey age range
m_def_1_text_adult,measure,Adult indicator 1 definition
m_def_1_prev_adult,measure,Adult indicator 1 rate
m_def_2_text_adult,measure,Adult indicator 2 definition
m_def_2_prev_adult,measure,Adult indicator 2 rate
m_smkless_svy_yr_adult,measure,Year of survey of adults - smokeless
m_smkless_survey_title_adult,measure,Name of survey of adults - smokeless
m_smkless_svy_national_adult,measure,Representativeness of survey of adults - smokeless
m_smkless_age_range_adult,measure,Adult survey age range - smokeless
m_smkless_def_text_adult,measure,Adult smokeless tobacco use indicator definition
m_smkless_prev_adult,measure,Adult smokeless tobacco use indicator rate
m_svy_yr_youth,measure,Year of survey of youth
m_survey_title_youth,measure,Name of survey of youth
m_svy_national_youth,measure,Representativeness of youth survey
m_svy_age_youth,measure,Youth survey age range
m_def_1_text_youth,measure,Youth indicator 1 definition
m_def_1_prev_youth,measure,Youth indicator 1 rate
m_def_2_text_youth,measure,Youth indicator 2 definition
m_def_2_prev_youth,measure,Youth indicator 2 rate
m_smkless_svy_yr_youth,measure,Year of survey of youth - smokeless
m_smkless_survey_title_youth,measure,Name of survey of youth - smokeless
m_smkless_svy_national_youth,measure,Representativeness of survey of youth - smokeless
m_smkless_age_range_youth,measure,Youth survey age range - smokeless
m_smkless_def_text_youth,measure,Youth smokeless tobacco use indicator definition
m_smkless_prev_youth,measure,Youth smokeless tobacco use indicator rate
p1_healthcare,measure,National smoking ban in HEALTH-CARE FACILITIES
p2_education,measure,National smoking ban in EDUCATIONAL FACILITIES EXCEPT UNIVERSITIES
p3_universities,measure,National smoking ban in UNIVERSITIES
p4_govt,measure,National smoking ban in GOVERNMENT FACILITIES
p5_indoor_off,measure,National smoking ban in INDOOR OFFICES
p6_restaurants,measure,National smoking ban in RESTAURANTS
p7_pubs,measure,National smoking ban in PUBS AND BARS
p8_pub_transp,measure,National smoking ban in PUBLIC TRANSPORT
p9_all_other,measure,National smoking ban in ALL OTHER INDOOR PUBLIC PLACES
pc_sfe_compliance,measure,Compliance with regulations on smoke-free environments (national legislation)
p_count_places_sf,measure,National smoking ban: NUMBER OF PLACES SMOKE-FREE
p11_fines_any,measure,National smoking ban: FINES FOR VIOLATIONS
p12_fines_establishment,measure,National smoking ban: FINES ON THE ESTABLISHMENT
p13_fines_smoker,measure,National smoking ban: FINES ON THE PATRON
p14_funds_for_enforce,measure,National smoking ban: DEDICATED FUNDS FOR ENFORCEMENT
p15_complaints,measure,National smoking ban: CITIZEN COMPLAINTS AND INVESTIGATIONS
p10_subnat_auth_exists,measure,Subnational smoking bans - authority exists
p_subnat_complete_ban_exists,measure,Comprehensive bans in place subnationally
o_quitline,measure,Access to a toll-free quit line
o_avail_hosp,measure,Treatment for tobacco dependence available in hospitals
o_ins_hosp,measure,Treatment for tobacco dependence in hospitals cost covered
o_avail_hlthspaceclin,measure,Treatment for tobacco dependence available in health clinics or other primary care facilities
o_avail_off_hlth_prof,measure,Treatment for tobacco dependence available in offices of health professionals
o_ins_off_hlth_prof,measure,Treatment for tobacco dependence in offices of health professionals cost covered
o_avail_community,measure,Treatment for tobacco dependence available in the community
o_ins_community,measure,Treatment for tobacco dependence in the community cost covered
o_avail_other,measure,Treatment for tobacco dependence available in other settings
o_ins_other,measure,Treatment for tobacco dependence in other settings cost covered
o_nrt_sold,measure,Nicotine replacement therapy - legally sold
o_nrt_where,measure,Nicotine replacement therapy - place available
o_nrt_ins,measure,Nicotine replacement therapy - cost covered
o_nrt_eml,measure,Nicotine replacement therapy on the Essential Medicines List
o_bup_sold,measure,Bupropion - legally sold
o_bup_where,measure,Bupropion - place available
o_bup_ins,measure,Bupropion - cost covered
o_varen_sold,measure,Varenicline - legally sold
o_varen_where,measure,Varenicline - place available
o_varen_ins,measure,Varenicline - cost covered
w1_hw_law_a,measure,Law mandates that health warnings appear on tobacco packages
w2_pc_front_back_a,measure,Percentage of principal display area mandated to be covered by health warnings - front and back of cigarette packaging
w3_pc_front_a,measure,Percentage of principal display area mandated to be covered by health warnings - front of cigarette packaging
w4_pc_back_a,measure,Percentage of principal display area mandated to be covered by health warnings - back of cigarette packaging
w15_specific_hw_a,measure,Does the law mandate specific health warnings on cigarette packaging?
w16_number_hw_a,measure,How many health warnings are approved by the law for cigarette packaging?
w11_outside_pack_a,measure,Do health warnings appear on each cigarette package and any outside packaging and labelling used in the retail sale?
w14_harm_effects_a,measure,Do health warnings on cigarette packaging describe the harmful effects of tobacco use on health?
w6_font_a,measure,"Does the law mandate font style, font size and colour of health warnings on cigarette packaging?"
w7_rotation_a,measure,Are the health warnings on cigarette packaging rotating?
w8_princ_langs_a,measure,Are the health warnings on cigarette packaging written in the principal language(s) of the country?
w10_graphic_a,measure,Do the health warnings on cigarette packaging include a photograph or graphic?
w5_top_side_a,measure,Health warnings on cigarette packaging must be placed at the top of the principal display areas of the package
w13_ind_liability_a,measure,Health warnings on cigarette packaging do not remove or diminish the liability of the tobacco industry
w12_imports_dutyfree_a,measure,Health warnings on cigarette packaging law applys to products whether manufactured domestically imported AND for duty-free sale
w9_no_obscure_a,measure,Health warnings on cigarette packaging must not be obscured in any way including by required markings such as tax stamps
w17_fines_a,measure,Health warnings on cigarette packaging law requires or establishes fines for violations
w18_misleading_terms_a,measure,Ban on deceitful terms on cigarette packaging
w19_colours_numbers_a,measure,Cigarette packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors
w20_flavours_a,measure,Cigarette packaging and labelling must not use descriptors depicting flavours
w21_emissions_a,measure,Cigarette packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark
w22_emissions_qual_a,measure,Cigarette packaging and labelling must display qualitative information on relevant constituents and emissions
w23_emissions_front_back_a,measure,Cigarette packaging and labelling must display qualitative information on constituents and emissions on one or more of the principal display areas
w24_exp_date_a,measure,Cigarette packaging and labelling must not display expiry dates
w25_quitline_number_a,measure,The quit line number must appear on cigarette packaging or labelling
w26_plainspacepackaging_a,measure,Plain packaging of cigarettes is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited).
w27_smokeless_prod_ban,measure,The sale of all smokeless tobacco products is completely banned
w1_hw_law_c,measure,Law mandates that health warnings appear on smokeless tobacco packages
w2_pc_front_back_c,measure,Percentage of principal display area mandated to be covered by health warnings - front and back of smokeless tobacco packaging
w3_pc_front_c,measure,Percentage of principal display area mandated to be covered by health warnings - front of smokeless tobacco packaging
w4_pc_back_c,measure,Percentage of principal display area mandated to be covered by health warnings - back of smokeless tobacco packaging
w15_specific_hw_c,measure,Does the law mandate specific health warnings on smokeless tobacco packaging?
w16_number_hw_c,measure,How many health warnings are approved by the law for smokeless tobacco packaging?
w11_outside_pack_c,measure,Do health warnings appear on each smokeless tobacco package and any outside packaging and labelling used in the retail sale?
w14_harm_effects_c,measure,Do health warnings on smokeless tobacco packaging describe the harmful effects of tobacco use on health?
w6_font_c,measure,"Does the law mandate font style, font size and colour of health warnings on smokeless tobacco packaging?"
w7_rotation_c,measure,Are the health warnings on smokeless tobacco packaging rotating?
w8_princ_langs_c,measure,Are the health warnings on smokeless tobacco packaging written in the principal language(s) of the country?
w10_graphic_c,measure,Do the health warnings on smokeless tobacco packaging include a photograph or graphic?
w5_top_side_c,measure,Health warnings on smokeless tobacco packaging must be placed at the top of the principal display areas of the package
w13_ind_liability_c,measure,Health warnings on smokeless tobacco packaging do not remove or diminish the liability of the tobacco industry
w12_imports_dutyfree_c,measure,Health warnings on smokeless tobacco packaging law applys to products whether manufactured domestically imported AND for duty-free sale
w9_no_obscure_c,measure,Health warnings on smokeless tobacco packaging must not be obscured in any way including by required markings such as tax stamps
w17_fines_c,measure,Health warnings on smokeless tobacco packaging law requires or establishes fines for violations
w18_misleading_terms_c,measure,Ban on deceitful terms on smokeless tobacco packaging
w19_colours_numbers_c,measure,Smokeless tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors
w20_flavours_c,measure,Smokeless tobacco packaging and labelling must not use descriptors depicting flavours
w21_emissions_quant_c,measure,Smokeless tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark
w22_emissions_qual_c,measure,Smokeless tobacco packaging and labelling must display qualitative information on relevant constituents and emissions
w23_emissions_front_back_c,measure,Smokeless tobacco packaging and labelling must display qualitative information on constituents and emissions on one or more of the principal display areas
w24_exp_date_c,measure,Smokeless tobacco packaging and labelling must not display expiry dates
w25_quitline_number_c,measure,The quit line number must appear on smokeless tobacco packaging or labelling
w26_plainspacepackaging_c,measure,Plain packaging of smokeless tobacco products is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited).
camp_nat,measure,At least one national mass media campaign ran during the survey period
camp_gov_prog,measure,Campaign was part of a comprehensive tobacco control programme
camp_mat_tested,measure,Campaign was pre-tested
camp_aud_research,measure,Formative research was conducted
camp_tv_radio,measure,Campaign aired on television and/or radio
camp_media_planning,measure,Campaign utilized media planning
camp_news,measure,Earned media/public relations were used to promote the campaign
camp_airtime,measure,Process evaluation was employed to assess implementation
camp_eval_impact,measure,Outcome evaluation was employed to assess effectiveness
e1_nat_tv_radio,measure,Ban on advertising: National TV and radio
e2_intl_tv_radio,measure,"Ban on advertising: International TV and radio (broadcast from abroad, including satellite)"
e3_nat_print,measure,Ban on advertising: Local magazines and newspapers
e4_intl_print,measure,Ban on advertising: International magazines and newspapers
e5_billboards,measure,Ban on advertising: Billboards and outdoor advertising
e6_pt_of_sale,measure,Ban on advertising: Point of sale
e7_internet,measure,Ban on advertising: Internet
ec_direct_compliance,measure,Compliance with bans on direct advertising
e9_free_distrib,measure,Ban on free distribution of tobacco products in the mail or through other means
e10_promo_discounts,measure,Ban on promotional discounts
e11_brand_stretching,measure,Ban on non-tobacco goods AND services identified with tobacco brand names
e12_brand_sharing,measure,Ban on brand name of non-tobacco products used for tobacco product
e13_brand_placement,measure,Ban on appearance of tobacco brands in TV and/or films (product placement)
e14_prod_tv_films,measure,Appearance of tobacco products in TV and/or films
e15_sponsored_events,measure,Sponsored events
ec_indirect_compliance,measure,Compliance with bans on promotion and sponsorship
e16_csr_promo_self,measure,Ban on tobacco companies/tobacco industry publicizing their “Corporate Social Responsibility” activities
e17_csr_promo_others,measure,Ban on entities other than tobacco companies/tobacco industry publicizing the Corporate Social Responsibility� activities of the tobacco companies
e18_csr_anti_tobacco_media,measure,"Ban on tobacco companies funding or making contributions (including in-kind contributions) to smoking prevention media campaigns, including those directed at youth"
e19_movies_anti_tob_ads,measure,"Required anti-tobacco ads for any visual entertainment media product that depicts tobacco products, use or images"
e21_vending_machines,measure,Complete ban on tobacco vending machines
e22_subnational_exists,measure,"Subnational bans on tobacco advertising, promotion and sponsorship"
r_curr_mp,measure,Most sold brand of cigarettes - currency reported
r_price_mp_estimate,measure,Most sold brand of cigarettes - price in currency reported
r_price_mp_ppp,measure,Most sold brand of cigarettes - price in international dollars
r_price_mp_usd,measure,Most sold brand of cigarettes - price in US$ at official exchange rates
r_curr_lowest_cost,measure,Cheapest brand of cigarettes - currency reported
r_price_lowest_estimate,measure,Cheapest brand of cigarettes - price in currency reported
r_price_lowest_ppp,measure,Cheapest brand of cigarettes - price in international dollars
r_price_lowest_usd,measure,Cheapest brand of cigarettes - price in US$ at official exchange rates
r_sp_excise_estimate,measure,Most sold brand of cigarettes - taxes as a % of price - specific excise
r_ad_val_estimate,measure,Most sold brand of cigarettes - taxes as a % of price - ad valorem excise
r_imp_duty_estimate,measure,Most sold brand of cigarettes - taxes as a % of price - import duties
r_vat_estimate,measure,Most sold brand of cigarettes - taxes as a % of price - value added tax
r_other_estimate,measure,Most sold brand of cigarettes - taxes as a % of price - other taxes
r_total_tax_estimate,measure,Most sold brand of cigarettes - taxes as a % of price - total tax
r_excise_incr,measure,Tobacco excises increased over the survey period
r_curr_average,measure,Average -  cigarette currency
r_price_average_curr,measure,Average -  cigarette price in currency
r_price_average_ppp,measure,Average -  cigarette price in international dollars
r_price_average_usd,measure,Average -  cigarette price in US$ at official exchange rates
r_sp_excise_average,measure,Average - taxes as a % of cigarette price - specific excise
r_ad_val_average,measure,Average - taxes as a % of cigarette price - ad valorem excise
r_imp_duty_average,measure,Average - taxes as a % of cigarette price - import duties
r_vat_average,measure,Average - taxes as a % of cigarette price - value added tax
r_other_average,measure,Average - taxes as a % of cigarette price - other taxes
r_total_tax_average,measure,Average - taxes as a % of cigarette price - total tax
rev_type,measure,Annual tax revenues - tobacco products included
rev_year,measure,Annual tax revenues - year
rev_curr,measure,Annual tax revenues - currency
rev_excise,measure,Annual tax revenues - total excise (specific and ad valorem)
rev_vat,measure,Annual tax revenues - value added tax (vat) and other sales taxes
rev_imp_other,measure,Annual tax revenues - import duties and all other taxes (excluding corporate taxes on tobacco companies)
rev_govt_total,measure,Annual tax revenues - total revenues
ntcp_govt_obj,measure,Government objectives on tobacco control exist
ntcp_agcy,measure,National agency for tobacco control exists
ntcp_fte,measure,Number of full-time equivalent staff in national agency
ntcp_govt_exp,measure,Annual budget for tobacco control in currency reported
ntcp_curr,measure,Reported currency
ntcp_budget_year,measure,Budget year
ntcp_usd,measure,Budget year
p16_subnat_complete_bans_exist,measure,Comprehensive bans in place subnationally
eq_underweight,measure,Prevalence of (moderate or severe) underweight in children
eq_overweight,measure,Prevalence of (moderate or severe) overweight in children
eq_waterimproved,measure,Households using an improved drinking-water source (%)
eq_waterpiped,measure,Households using a piped drinking-water source (%)
eq_waterpremises,measure,Households using a piped onto premises drinking-water source (%)
eq_housenets,measure,Households that have a bednet for sleeping (%)
eq_sleptnets,measure,Women that slept under a bednet last night (%)
eq_solidfuels,measure,Households that use solid fuels for cooking (%)
eq_slum,measure,Proportion of urban residents living in a slum area
tb_newinc,measure,Tuberculosis - new and relapse cases
ntd_yawsend,measure,Status of yaws endemicity
ntd_yawsnum,measure,Number of cases of yaws reported
tb_c_newinc,measure,Tuberculosis - new and relapse cases
tb_hivtest_pct,measure,TB patients with known HIV status (%)
tb_hivtest_pos_pct,measure,Tested TB patients HIV-positive (%)
tb_hiv_cpt_pct,measure,HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%)
tb_hiv_art_pct,measure,HIV-positive TB patients on ART (antiretroviral therapy) (%)
tb_e_mdr_num,measure,Estimated MDR-TB cases among notified pulmonary TB cases
tb_c_dst_rlt_new_pct,measure,New cases tested for RR-/MDR-TB (%)
tb_c_dst_rlt_ret_pct,measure,Previously treated cases tested for RR-/MDR-TB (%)
tb_mdr,measure,Confirmed cases of MDR-TB
tb_conf_mdr_tx_pct,measure,Confirmed cases of MDR-TB started treatment for MDR-TB (%)
tb_c_mdr_tsr,measure,Treatment success rate for patients treated for MDR-TB (%)
tb_c_notified,measure,Total number of notified TB cases
o_avail_hlth_clin,measure,Treatment for tobacco dependence available in health clinics or other primary care facilities
o_ins_hlth_clin,measure,Treatment for tobacco dependence in health clinics or other primary care facilities cost covered
mort_600,measure,Projection of number of deaths
mort_700,measure,Projection of deaths per 100 000 population
itu_idi,measure,ICT Development Index (IDI)
itu_idi_rank,measure,ICT Development Index (IDI) rank
itu_ict_1,measure,Percentage of individuals using the Internet
ghe_dalynum,measure,Disability-adjusted life years (DALYs)
ghe_dalyrate,measure,Disability-adjusted life years (DALYs) (per 100 000 population)
ghe_yldnum,measure,Years of healthy life lost due to disability (YLDs)
ghe_yldrate,measure,Years of healthy life lost due to disability (YLDs) (per 100 000 population)
ghe_yllnum,measure,Years of life lost from mortality (YLLs)
ghe_yllrate,measure,Years of life lost from mortality (YLLs) (per 100 000 population)
itu_ict_2,measure,Mobile-cellular telephone subscriptions per 100 inhabitants
ntd_leishcend,measure,Status of endemicity of cutaneous leishmaniasis
ntd_leishvend,measure,Status of endemicity of visceral leishmaniasis
ntd_leishcnum,measure,Number of cases of cutaneous leishmaniasis reported
ntd_leishvnum,measure,Number of cases of visceral leishmaniasis reported
sa_0000001736,measure,Action Plan for implementation of alcohol policy
sa_0000001719,measure,Advertising restrictions on social media
sa_0000001720,measure,Restrictions on product placement in films/movies
sa_0000001721,measure,Importance of measures for enhancing compliance with age limits
sa_0000001726,measure,Penalties for drink driving
sa_0000001727,measure,Sobriety checkpoints
sa_0000001730,measure,Price measures
sa_0000001732,measure,New types of alcoholic beverages emerging
sa_0000001731,measure,Level of taxation adjusted for inflation
sa_0000001733,measure,"Consumer information about calories, additives, etc on containers"
sa_0000001734,measure,Number of standard alcoholic drinks displayed on containers
sa_0000001735,measure,Alcohol content displayed on containers
sa_0000001722,measure,Government support for community action
sa_0000001723,measure,Community-based interventions involving stakeholders
sa_0000001724,measure,National guidelines for implementing effective community-based interventions
sa_0000001725,measure,National alcohol policy specifically involves young people activities
sa_0000001728,measure,Detection of marketing infringements
sa_0000001729,measure,Penalties for marketing infringements
perctreatedanc,measure,Antenatal care attendees positive for syphilis who received treatment (%)
emfstandard,measure,Existence of standards
emfstatus,measure,Legislative status
emfsar,measure,Specific absorption rate (SAR) (W/kg)
emflimits,measure,Limit values
ntd_2_year_certified,measure,Year country was certified
ntd_dracases,measure,Dracunculiasis cases
air_2_2,measure,Ambient air pollution  in urban areas (Annual PM<sub>2.5</sub> [&#956;g/m<sup>3</sup>])
air_35,measure,Joint effects of air pollution attributable deaths
air_36,measure,Joint effects of air pollution attributable deaths in children under 5 years
air_37,measure,Joint effects of air pollution attributable deaths  per 100'000 capita
air_38,measure,Joint effects of air pollution attributable deaths per 100'000 children under 5 years
nhagghegdp,measure,General government expenditure on health as percentage of gross domestic product
nhaoopsthe,measure,Out-of-Pocket expenditure on health as percentage of total health expenditure??
nhaprepaidthe,measure,Prepaid plans as percentage of total health expenditure?
ihr01,measure,Legislation
ihr02,measure,Coordination
ihr03,measure,Surveillance
ihr04,measure,Response
ihr05,measure,Preparedness
ihr06,measure,Risk communication
ihr07,measure,Human resources
ihr08,measure,Laboratory
ihr09,measure,Points of entry
ihr10,measure,Zoonosis
ihr11,measure,Food safety
ihr12,measure,Chemical
ihr13,measure,Radionuclear
emfpowerfrequency,measure,Power frequency (Hz)
carep,measure,Children aged < 5 years with pneumonia symptoms taken to a health facility (%)
fps,measure,Demand for family planning satisfied - modern and traditional methods (%)
fullv,measure,Full immunization coverage among one-year-olds (%)
itnch,measure,Children aged < 5 years sleeping under insecticide-treated nets (%)
itnwm,measure,Pregnant women sleeping under insecticide-treated nets (%)
mslv,measure,Measles immunization coverage among one-year-olds (%)
obesewm,measure,"Obesity prevalence in non-pregnant women aged 15-49 years, BMI >= 30 (%)"
anc4,measure,Antenatal care coverage - at least four visits (in the two or three years preceding the survey) (%)
csection,measure,Births by caesarean section (in the two or three years preceding the survey) (%)
pncall,measure,Postnatal care visit within two days of birth (in the x years preceding the survey) (%)
pnchome,measure,Postnatal care visit within two days of birth - born outside a health facility (in the x years preceding the survey) (%)
sa_0000001737,measure,"Alcohol, regional per capita (15+) consumption (in litres of pure alcohol)"
sa_0000001739,measure,"Alcohol, heavy episodic drinking (population) past 30 days (%), age-standardized with 95%CI"
sa_0000001740,measure,Alcohol-attributable Years of Life Lost (YLL) score
sa_0000001741,measure,"Alcohol-attributable fractions (15+), liver cirrhosis deaths (%)"
sa_0000001742,measure,"Alcohol-attributable fractions (15+), road traffic crash deaths (%)"
sa_0000001743,measure,"Alcohol-attributable fractions, all-cause deaths (%)"
sa_0000001744,measure,"Alcohol, regional prevalence of alcohol dependence (%)"
sa_0000001745,measure,"Alcohol, regional prevalence of alcohol use disorders (%)"
sa_0000001746,measure,"Alcohol, total  (recorded + unrecorded) per capita (15+) consumption with 95%CI, projections to 2025"
sa_0000001747,measure,"Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average with 95%CI"
sa_0000001748,measure,"Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) with 95%CI"
sa_0000001749,measure,"Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol) with 95%CI"
sa_0000001751,measure,"Alcohol, average daily intake in grams among drinkers with 95%CI"
sa_0000001752,measure,"Alcohol, total (recorded + unrecorded) per capita (15+) consumption, projected estimates for 2016"
sa_0000001753,measure,"Alcohol use disorders (15+), 12 month prevalence (%), age standardized, with 95%CI"
sa_0000001754,measure,"Alcohol, harmful use (15+), 12 month prevalence (%) with 95%CI"
sa_0000001755,measure,"15-19 years old heavy episodic drinkers (population), % with 95%CI"
sa_0000001756,measure,"15-19 years old heavy episodic drinkers (drinkers only), %"
sa_0000001757,measure,"15-19 years old abstainers, lifetime (%)"
sa_0000001758,measure,15-19 years old former drinkers (%)
sa_0000001759,measure,"15-19 years old, current drinkers (%)"
emflimitelectric,measure,Electric field (kV/m)
emflimitmagnetic,measure,Magnetic flux density (microT)
emflimitelectric1800,measure,Electric field limit at 1800 MHz (V/m)
emflimitelectric900,measure,Electric field limit at 900 MHz (V/m)
emflimitpowerdensity1800,measure,Power density limit at 1800 MHz (W/m^2)
emflimitpowerdensity900,measure,Power density limit at 900 MHz (W/m^2)
ntd_onchemo,measure,Estimated number of individuals in the country requiring preventive chemotherapy for onchocerciasis
ntd_onctreat,measure,Reported number of individuals treated for onchocerciasis
ntd_onchstatus,measure,Status of endemicity of onchocerciasis
deathstotal,measure,Deaths total
deaths04y,measure,"Deaths, children aged under 5 years"
dalystotal,measure,Disability-adjusted life years (DALYs) total (000s)
dalys04y000,measure,"Disability-adjusted life years (DALYs), children aged under 5 years (000s)"
deathsper100000,measure,Deaths per 100 000 population
dalysper100000,measure,Disability-adjusted life years (DALYs) per 100 000 population
whs7_150,measure,Out-of-pocket expenditure as a percentage of total expenditure on health
ncd_ccs_ncdguide,measure,Existence of evidence-based national guidelines/protocols/standards for the management of major NCDs through a primary care approach
ncd_ccs_multisecncdplan,measure,"Existence of at least one operational multisectoral national policy, strategy or action plan that integrates several noncommunicable diseases and shared risk factors in conformity with the global/regional noncommunicable disease action plans 2013?2020"
ncd_ccs_survmonrep9ncd,measure,Existence of an NCD surveillance and monitoring system in place to enable reporting against the nine global NCD targets
ncd_ccs_cancerregnational,measure,Existence of population-based cancer registry
ncd_ccs_ncdunit_operational,measure,"Existence of an Operational Unit, Branch, or Dept. in Ministry of Health with responsibility for NCDs"
sa_0000001761,measure,National guidelines for the prevention and reduction of alcohol-related harm in schools
sa_0000001762,measure,National guidelines for alcohol problem prevention and counselling at workplaces
sa_0000001763,measure,Workplace representatives nationally involved to prevent and address alcohol-related harm
sa_0000001764,measure,Server training
sa_0000001765,measure,Legal obligation for schools to include alcohol use prevention
sa_0000001766,measure,Legal obligation for schools to interact with parents regarding education and well-being
sa_0000001767,measure,Legislation on alcohol testing at workplaces
sa_0000001768,measure,Standard drink defined
sa_0000001769,measure,National sytems for monitoring alcohol consumption and harms
sa_0000001770,measure,Regular reports from national monitoring systems
sa_0000001771,measure,Comprehensive and regular reporting of alcohol situation
sa_0000001772,measure,Clinical guidelines for brief interventions
sa_0000001773,measure,National surveys on adult alcohol consumption
sa_0000001774,measure,National surveys on youth alcohol consumption
sa_0000001775,measure,National surveys on heavy espisodic drinking
sa_0000001776,measure,Data collection on Foetal Alcohol Syndome
sa_0000001777,measure,Data collected on harm from alcohol at workplace
sa_0000001778,measure,New types of alcoholic beverages emerging
tb_c_mdr_tx,measure,Cases started on MDR-TB treatment
tb_new_clindx,measure,"New or unknown treatment history cases: Pulmonary, clinically diagnosed"
tb_new_labconf,measure,"New or unknown treatment history cases: Pulmonary, bacteriologically confirmed"
tb_new_snsuoth,measure,"New cases: Pulmonary, smear-negative/unknown/not done and other new cases"
tb_ret_nrel,measure,"Previously treated  cases, excluding relapse"
tb_ret_rel_clindx,measure,"Relapse cases: Pulmonary, clinically diagnosed"
tb_ret_rel_ep,measure,Relapse cases: extrapulmonary
tb_ret_rel_labconf,measure,"Relapse cases: Pulmonary, bacteriologically confirmed"
tb_rr_mdr,measure,Confirmed cases of RR-/MDR-TB
tb_c_new_tsr,measure,Treatment success rate: new TB cases
tb_c_tbhiv_tsr,measure,Treatment success rate: HIV-positive TB cases
tb_c_xdr_tsr,measure,Treatment success rate: XDR-TB cases
tb_new_snuoth,measure,TB_new_snuoth
ntd_bejelstatus,measure,Status of bejel endemicity
ntd_bejelnum,measure,Number of cases of bejel reported
ntd_pintastatus,measure,Status of pinta endemicity
ntd_pintanum,measure,Number of cases of pinta reported
sa_0000001760,measure,15-19 years old total alcohol consumption in litres of pure alcohol
violence_extentimp_childhomevisit,measure,Child maltreatment: Extent of implementation of home-visiting programmes
violence_extentimp_youthlifeskills,measure,Youth violence: Extent of implementation of life-skills and social development programmes
violence_extentimp_partnerviolprevention,measure,Intimate partner violence: Extent of implementation  of dating violence prevention programmes
violence_extentimp_eldercaregiver,measure,Elder abuse: Extent of implementation  of caregiver-support programmes
violence_extentimp_alltypes,measure,Extent of implementation of  mental health services for victims of all types of violence
violence_extentimp_childprotection,measure,Extent of implementation of child protection services
violence_extentimp_victimsmedicolegal,measure,Extent of implementation of medico-legal services for victims of sexual violence
violence_child_physical,measure,Lifetime prevalence of child physical abuse (%)
violence_child_emotional,measure,Lifetime prevalence of child emotional abuse (%)
violence_child_sexual,measure,Lifetime prevalence of child sexual abuse (%)
violence_child_neglect,measure,Lifetime prevalence of child physical neglect (%)
violence_homicidenum,measure,Estimates of number of homicides
violence_homiciderate,measure,Estimates of rates of homicides per 100 000 population
hiv_artcoverage,measure,Estimated antiretroviral therapy coverage among people living with HIV (%)
lepto_mortality,measure,Estimated leptospirosis deaths (per 100 000 population)
lepto_morbidity,measure,Estimated leptospirosis incidence (per 100 000 population)
cci,measure,Composite coverage index (%)
ors,measure,Children aged < 5 years with diarrhoea receiving oral rehydration salts (%)
overwgt3,measure,Overweight prevalence in children aged <three years (%)
overwgt5,measure,Overweight prevalence in children aged <five years (%)
wast3,measure,Wasting prevalence in children aged < 3 years (%)
wast5,measure,Wasting prevalence in children aged < 5 years (%)
ncd_pac_ado,measure,Insufficiently active (crude estimate)
ntd_leishcnum_im,measure,Number of imported cases of cutaneous leishmaniasis reported
ntd_leishvnum_im,measure,Number of imported cases of visceral leishmaniasis reported
devices00,measure,Total density per 100 000 population: Hospitals
ir_insecticideresistance_prev,measure,Number of insecticide classes to which resistance was reported
ir_pyrethroid_presence,measure,Pyrethroid resistance reported for at least one site
ir_organochlorine_presence,measure,Organochlorine resistance reported for at least one site
ir_carbamate_presence,measure,Carbamate resistance reported for at least one site
ir_organophosphate_presence,measure,Organophosphate resistance reported for at least one site
ir_pyrethroid_extent,measure,Percentage of sites for which pyrethroid resistance was reported
ir_organochlorine_extent,measure,Percentage of sites for which organochlorine resistance was reported
ir_carbamate_extent,measure,Percentage of sites for which carbamate resistance was reported
ir_organophosphate_extent,measure,Percentage of sites for which organophosphate resistance was reported
sa_0000001779,measure,Level of enforcement of BAC limits
air_40,measure,Household air pollution attributable DALYs
ncd_ccs_urinealbumin,measure,General availability of urine testing for albumin
ncd_ccs_bronchodilators,measure,General availability of bronchodilators in the public health sector
prevanemia,measure,Prevalence of anaemia in women of reproductive age (%)
hrh_40,measure,Biomedical engineers density (per 10 000 population)
sa_0000001750,measure,Average daily intake in grams of alcohol among drinkers
sa_0000001780,measure,"15-years old any alcoholic beverage consumed at least once in lifetime, (%)"
sa_0000001781,measure,"15-years old any alcoholic beverage consumed in past 12 months, (%)"
sa_0000001782,measure,"15-years old first drink at 13 years or younger, (%)"
sa_0000001783,measure,"15-years old any alcoholic beverage consumed in past 30 days, (%)"
sa_0000001784,measure,"15-years old, any alcoholic beverage consumed at least once a week, (%)"
sa_0000001785,measure,"15-years old ever got drunk in the past 30 days, (%)"
sa_0000001786,measure,"13-15-years old any alcoholic beverage consumed in past 30 days, (%)"
sa_0000001787,measure,"13-15-years old first drink before age 14, (%)"
casecs,measure,Congenital syphilis number of reported cases
ratecs,measure,Congenital syphilis rate per 100 000 live births
mh_19,measure,"Mental hospital admissions (per 100,000)"
mh_20,measure,"Outpatient visits (per 100,000)"
mh_21,measure,"Total workforce in mental health sector (per 100,000)"
mh_22,measure,"Occupational therapists in mental health sector (per 100,000)"
mh_23,measure,"Other non-specialized doctors in mental health sector (per 100,000)"
mh_24,measure,"Mental health units in general hospitals admissions (per 100,000)"
mh_25,measure,Stand-alone policy or plan for mental health
sa_0000001718,measure,Action Plan for implementation of alcohol policy
sa_0000001738,measure,Regional alcohol per capita (15+) consumption- total
sa_0000001788,measure,"Alcohol-related road traffic crashes with fatalities, per 100,000  population"
violence_physical_fighting,measure,"Physical fighting, past 12 months (%)"
violence_bullied,measure,"Bullied, past 30 days (%)"
w1_hw_law_b,measure,Law mandates that health warnings appear on other smoked tobacco packages
w2_pc_front_back_b,measure,Percentage of principal display area mandated to be covered by health warnings - front and back of other smoked tobacco packaging
w3_pc_front_b,measure,Percentage of principal display area mandated to be covered by health warnings - front of other smoked tobacco packaging
w4_pc_back_b,measure,Percentage of principal display area mandated to be covered by health warnings - back of other smoked tobacco packaging
w15_specific_hw_b,measure,Does the law mandate specific health warnings on other smoked tobacco packaging?
w16_number_hw_b,measure,How many health warnings are approved by the law for other smoked tobacco packaging?
w11_outside_pack_b,measure,Do health warnings appear on each other smoked tobacco package and any outside packaging and labelling used in the retail sale?
w14_harm_effects_b,measure,Do health warnings on other smoked tobacco packaging describe the harmful effects of tobacco use on health?
w6_font_b,measure,"Does the law mandate font style, font size and colour of health warnings on other smoked tobacco packaging?"
w7_rotation_b,measure,Are the health warnings on other smoked tobacco packaging rotating?
w8_princ_langs_b,measure,Are the health warnings on other smoked tobacco packaging written in the principal language(s) of the country?
w10_graphic_b,measure,Do the health warnings on other smoked tobacco packaging include a photograph or graphic?
w5_top_side_b,measure,Health warnings on other smoked tobacco packaging must be placed at the top of the principal display areas of the package
w13_ind_liability_b,measure,Health warnings on other smoked tobacco packaging do not remove or diminish the liability of the tobacco industry
w12_imports_dutyfree_b,measure,Health warnings on other smoked tobacco packaging law applys to products whether manufactured domestically imported AND for duty-free sale
w9_no_obscure_b,measure,Health warnings on other smoked tobacco packaging must not be obscured in any way including by required markings such as tax stamps
w17_fines_b,measure,Health warnings on other smoked tobacco packaging law requires or establishes fines for violations
w18_misleading_terms_b,measure,Ban on deceitful terms on other smoked tobacco packaging
w19_bolours_numbers_b,measure,Other smoked tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors
w20_flavours_b,measure,Other smoked tobacco packaging and labelling must not use descriptors depicting flavours
w21_emissions_quant_b,measure,Other smoked tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark
w22_emissions_qual_b,measure,Other smoked tobacco packaging and labelling must display qualitative information on relevant constituents and emissions
w23_emissions_front_back_b,measure,Other smoked tobacco packaging and labelling must display qualitative information on constituents and emissions on one or more of the principal display areas
w24_exp_date_b,measure,Other smoked tobacco packaging and labelling must not display expiry dates
w25_quitline_number_b,measure,The quit line number must appear on other smoked tobacco packaging or labelling
e26_direct_ad_fines,measure,Law requires fines for violations of direct advertising bans
e27_indirect_ad_fines,measure,Law requires fines for violations of indirect advertising bans
e24_internet_sales_ban,measure,Ban on internet sales of tobacco products
e25_ban_display_pt_of_sale,measure,Ban on display of tobacco products at points of sale
e23_subnat_complete_bans_exist,measure,"Subnational advertising, promotion and sponsorship bans - at least one jurisdiction has a comprehensive ban in place"
r_curr_premium_cost,measure,Premium brand of cigarettes - currency reported
r_price_premium_estimate,measure,Premium brand of cigarettes - price in currency reported
r_price_premium_ppp,measure,Premium brand of cigarettes - price in international dollars
r_price_premium_usd,measure,Premium brand of cigarettes - price in US$ at official exchange rates
r_excise_type,measure,Tax structure: Type of excise tax applied
r_excise_uniform_varied,measure,Tax structure: Uniform excise tax
r_excise_specific_reliance,measure,Tax structure: Greater reliance on specific tax in mixed excise regime
r_excise_min_specific,measure,Tax structure: Minimum specific tax applied in ad valorem or mixed excise regime
r_excise_retail_price_base,measure,Tax structure: Retail price used as base of ad valorem component in ad valorem or mixed excise regime (or retail price exclusive of VAT)
r_afford_less,measure,Affordability: Cigarettes are less affordable in 2014 compared to 2008
r_afford_tax_auto_adjust,measure,Affordability: Specific tax component automatically adjusted for inflation (or other)
r_admin_tax_stamps,measure,Tax administration: Tax stamps applied on tobacco products
r_admin_duty_free_limited,measure,Tax administration: Bans or limits on duty free imports by travellers
r_admin_duty_free_allowance,measure,"Tax administration: If duty free imports are limited, duty free allowance (number of cigarette sticks)"
p1_compliance,measure,Compliance of ban on smoking in HEALTH-CARE FACILITIES
p2_compliance,measure,Compliance of ban on smoking in EDUCATIONAL FACILITIES EXCEPT UNIVERSITIES
p3_compliance,measure,Compliance of ban on smoking in UNIVERSITIES
p4_compliance,measure,Compliance of ban on smoking in GOVERNMENT FACILITIES
p5_compliance,measure,Compliance of ban on smoking in INDOOR OFFICES
p6_compliance,measure,Compliance of ban on smoking in RESTAURANTS
p7_compliance,measure,Compliance of ban on smoking in PUBS AND BARS
p8_compliance,measure,Compliance of ban on smoking in PUBLIC TRANSPORT
e1_compliance,measure,Compliance of ban on advertising on national TV and radio
e3_compliance,measure,Compliance of ban on advertising on local magazines and newspapers
e5_compliance,measure,Compliance of ban on advertising on billboards and outdoor advertising
e6_compliance,measure,Compliance of ban on advertising at point of sale
e9_compliance,measure,Compliance of ban on free distribution of tobacco products in the mail or through other means
e10_compliance,measure,Compliance of ban on promotional discounts
e11_compliance,measure,Compliance of ban on non-tobacco goods AND services identified with tobacco brand names
e12_compliance,measure,Compliance of ban on brand name of non-tobacco products used for tobacco product
e13_compliance,measure,Compliance of ban on appearance of tobacco brands in TV and/or films (product placement)
e14_compliance,measure,Compliance of ban on appearance of tobacco products in TV and/or films
e15_compliance,measure,Compliance of ban on sponsored events
w19_colours_numbers_b,measure,Other smoked tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors
w21_emissions_b,measure,Other smoked tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark
r_excise_proportion,measure,Tax structure: Excise tax proportion of price
r_afford_gdp,measure,"Affordability: % of GDP per capita required to purchase 100 packs of most sold brand (the higher the %, the less affordable)"
r_afford_price_dispersion,measure,Affordability: Price dispersion: share of cheapest brand price in premium brand price (the higher the % the smaller the gap)
w26_plain_packaging_a,measure,Plain packaging of cigarettes is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited).
w26_plain_packaging_c,measure,Plain packaging of smokeless tobacco products is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited).
w26_plain_packaging_b,measure,Plain packaging of other smoked tobacco products is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited).
mort_maternalnum,measure,Number of maternal deaths
rs_223_bis,measure,Law requires helmet to be fastened
sunbedexist,measure,Existence of national regulation
sunbedexistyear,measure,Year of national implementation of regulation
rs_242,measure,Vehicle standards
sunbedreg_access,measure,Access restrictions
sunbedreg_control,measure,Restriction and inspection of facilities
sunbedreg_info,measure,Information requirements
sunbedreg_training,measure,Training requirements
sunbedreg_safety,measure,Safety requirements
hrh_41,measure,Number of licensed qualified surgeons actively working
hrh_42,measure,Number of licensed qualified obstetricians actively working
hrh_43,measure,Number of licensed qualified anaesthesiologists actively working
lepto_yld,measure,Years of healthy life lost to disability (YLDs) due to leptospirosis
lepto_yld100k,measure,Years of healthy life lost to disability (YLDs) (per 100 000 population) due to leptospirosis
lepto_yll,measure,Years of life lost (YLLs) due to leptospirosis
lepto_yll100k,measure,Years of life lost (YLLs)  (per 100 000 population) due to leptospirosis
lepto_daly,measure,Disability-adjusted life years (DALYs) due to leptospirosis
lepto_daly100k,measure,Disability-adjusted life years (DALYs) (per 100 000 population) due to leptospirosis
eq_adobirth,measure,"Adolescent birth rate (births per 1,000 women aged 15 to 19)"
eq_itn,measure,Households with at least one ITN for sleeping (%)
eq_u5sleptnets,measure,Children under five who slept under a bednet the previous night (%)
eq_itnunder5,measure,Children under five who slept under an ITN the previous night (%)
eq_contraceptive,measure,Contraceptive prevalence rate among women married or in union
eq_handwashing,measure,Households with soap and water at a handwashing facility (%)
eq_condomuse,measure,People who identify the use of condoms as a way to avoid AIDS (%)
eq_dirtfloor,measure,Households with dirt floor (%)
eq_opendefecation,measure,Population not using any sanitation facility (open defecation) (%)
malaria_15081,measure,IPT 3rd dose
eq_overweightadult,measure,Prevalence of overweight and obesity
sdgairbod,measure,Mortality rate attributed to household and ambient air pollution (per 100 000 population)
sdghiv,measure,New HIV infections (per 1000 uninfected population)
sdgmalaria,measure,Malaria incidence (per 1 000 population at risk)
sdgpm25,measure,Concentrations of fine particulate matter (PM2.5)
sdgpoison,measure,Mortality rate attributed to unintentional poisoning (per 100 000 population)
sdgpollutingfuels,measure,Proportion of population with primary reliance on clean fuels and technologies (%)
sdgroadage,measure,Age-standardized road traffic  mortality (per 100 000 population)
sdgtobacco,measure,Age-standardized prevalence of current tobacco smoking among persons aged 15 years and older
sdgwshbod,measure,Mortality rate attributed to exposure to unsafe WASH services (per 100 000 population)
sdgntdtreatment,measure,Reported number of people requiring interventions against NTDs
sdgoop,measure,Out-of-pocket expenditure as a percentage of total expenditure on health
sdgsab,measure,Proportion of births attended by skilled health personnel (%)
sdgfp,measure,Married or in-union women of reproductive age who have their need for family planning satisfied with modern methods (%)
sdgabr,measure,Adolescent birth rate (births per 1 000 women aged 15-19)
cco_whs9_85,measure,Literacy rate among adults aged >= 15 years (%)
leadcontrol,measure,Legally binding lead controls
leadcontrolegislation,measure,Name of legislation for lead controls
leadcontrolegislationdesc,measure,Description of legislation for lead controls
sdgconflict,measure,Estimated direct deaths from major conflicts (per 100 000 population)
sdgdisaster,measure,Average death rate due to natural disasters (per 100 000 population)
sdgsuicide,measure,Crude suicide rates (per 100 000 population)
sdgshp,measure,Skilled health professionals density (per 10 000 population)
sdgihr,measure,Average of 13 International Health Regulations core capacity scores
emflimitpowerdensity,measure,Power density (W/m^2)
emflimitelectricradio,measure,Electric field limit (V/m)
whosis_000007,measure,Healthy life expectancy (HALE) at age 60 (years)
ntd_rab2,measure,Reported number of human rabies deaths
ntd_tra5,measure,Number of people operated for trachomatous trichiasis
ncd_ccs_multiseccomm,measure,"Existence of a national multisectoral commission, agency or mechanism for NCDs"
ncd_ccs_ncdindicators,measure,Existence of a set of national NCD indicators and has set time-bound national targets for these indicators
ncd_ccs_integncdplan,measure,"Existence of an operational, multisectoral national NCD policy, strategy or action plan that integrates several NCDs and their risk factors"
ncd_ccs_mkting,measure,Existence of any policies on marketing of foods to children
ncd_ccs_saltpol,measure,Existence of any policies to reduce population salt consumption
ncd_ccs_satfat,measure,Existence of national policies on saturated fatty acids / trans-fats
ncd_ccs_dietpaaware,measure,Implementation of diet and/or physical activity public awareness program
emflimitelectricrf,measure,Electric field (V/m)
emflimitelectriclf,measure,Electric field (kV/m)
ncd_ccs_diabtest,measure,"General availability of diabetes testing (by blood glucose measurement, OGTT) at the primary health care level"
ncd_ccs_hba1c,measure,General availability of diabetes testing (by HbA1c) at the primary health care level
ncd_ccs_diabetesreg,measure,Existence of a diabetes registry
ncd_ccs_pm3_surv,measure,Has a STEPS survey or a comprehensive health examination survey every 5 years
ncd_ccs_breastcancerscreening,measure,Existence of national screening program for breast cancer
ncd_ccs_cervicalcancerscreening,measure,Existence of national screening program for cervical cancer
ncd_ccs_cervicalcancermethod,measure,Most widely used screening method in national cervical cancer screening program
ncd_ccs_cervicalcancerpgmtype,measure,Type of national cervical cancer screening program
ncd_ccs_cervicalcancerpgmcvg,measure,Coverage of national cervical cancer screening program (%)
ncd_ccs_hpv,measure,Existence of national HPV vaccination programme
ncd_ccs_photocoag,measure,General availability of retinal photocoagulation in the public health system
ncd_ccs_dialysis,measure,General availability of dialysis in the public health system
ncd_ccs_renaltrans,measure,General availability of renal replacement by transplantation in the public health system
ncd_ccs_coronary,measure,General availability of coronary bypass or stenting in the public health system
ncd_ccs_thrombolytic,measure,General availability of thrombolytic therapy in the public health system
ncd_ccs_palliative_prim,measure,General availability of palliative care in primary health care in the public health system
ncd_ccs_palliative_home,measure,General availability of palliative care in community or home-based care in the public health system
ncd_ccs_riskstrat,measure,Availability of cardiovascular risk stratification in 50% or more primary health care facilities
ncd_ccs_stroke,measure,Provision for care of acute stroke and rehabilitation in more than 50% of public sector health facilities
ncd_ccs_rheum,measure,Provision for secondary prevention of rheumatic fever and rheumatic heart disease in more than 50% of public sector health facilities
ncd_ccs_betablockers,measure,General availability of beta blockers in the public health sector
ncd_ccs_sulphonylurea,measure,General availability of sulphonylurea(s) in the public health sector
air_41,measure,Ambient air pollution attributable deaths
air_42,measure,"Ambient air pollution attributable deaths (per 100 000 population, age-standardized)"
air_43,measure,Ambient air pollution attributable DALYs
air_44,measure,DALYs attributable to ambient air pollution (age-standardized)
sdgairboda,measure,Age-standardized mortality rate attributed to household and ambient air pollution (per 100 000 population)
air_45,measure,Ambient air pollution attributable YLLs
air_46,measure,YLLs attributable to ambient air pollution (age-standardized)
air_50,measure,"Ambient air pollution attributable deaths (per 100 000 population, age-standardized)"
tb_e_rr_in_notified_pulm,measure,Estimated MDR/RR-TB cases among notified pulmonary TB cases
oa_dmft,measure,"Decayed, missing, or filled teeth"
cataractsurgical,measure,Cataract surgical coverage of adults aged 50 and over (%)
cataractsurgicaleffective,measure,Effective cataract surgical coverage of adults aged 50 and over (%)
mortado,measure,Adolescent mortality rate (per 100 000 population)
sg_reg_brth,measure,Proportion of children under 5 years of age whose births have been registered with a civil authority
se_g23_math,measure,Proportion of children in grades 2/3 achieving at least a minimum proficiency level in mathematics (%)
se_g23_rdg,measure,Proportion of children in grades 2/3 achieving at least a minimum proficiency level in reading (%)
se_lsc_math,measure,Proportion of children at the end of lower secondary achieving at least a minimum proficiency level in mathematics (%)
se_lsc_rdng,measure,Proportion of children at the end of lower secondary achieving at least a minimum proficiency level in reading (%)
se_prm_math,measure,Proportion of children at the end of primary achieving at least a minimum proficiency level in mathematics (%)
se_prm_rdng,measure,Proportion of children at the end of primary achieving at least a minimum proficiency level in reading (%)
vc_vaw_sxvln,measure,Proportion of young women and men aged 18-29 years who experienced sexual violence by age 18 (%)
sg_reg_census,measure,Proportion of countries that have conducted at least one population and housing census in the last 10 years (%)
sg_reg_censusn,measure,Number of countries that have conducted at least one population and housing census in the last 10 years
unicef_pncmother,measure,Women age 15-49 years who received a health check within 2 days after delivery of their most recent live birth in the last 2 years (%)
unicef_newborn,measure,Proportion of newborns who have postnatal contact with a health provider within 2 days of delivery (%)
unicef_pncnewborn,measure,Proportion of newborns who have postnatal contact with a health provider within 2 days of delivery (%)
unicef_ors,measure,Children aged <5 years with diarrhoea receiving ORS (%)
unicef_pneumoniacare,measure,Children aged < 5 years with pneumonia symptoms taken to a healthcare provider (%)
malaria_itnpop,measure,Population sleeping under a bed net(%)
malaria_itnpreg,measure,Pregnant women sleeping under insecticide-treated nets the previous night (%)
si_pov_day1,measure,Proportion of population below the international poverty line of US$1.90 per day (%)
si_pov_emp1,measure,Employed population below the international poverty line of US$1.90 per day (the working poor) (%)
se_dev_ontrk,measure,"Children aged 36-59 months who are developmentally on track in at least three of the following domains: literacy-numeracy, physical development, social-emotional development and learning (%)"
se_pre_partn,measure,Participation rate in organized learning (one year before the official primary entry age) (%)
sp_dyn_mrbf15,measure,Proportion of women aged 20-24 years who were married or in a union by age 15 (%)
sp_dyn_mrbf18,measure,Proportion of women aged 20-24 years who were married or in a union by age 18 (%)
sh_sta_fgms,measure,Proportion of girls and women aged 15-49 years who have undergone female genital mutilation/cutting (FMG/C) (%)
gb_xpd_rsdv,measure,Research and development (R&amp;D) expenditure as a proportion of GDP
hss_uhclegislation,measure,Countries that have passed legislation on Universal Health Coverage (UHC)
hss_comprehensivehealthpolicy,measure,Countries that have a comprehensive national health sector policy/ strategy/ plan with goals and targets updated within the last 5 years
hss_monitorprogress,measure,Countries that have monitored the progress of their national health policy/strategy/plan regularly
sdgoda,measure,"Total net official development assistance to medical research and basic health sectors per capita (constant 2014 US$), by recipient"
sdgcodcompleteness,measure,Completeness of cause-of-death data (%)
goe_q001,measure,National universal health coverage strategy
goe_q002,measure,strategy refers to the use of ICT to support UHC
goe_q003,measure,National eHealth strategy
goe_q004,measure,National eHealth strategy refers to objectives of UHC
goe_q006,measure,National  health information system (HIS) policy or strategy
goe_q007,measure,Public funding for eHealth
goe_q008,measure,Private funding for eHealth
goe_q009,measure,Donor/ non-public development funding for eHealth
goe_q010,measure,Public-private partnerships for eHealth
goe_q011,measure,Strategy implementation funding available for eHealth
goe_q012,measure,Proportion of public funding
goe_q013,measure,Proportion of private funding
goe_q014,measure,Proportion of donor/non public development funding
goe_q015,measure,Proportion ofpublic private partnerships funding
goe_q017,measure,Government-supported health internet sites provide information in multiple languages
goe_q018,measure,Tertiary institutions provide students of health sciences with training on eHealth
goe_q022,measure,Institutions offer in-service training to health professionals on ICT for health
goe_q028,measure,mHealth programmes are sponsored by government
goe_q030_1,measure,Regulating mobile devices and software
goe_q030_2,measure,Promoting standards and interoperability
goe_q030_3,measure,Providing guidance on privacy and security
goe_q030_4,measure,Providing oversight and enforcement of data ownership
goe_q030_5,measure,Promoting the development and adoption of mHealth
goe_q031,measure,"Regulatory oversight of mobile apps for quality, safety and reliability"
goe_q032,measure,Providing incentives and guidance for innovation research and evaluation of health
goe_q047,measure,Government-sponsored mHealth programmes are being evaluated
goe_q057,measure,Capacity
goe_q058,measure,Infrastructure
goe_q059,measure,Funding
goe_q060,measure,Effectiveness
goe_q061,measure,Cost-effectiveness
goe_q062,measure,Demand
goe_q063,measure,Legal
goe_q064,measure,Policy
goe_q065,measure,Priorities
goe_q069,measure,Country has telehealth policy or strategy
goe_q070,measure,Strategy includes objectives as to how telehealth contributes to UHC
goe_q081,measure,Evaluation of any government-sponsored telehealth programmes
goe_q103,measure,eLearning is used in pre-service education to teach health sciences students
goe_q104_1,measure,Reducing cost of delivering content
goe_q104_2,measure,Improving access to content and experts
goe_q104_3,measure,Enabling access to education where learning facilities are limited
goe_q109,measure,Pre-service eLearning programmes have been evaluated
goe_q118,measure,eLearning used for in-service training of health professionals
goe_q119_1,measure,Reducing cost of delivering content
goe_q119_2,measure,Improving access to content and experts
goe_q119_3,measure,Enabling access to education where learning facilities are limited
goe_q120,measure,eLearning courses accredited by continuing medical education or professional licensing bodies
goe_q122,measure,eLearning programmes for in-service training of health professionals have been evaluated
goe_q131,measure,Lack of capacity
goe_q132,measure,Lack of infrastructure
goe_q133,measure,Lack of funding
goe_q134,measure,Not possible to gain a health sciences degree entirely through eLearning
goe_q135,measure,Lack of evidence that eLearning is effective
goe_q136,measure,Lack of evidence over cost-effectiveness
goe_q137,measure,Lack of demand for eLearning programmes
goe_q138,measure,Lack of suitable courses available
goe_q139,measure,Insitutional educational policy does not include eLearning as an approach to teaching health sciences
goe_q140,measure,Competing educational priorities
goe_q144,measure,Country has national EHR
goe_q146,measure,Country has specific legislation governing the use of national EHR system
goe_q153,measure,Lack of capacity
goe_q154,measure,Lack of infrastructure
goe_q155,measure,Lack of funding
goe_q156,measure,lack of evidence showing effectiveness of EHR
goe_q157,measure,Lack of evidence showing cost-effectiveness or EHR
goe_q158,measure,Lack of demand by health professionals and patients
goe_q159,measure,Lack of legislation or regulations covering use of EHR
goe_q160,measure,National strategy does not promote the adoption of EHR
goe_q161,measure,Lack of national or international standards for interoperability of EHR
goe_q162,measure,Competing health system priorities
goe_q168,measure,"to define medical jurisdiction, liability or reimbursement of eHealth services such as telehealth"
goe_q169,measure,"to address patient safety and quality of care based on data quality, data transmission standards, or clinical competency criteria"
goe_q170,measure,to protect privacy of personally identifiable data of individuals irrespective of whether it is paper or digital format
goe_q171,measure,to protect the privacy of individuals' health-related  data held in electronic format as an EHR
goe_q172,measure,which governs the sharing of digital data between health professionals in other health services in the same country through the use of an EHR
goe_q173,measure,which governs the sharing of digital data between health professionals  in health services in other countries through the use of an EHR
goe_q174,measure,which allows for the sharing of personal and health data between research entities
goe_q175,measure,which allows individuals electronic access to their own health-related data when held in an EHR
goe_q176,measure,which allows individuals to demand that their own data be corrected  when held in an EHR if it is known to be inaccurate
goe_q177,measure,which allows individuals to demand the deletion of health-related data from their EHR
goe_q178,measure,Individuals have the legal right to specify which health-related data from their EHR can be shared with health professionals of their choice
goe_q181,measure,Country has national policy or strategy on the use of social media by government organizations
goe_q182,measure,Policy or strategy makes specific reference tothe use of social media in the health domain
goe_q196,measure,Country has  national policy or strategy regulating the use of big data in the health sector
goe_q197,measure,Country has national policy or strategy regulating the use of big data by private companies
goe_q198,measure,Effective standards and best practices for data capture not fully established
goe_q199,measure,Insufficient incentives for data sharing
goe_q200,measure,Capacity building required for new skills
goe_q201,measure,Privacy and security laws need to be in place
goe_q202,measure,Research into new analytical methods needs occur to meet the challenges of working with big data
goe_q203,measure,Lack of integration between various health services
nutrition_wh_2,measure,Children aged <5 years wasted <br> (% weight-for-height <-2 SD)
nutrition_wh2,measure,Children aged <5 years overweight <br> (% weight-for-height >+2 SD)
nutrition_ha_2,measure,Children aged <5 years stunted <br> (% height-for-age <-2 SD)
nutrition_wa_2,measure,Children aged <5 years underweight <br> (% weight-for-age <-2 SD) (%)
malaria_householditnirs,measure,Households with at least one insecticide-treated net (ITNs) or indoor residual spraying (IRS)(%)
amr_gi_001,measure,Status of countries enrolled in GLASS
amr_gi_002,measure,Status of National coordination center establishment
amr_gi_003,measure,Status of National plans to implement and strengthen antimicrobial surveillance
sa_0000001789,measure,Alcohol-related crimes (% of all crimes)
sunbedexistsubnational,measure,Existence of subnational regulation
rsud_100,measure,Government unit/official responsible for prevention for substance use
rsud_110,measure,Ministry/office that takes primary responsibility for prevention for substance use
rsud_120,measure,Five years change in international cooperation for prevention for substance use
rsud_130,measure,Government unit/official responsible for treatment of substance use disorders
rsud_140,measure,Ministry/office that takes primary responsibility for treatment of substance use disorders
rsud_150,measure,Involvement of representatives of affected or targeted populations in the development and formulation of policies and strategies for treatment of substance use disorders
rsud_160,measure,Involvement of representatives of affected or targeted populations in the development and implementation of national programmes for treatment of substance use disorders
rsud_170,measure,Involvement of representatives of affected or targeted populations in the development and formulation of policies and strategies for prevention for alcohol and drugs
rsud_180,measure,Involvement of representatives of affected or targeted populations in the development and implementation of national programmes for prevention for alcohol and drugs
rsud_190,measure,Five years change in international cooperation for treatment of substance use disorders
rsud_200,measure,Confidentiality of people in treatment for substance use disorders
rsud_210,measure,Voluntary treatment for people with alcohol use disorders in the criminal justice system
rsud_220,measure,Voluntary treatment for people with drug use disorders in the criminal justice system
rsud_230,measure,Compulsory treatment for people with alcohol use disorders in the criminal justice system
rsud_240,measure,Compulsory treatment for people with drug use disorders in the criminal justice system
rsud_250,measure,Five-year change in government resources for prevention for substance use
rsud_260,measure,Five-year change in government resources for treatment of substance use disorders
rsud_270,measure,Financing methods for treatment for alcohol use disorders
rsud_280,measure,Financing methods for treatment for drug use disorders
rsud_290,measure,Hypothecated taxes to be spent on prevention and treatment for substance use disorders
rsud_300,measure,Government benefits for people with alcohol use disorders
rsud_310,measure,Government benefits for people with drug use disorders
rsud_320,measure,Main sector for treatment for alcohol use disorders
rsud_330,measure,Main sector for treatment for drug use disorders
rsud_340,measure,Treatment programmes for children and adolescents with alcohol use disorders
rsud_350,measure,Treatment programmes for children and adolescents with drug use disorders
rsud_360,measure,Specialized treatment facilities for substance use disorders
rsud_370,measure,Specialized treatment facilities for alcohol use disorders
rsud_380,measure,Specialized treatment facilities for drug use disorders
rsud_390,measure,Self-help groups
rsud_400,measure,Main substance at treatment entry
rsud_410,measure,Reported treatment coverage for substance dependence
rsud_420,measure,Guidelines on pharmacological treatment for substance use disorders
rsud_430,measure,Pharmacotherapy with methadone
rsud_440,measure,Pharmacotherapy with buprenorphine
rsud_450,measure,Pharmacotherapy with buprenorphine/naloxone
rsud_460,measure,Access restrictions to maintenance treatment
rsud_470,measure,Timeframe for maintenance treatment of opioid dependence
rsud_480,measure,Registration of medications for alcohol dependence and withdrawal
rsud_490,measure,Registration of medications for opioid dependence
rsud_500,measure,Registration of medications for opioid withdrawal
rsud_510,measure,Registration of naloxone for injection for opioid overdose
rsud_520,measure,Availability of naloxone
rsud_530,measure,Screening and brief intervention for substance use in primary health care
rsud_540,measure,Screening and brief intervention for substance use in antenatal services
rsud_550,measure,Recommendations for screening and brief interventions for substance use in primary health care
rsud_560,measure,Recommendations for screening and brief interventions for substance use in antenatal services
rsud_570,measure,Groups and agencies involved in prevention programs
rsud_580,measure,Prevention programmes for alcohol
rsud_590,measure,Prevention programmes for specific populations for alcohol
rsud_600,measure,Prevention programmes for drugs
rsud_610,measure,Prevention programmes for specific populations for drugs
rsud_620,measure,"HIV, Hepatitis counselling and treatment availability in specialized facilities and services"
rsud_630,measure,Programmes readily available
rsud_640,measure,Standards of treatment and care for public specialized treatment facilities
rsud_650,measure,Special treatment programmes for gambling disorder
rsud_660,measure,Treatment programmes for women with alcohol use disorders
rsud_670,measure,Treatment programmes for women with drug use disorders
rsud_680,measure,Special housing services for alcohol use disorders
rsud_690,measure,Special housing services for drug use disorders
rsud_700,measure,Employment services for alcohol use disorders
rsud_710,measure,Employment services for drug use disorders
rsud_720,measure,Open access interventions for alcohol
rsud_730,measure,Open access interventions for drugs
rsud_740,measure,Health professionals providing treatment for alcohol and drug use disorders
rsud_750,measure,Standards of care for professionals providing treatment for alcohol and drug use disorders
rsud_760,measure,Educational attainment in prevention
rsud_770,measure,Postgraduate training programme in prevention
rsud_780,measure,Continuing professional development in prevention
rsud_790,measure,Educational attainment in treatment
rsud_800,measure,Postgraduate training programme in treatment
rsud_810,measure,Continuing professional development in treatment
rsud_820,measure,Epidemiological data collection for substance use
rsud_830,measure,Service delivery data collection for substance use
rsud_840,measure,Regular reports on epidemiological and service delivery data for substance use
rsud_850,measure,System of monitoring alcohol involvement in forensic pathology
rsud_860,measure,System of monitoring drugs involvement in forensic pathology
rsud_870,measure,Epidemiological data collection system for substance use among children and adolescents
rsud_880,measure,Epidemiological data collection system for substance use among children and adolescents
rsud_890,measure,Treatment programmes for children and adolescents with alcohol use disorders
rsud_900,measure,Treatment programmes for children and adolescents with drug use disorders
air_90,measure,"Ambient air pollution attributable DALYs  (per 100 000 population, age-standardized)"
air_51,measure,Household air pollution attributable mortality rate (attributable deaths per 100 000 population)
air_52,measure,"Household air pollution attributable mortality rate (attributable deaths per 100 000 population, age-standardized)"
mcv2,measure,Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)
pcv3,measure,Pneumoccocal conjugate vaccines (PCV3) immunization coverage among 1-year-olds (%)
rotac,measure,Rotavirus vaccines completed dose (RotaC) immunization coverage among 1-year-olds (%)
e14b_movies_anti_tob_ads,measure,"Requirement to present prescribed anti-tobacco ads before, during or after the broadcasting or showing of any visual entertainment media product that depicts tobacco products, use or images"
e15a_sponsorship,measure,Complete ban on sponsorship
e15b_sponsor_contribution,measure,"Ban on any form of contribution (financial or other support) to any event, activity or individual"
e15c_sponsor_publicity,measure,"Banning the publicity of financial or other sponsorship or support by the tobacco industry of events, activities, individuals"
e15d_csr_ban,measure,Ban on Corporate Social Responsibility activities (CSR)
totenv_70,measure,Total environment attributable deaths in children under 5 years
totenv_90,measure,Total environment attributable DALYs  in children under 5 years
wsh_water_safely_managed,measure,Population using safely managed drinking-water services (%)
wsh_water_basic,measure,Population using at least basic drinking-water services (%)
wsh_sanitation_safely_managed,measure,Population using safely managed sanitation services (%)
wsh_sanitation_basic,measure,Population using at least basic sanitation services (%)
wsh_hygiene_basic,measure,Population with basic handwashing facilities at home (%)
anemiau5,measure,Prevalence of anaemia in children under 5 years (%)
anemianpw,measure,Prevalence of anaemia in non-pregnant women (%)
anemiapw,measure,Prevalence of anaemia in pregnant women (%)
childmort5to14,measure,Mortality rate for 5-14 year-olds (probability of dying per 1000 children aged 5-14 years)
ncd_bmi_18a,measure,"Prevalence of underweight among adults, BMI < 18 (age-standardized estimate) (%)"
ncd_bmi_18c,measure,"Prevalence of underweight among adults, BMI < 18 (crude estimate) (%)"
ncd_bmi_plus1a,measure,"Prevalence of overweight among children and adolescents, BMI > +1 standard deviations above the median (age-standardized estimate) (%)"
ncd_bmi_plus1c,measure,"Prevalence of overweight among children and adolescents, BMI > +1 standard deviations above the median (crude estimate) (%)"
ncd_bmi_plus2c,measure,"Prevalence of obesity among children and adolescents, BMI > +2 standard deviations above the median (crude estimate) (%)"
ncd_bmi_plus2a,measure,"Prevalence of obesity among children and adolescents, BMI > +2 standard deviations above the median (age-standardized estimate) (%)"
ncd_bmi_minus2a,measure,"Prevalence of thinness among children and adolescents, BMI < -2 standard deviations below the median (age-standardized estimate) (%)"
ncd_bmi_minus2c,measure,"Prevalence of thinness among children and adolescents, BMI < -2 standard deviations below the median (crude estimate) (%)"
uhc_data_avail_code,measure,Data availability for UHC index of essential service coverage (ranking)
uhc_index_reported,measure,UHC index of essential service coverage (%)
uhc_index_actual,measure,Index of Essential Service Coverage (Actual)
uhc_availability_score,measure,Data availability for UHC index of essential service coverage (%)
finprotection_cata_tot_10_pop,measure,Population with household expenditures on health greater than 10% of total household expenditure or income (SDG 3.8.2) (%)
finprotection_cata_tot_25_pop,measure,Population with household expenditures on health greater than 25% of total household expenditure or income  ( SDG indicator 3.8.2) (%)
finprotection_imp_np190_pop,measure,Population  pushed below the $1.90 a day  poverty line by household  health expenditures (%)
finprotection_imp_np310_pop,measure,Population  pushed below the $3.10 a day  poverty line by household  health expenditures (%)
finprotection_p1_190_pop,measure,Changes in poverty gap due to health expenditure at the $1.90 a-day poverty line (in 2011 PPs)
finprotection_p1_310_pop,measure,Changes in poverty gap due to health expenditure at the $3.10 a-day poverty line (in 2011 PPs)
uhc_tb_dt,measure,Tuberculosis detection and treatment
uhc_ncd_nonelevbp,measure,Prevalence of non-elevated blood pressure (%)
uhc_ncd_fpg,measure,Mean fasting plasma glucose
uhc_hrhsurgeondensity,measure,Surgeons (per 100 000)
uhc_tobaccono,measure,Prevalence of non-use of tobacco
uhc_ihr,measure,Compliance with international health regulations
gdo_q1x1,measure,Inclusion of dementia in ministry portfolio
gdo_q1x1x1,measure,"Inclusion of dementia in a branch of government [health, ageing, social services, mental health, noncommunicable disease]"
gdo_q1x2,measure,Existence of dementia representative in ministry
gdo_q2x1,measure,Existence of dementia national plan
gdo_q2x1x2,measure,Availability of funding for dementia national plan
gdo_q2x1x3,measure,Targets for monitoring implementation of dementia national plan
gdo_q2x2,measure,Dementia integrated into other national plan
gdo_q2x2x1_mental,measure,Identification of other plans in which dementia is integrated (Mental health)
gdo_q2x2x1_age,measure,Identification of other plans in which dementia is integrated (Ageing)
gdo_q2x2x1_ncd,measure,Identification of other plans in which dementia is integrated (NCD)
gdo_q2x2x1_disab,measure,Identification of other plans in which dementia is integrated (Disability)
gdo_q2x2x1_other,measure,Identification of other plans in which dementia is integrated (Other)
gdo_q2x3,measure,Existence of dementia sub-national plan(s)
gdo_q2x3x1_1,measure,Percentage of sub-national regions covered by dementia plan
gdo_q2x4_1,measure,Inclusion of human rights as a guiding principle of the dementia plan
gdo_q2x4_2,measure,Inclusion of equity as a guiding principle of the dementia plan
gdo_q2x4_3,measure,Inclusion of empowerment as a guiding principle of the dementia plan
gdo_q2x4_4,measure,Inclusion of multisectoral collaboration as a guiding principles of the dementia plan
gdo_q2x4_5,measure,Inclusion of universal health coverage as a guiding principle of the dementia plan
gdo_q2x5_1,measure,Inclusion of dementia-friendly communities as a specific action of the dementia plan
gdo_q2x5_2,measure,Inclusion of dementia risk reduction as a specific action of the dementia plan
gdo_q2x5_3,measure,"Inclusion of dementia diagnosis, care and support as a specific action of the dementia plan"
gdo_q2x5_4,measure,Inclusion of dementia workforce training as a specific action of the dementia plan
gdo_q2x5_5,measure,Inclusion of support for dementia carers and families as a specific action of the dementia plan
gdo_q2x5_6,measure,Inclusion of improved information system as a specific action of the dementia plan
gdo_q2x5_7,measure,Inclusion of research and innovation as a specific action of the dementia plan
gdo_q3x1,measure,Existence of dementia legislation
gdo_q3x1x1_1,measure,Implementation level [national/subnational] of dementia legislation
gdo_q3x2,measure,Existence of other laws that apply to the rights of people with dementia
gdo_q3x3a_1,measure,Existence of legislation for supported decision making for people with dementia
gdo_q3x3a_2,measure,Existence of legislation to file appeals protecting the rights of people with dementia
gdo_q3x3a_3,measure,Existence of legislation to promote community-based services for people with dementia
gdo_q3x3a_4,measure,Existence of legislation to promote monitoring of human rights conditions of people with dementia in facilities where they reside
gdo_q3x4_1,measure,Existence of legislation for advanced care directives for people with dementia
gdo_q3x4_2,measure,Existence of legislation to end discrimination against people with dementia
gdo_q3x4_3,measure,Existence of legislation to end discrimination against carers of people with dementia
gdo_q3x3b_1,measure,Existence of legislation to end coercieve practices for people with dementia
gdo_q4x1,measure,Existence of dementia standards/ guidelines/ protocols
gdo_q4x1x1_sq001,measure,Implementation level of dementia standards/ guidelines/ protocols (National)
gdo_q4x1x1_sq002,measure,Implementation level of dementia standards/ guidelines/ protocols (Sub-national)
gdo_q4x1x2,measure,Existence of approved government dementia standards/ guidelines/ protocols
gdo_q4x2_1,measure,Existence of standards/ guidelines/ protocols for prevention and risk reduction of dementia
gdo_q4x2_2,measure,Existence of standards/ guidelines/ protocols for diagnosis of dementia
gdo_q4x2_3,measure,Existence of standards/ guidelines/ protocols for management of dementia
gdo_q4x2_4,measure,Existence of standards/ guidelines/ protocols for other post-diagnostic supports of people with dementia
gdo_q4x3x4_1,measure,"Existence of standards/ guidelines/ protocols for advance care directives, power of attorney or guardianship for people with dementia"
gdo_q4x3x4_2,measure,Existence of standards/ guidelines/ protocols for palliative and end-of-life care for people with dementia
gdo_q4x3x4_3,measure,Existence of standards/ guidelines/ protocols of care in nursing & residential care facilities for people with dementia
gdo_q4x3x4_4,measure,Existence of standards/ guidelines/ protocols of care in hospital for people with dementia
gdo_q4x2_5,measure,Existence of standards/ guidelines/ protocols for treatment and support of carers and families of people with dementia
gdo_q5x1,measure,Availability of mechanisms to coordinate dementia care across sectors
gdo_q5x1x1_1,measure,Identification of different sectors in dementia care coordination  (Health)
gdo_q5x1x1_2,measure,Identification of different sectors in dementia care coordination (Social)
gdo_q5x1x1_3,measure,Identification of different sectors in dementia care coordination (Education)
gdo_q5x1x1_4,measure,Identification of different sectors in dementia care coordination (Employment)
gdo_q5x1x1_5,measure,Identification of different sectors in dementia care coordination (Justice)
gdo_q5x1x1_6,measure,Identification of different sectors in dementia care coordination (Housing)
gdo_q5x1x1_7,measure,Identification of different sectors in dementia care coordination (Civil society)
gdo_q5x1x1_8,measure,Identification of different sectors in dementia care coordination (Private sector)
gdo_q5x1x1_other,measure,Identification of different sectors in dementia care coordination (Other)
gdo_q5x1x2,measure,Implementation level [national/subnational] of dementia care coordination
gdo_q5x1x3,measure,Presence of formal agreement/joint plan for dementia care coordination
gdo_q5x2,measure,Availability of dementia care coordination standards/ guidelines/ protocols
gdo_,measure,EXISTING GHO INDICATOR Number of Personal care workers (Health workforce)
gdo_q6x1_2,measure,"Number of neurologists (per 100,000)"
gdo_q6x1_3,measure,"Number of geriatricians or psychogeriatricians (per 100,000)"
gdo_q6x2_1,measure,Inclusion of basic dementia competencies in training of physicians
gdo_q6x2_2,measure,Inclusion of basic dementia competencies in training of specialists
gdo_q6x2_3,measure,Inclusion of basic dementia competencies in training of nurses
gdo_q6x2_4,measure,Inclusion of basic dementia competencies in training of pharmaceutical personnel
gdo_q6x2_5,measure,Inclusion of basic dementia competencies in training of social workers
gdo_q6x2_6,measure,Inclusion of basic dementia competencies in training of personal support workers
gdo_q7x1_avail,measure,Availability of dementia diagnostic rate
gdo_q8x1,measure,Existence of community-based health or social care services for dementia
gdo_q8x2_1,measure,Availability of diagnostic services in community for dementia
gdo_q8x3_1,measure,"Accessibility of diagnostic services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas]"
gdo_q8x4_1,measure,"Majority provider of diagnostic services in community for dementia [public, private]"
gdo_q8x2_2,measure,Availability of behaviour and psychological management in community for dementia
gdo_q8x3_2,measure,"Accessibility of behaviour and psychological management in community for dementia [Capital/capital and main cities/capital, main cities, rural areas]"
gdo_q8x4_2,measure,"Majority provider of behaviour and psychological management in community for dementia [public, private]"
gdo_q8x5_2,measure,Estimated number of people receiving behaviour and psychological management services in community for dementia
gdo_q8x2_3,measure,Availability of psychosocial and rehabilitation services in community for dementia
gdo_q8x3_3,measure,"Accessibility of psychosocial and rehabilitation services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas]"
gdo_q8x4_3,measure,"Majority provider of psychosocial and rehabilitation services in community for dementia [public, private]"
gdo_q8x5_3,measure,Estimated number of people receiving psychosocial and rehabilitation services in community for dementia
gdo_q8x2_4,measure,Availability of activities of daily living suppport services in community for dementia
gdo_q8x3_4,measure,"Accessibility of activities of daily living support services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas]"
gdo_q8x4_4,measure,"Majority provider of activities of daily living support services in community for dementia [public, private]"
gdo_q8x5_4,measure,Estimated number of people receiving activities of daily living support services in community for dementia
gdo_q8x2_5,measure,Availability of palliative and end-of-life care services in community for dementia
gdo_q8x3_5,measure,"Accessibility of palliative and end-of-life care services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas]"
gdo_q8x4_5,measure,"Majority provider of palliative and end-of-life care services in community for dementia [public, private]"
gdo_q8x5_5,measure,Estimated number of people receiving palliative and end-of-life care services in community for dementia
gdo_q8x2_6,measure,Availability of social and financial protection for dementia
gdo_q8x3_6,measure,"Accessibility of social and financial protection for dementia [Capital/capital and main cities/capital, main cities, rural areas]"
gdo_q8x4_6,measure,"Majority provider of social and financial protection for dementia [public, private]"
gdo_q8x5_6,measure,Estimated number of people with dementia receiving social and financial protection for dementia
gdo_q9_1,measure,Dementia care facilities [hospitals]
gdo_q9x1_1,measure,EXISTING GHO INDICATOR Density of hospitals (per 100 000 population)
gdo_q9x1_2,measure,EXISTING GHO INDICATOR Hospital beds (per 10 000 population) (Health systems)
gdo_q9x1_3,measure,"Dementia-specific hospital beds (per 10,000 population)"
gdo_q9x1_4,measure,"Geriatric-specific hospital beds (per 10,000 population)"
gdo_q9x1_5,measure,"Total dementia hospital admissions (per 100,000)"
gdo_q9x1_7,measure,Estimated percentage of hospitals following national dementia standards
gdo_q9_2,measure,Care facilities [long-term care]
gdo_q9x2_1,measure,"Density of residential long-term care facilities (per 100,000 population)"
gdo_q9x2_2,measure,Residential long-term care beds (per 10 000 population)
gdo_q9x2_3,measure,"Dementia-specific residential long-term care beds (per 10,000 population)"
gdo_q9x2_4,measure,Estimated number of people with dementia living in residential long-term care
gdo_q9x2_5,measure,Estimated percentage of residential long-term care facilities following national dementia standards
gdo_q9_3,measure,Care facilities [hospice centres]
gdo_q9x3_1,measure,"Density of hospice centres (per 100,000 population)"
gdo_q9x3_2,measure,Hospice centre beds (per 10 000 population)
gdo_q9x3_3,measure,"Dementia-specific hospice care beds (per 10,000 population)"
gdo_q9_4,measure,Adult day centres
gdo_q9x4_1,measure,"Density of adult day centres (per 100,000 population)"
gdo_q9x4_2,measure,"Adult day centre places (per 10,000 population)"
gdo_q9x4_3,measure,"Dementia-specific adult day centre places (per 10,000 population)"
gdo_q9_5,measure,Outpatient health centres
gdo_q9x5_1,measure,"Density of outpatient health centres (per 100,000 population)"
gdo_q9x5_2,measure,Estimated number of people with dementia receiving services at outpatient health centre
gdo_q9_6,measure,Outpatient social centres
gdo_q9x6_1,measure,"Density of outpatient social centres (per 100,000 population)"
gdo_q9x6_2,measure,Estimated number of people with dementia receiving services at outpatient social centre
gdo_q10x1,measure,National regulator approval of anti-dementia medication
gdo_q10x1x1,measure,Availability of generic anti-dementia medication
gdo_q10x1x2,measure,Availability of at least one anti-dementia medication approved for on-label use reimbursement
gdo_q10x2_1avail,measure,Availability of atleast one adult hygiene products for people with dementia
gdo_q10x2_tech,measure,Availability of  atleast one assistive technology for people with dementia
gdo_q10x2_hosue,measure,Availability of atleast one housing adjustment for people with dementia
gdo_q11x1,measure,Existence of dementia national nongovernmental organization
gdo_q11x2x1,measure,Dementia nongovernmental organization equipped with office
gdo_q11x2x2_1,measure,Dementia nongovernmental organization office branches (Sub-national)
gdo_q11x2x2_2,measure,Dementia nongovernmental organization office branches (Local)
gdo_q11x2x2_3,measure,Dementia nongovernmental organization office branches (National only)
gdo_q11x2x3,measure,Dementia nongovernmental organization staff primarily salaried/volunteer
gdo_q11x2x5,measure,Provision of governmental funding to dementia nongovernmental organization for activities/services
gdo_q11x2x6,measure,Dementia nongovernmental organization's involvement in policy development
gdo_q12x1,measure,Existence of dementia carer support services
gdo_q12x1x1,measure,Implementation level [national/subnational] of dementia carer support services
gdo_q12x1x2,measure,Existence of dedicated resources for dementia carer support services
gdo_q12x1x3,measure,Existence of implementation plan for dementia carer support services
gdo_q12x2_1,measure,Existence of dementia carer training and education
gdo_q12x2x1x1_1,measure,"Accessibility of dementia carer training and education [Capital/capital and main cities/capital, main cities, rural areas]"
gdo_q12x2x1x1_1pub,measure,Majority provider of dementia carer training and education (Public sector)
gdo_q12x2x1x1_1prv,measure,Majority provider of dementia carer training and education (Private sector)
gdo_q12x2x1x1_1ngo,measure,Majority provider of dementia carer training and education (NGO)
gdo_q12x2x1x3,measure,Estimated number of dementia carers receiving training and education
gdo_q12x2_2,measure,Existence of psycho-social supports for dementia carers
gdo_q12x2x1x1_2,measure,"Accessibility of psycho-social supports for dementia carers [Capital/capital and main cities/capital, main cities, rural areas]"
gdo_q12x2x1x1_2pub,measure,Majority provider of psycho-social supports for dementia carers (Public sector)
gdo_q12x2x1x1_2prv,measure,Majority provider of psycho-social supports for dementia carers (Private sector)
gdo_q12x2x1x1_2ngo,measure,Majority provider of psycho-social supports for dementia carers (NGO)
gdo_q12x2x2x3,measure,Estimated number of dementia carers receiving psycho-social supports
gdo_q12x2_3,measure,Existence of respite care for dementia carers
gdo_q12x2x1x1_3,measure,"Accessibility of respite care for dementia carers [Capital/capital and main cities/capital, main cities, rural areas]"
gdo_q12x2x1x1_3pub,measure,Majority provider of respite care for dementia carers (Public sector)
gdo_q12x2x1x1_3prv,measure,Majority provider of respite care for dementia carers (Private sector)
gdo_q12x2x1x1_3ngo,measure,Majority provider of respite care for dementia carers (NGO)
gdo_q12x2x3x3,measure,Estimated number of dementia carers receiving respite care
gdo_q12x2_4,measure,Existence of information on legal rights for dementia carers
gdo_q12x2x1x1_4,measure,"Accessibility of information on legal rights for dementia carers [Capital/capital and main cities/capital, main cities, rural areas]"
gdo_q12x2x1x1_4pub,measure,Majority provider of information  on legal rights for dementia carers (Public sector)
gdo_q12x2x1x1_4prv,measure,Majority provider of information on legal rights for dementia carers (Private sector)
gdo_q12x2x1x1_4ngo,measure,Majority provider of information on legal rights for dementia carers (NGO)
gdo_q12x2x4x3,measure,Estimated number of dementia carers receiving information on legal rights
gdo_q12x2_5,measure,Existence of financial benefits/social protection for dementia carers
gdo_q12x2x1x1_5,measure,"Accessibility of financial benefits/social protection for dementia carers [Capital/capital and main cities/capital, main cities, rural areas]"
gdo_q12x2x1x1_5pub,measure,Majority provider of information  on financial benefits/social protection for dementia carers (Public sector)
gdo_q12x2x1x1_5prv,measure,Majority provider of information on financial benefits/social protection for dementia carers (Private sector)
gdo_q12x2x1x1_5ngo,measure,Majority provider of information on financial benefits/social protection for dementia carers (NGO)
gdo_q12x2x5x3,measure,Estimated number of dementia carers receiving financial benefits/social protection
gdo_q13x1,measure,Existence of at least one functioning dementia awareness campaign
gdo_q13x1x1,measure,Implementation level [national/subnational] of dementia awareness campaign
gdo_q13x3,measure,Existence of at least one functioning risk reduction campaign
gdo_q13x3x1,measure,Implementation level [national/subnational] of dementia risk reduction campaign
gdo_q14x1,measure,Availability of dementia-friendly initiatives that improve accessibility
gdo_q14x2_1,measure,Existence of dementia-friendly initiative to improve accessibility of public spaces
gdo_q14x2_2,measure,Existence of dementia-friendly initiative to improve accessibility of public transportation
gdo_q14x2_3,measure,Existence of dementia-friendly initiative for assistance with home modification
gdo_q14x2_4,measure,Existence of dementia-friendly initiative with assistive technology for loss of capacity
gdo_q14x2_5,measure,Existence of dementia-friendly initiative supporting community places for older people
gdo_q14x2_6,measure,Existence of dementia-friendly initiative supporting social opportunities
gdo_q15x1,measure,Inclusion of dementia training and education for non-health workers
gdo_q15x2_1,measure,Existence of dementia training for volunteers
gdo_q15x2_2,measure,Existence of dementia training for police and fire services
gdo_q15x2_3,measure,Existence of dementia training for first responders
gdo_q15x2_4,measure,Existence of dementia training for legal professionals
gdo_q15x2_5,measure,Existence of dementia training for community workers
gdo_q15x2_6,measure,Existence of dementia training for school children
gdo_q15x2_7,measure,Existence of dementia training for financial service staff
gdo_q15x2_8,measure,Existence of dementia training for retail and hospitality staff
gdo_q16x1,measure,Routine monitoring of people with dementia
gdo_q16x1x1_1,measure,Data sources used to routinely monitor people with dementia (Clinical records)
gdo_q16x1x1_2,measure,Data sources used to routinely monitor people with dementia (Household surveys)
gdo_q16x1x1_3,measure,Data sources used to routinely monitor people with dementia (Administrative data)
gdo_q16x1x1_4,measure,Data sources used to routinely monitor people with dementia (Facility survey or records)
gdo_q16x1x1_other,measure,Data sources used to routinely monitor people with dementia (Other)
gdo_q16x1x2_1,measure,Electronic availability of data sources used to routinely monitor people with dementia
gdo_q16x1x2_2,measure,Data used to routinely monitor people with dementia can be disaggregated
gdo_q16x2_1,measure,Availability of routine hospital admissions records for people with dementia for monitoring purposes
gdo_q16x2_2,measure,Availability of routine outpatient visit records for people with dementia for monitoring purposes
gdo_q16x2_3,measure,Availability of routine outpatient intervention and treatment records for people with dementia for monitoring purposes
gdo_q16x2_4,measure,Availability of routine pharmaceutical records for people with dementia for monitoring purposes
gdo_q16x2_5,measure,Availability of routine antipsychotic prescription records for people with dementia for monitoring purposes
gdo_q16x3,measure,Availability and status of dementia reporting in the past two years
gdo_q17x1,measure,Existence of a current dementia research plan/programme
gdo_q17x1x1,measure,Implementation level [national/subnational] of dementia research plan/programme
gdo_q17x2,measure,Dementia integrated into other national research plan/programme
gdo_q17x2x1_1,measure,Identification of other research plans in which dementia is integrated (Mental health)
gdo_q17x2x1_2,measure,Identification of other research plans in which dementia is integrated (Ageing)
gdo_q17x2x1_3,measure,Identification of other research plans in which dementia is integrated (Neuro or neurodegenerative disease)
gdo_q17x2x1_4,measure,Identification of other research plans in which dementia is integrated (NCD)
gdo_q17x2x2,measure,Implementation level [national/subnational] of research plan in which dementia is integrated
gdo_q18x1_1,measure,EXISTING GHO INDICATOR (SDG 9.5.1) Gross domestic R&D expenditure on health (health GERD) as a % of gross domestic product (GDP)
gdo_q18x2,measure,Availability of funding for dementia-specific research plan/programme
gdo_q18x2x1_1,measure,"Total expenditure on dementia research (local currency, self-report)"
gdo_q18x2x3_1,measure,"Total expenditure on dementia basic research (local currency, self-report)"
gdo_q18x2x3_2,measure,"Total expenditure on dementia clinical/translational research (local currency, self-report)"
gdo_q18x2x3_3,measure,"Total expenditure on dementia implementation research (local currency, self-report)"
gdo_q19x2,measure,Number of people with dementia involved in research routinely monitored
gdo_q19x3,measure,Availability of investigational pharmaceutical trials for dementia
gdo_q19x3x1_1,measure,Number of investigational pharmaceutical trials for dementia
wsh_sanitation_od,measure,Population practising open defecation (%)
tb_effective_treatment_coverage,measure,Tuberculosis effective treatment coverage (%)
tb_treatment_coverage,measure,xxx
finprotection_cata_estimate_available,measure,Availability of estimates on large  health expenditures as a share of total expenditure or income
finprotection_impov_estimate_available,measure,Availability of estimates on impoverishment due to out-of-pocket health expenditures
finprotection_imp_pg_190_std,measure,"Increase in poverty gap due to household  health expenditures, expressed as a proportion of the $1.90 a-day poverty line (%)"
finprotection_imp_pg_190,measure,"Increase in poverty gap  due to household  health expenditures at the $1.90 a day poverty line, in cents of international dollars"
finprotection_imp_pg_310_std,measure,"Increase in poverty gap due to household  health expenditures, expressed as a proportion of the 3.10 a-day poverty line (%)"
finprotection_imp_pg_310,measure,"Increase in poverty gap  due to household  health expenditures at the $3.10a day poverty line, in cents of international dollars"
finprotection_cata_tot_10_level_sh,measure,Total population with household expenditures on health greater than 10% of total household expenditure or income (SDG 3.8.2) (%)
finprotection_cata_tot_10_level_million,measure,Total population with household expenditures on health greater than 10% of total household expenditure or income (SDG 3.8.2) (millions)
finprotection_cata_tot_25_level_sh,measure,Total population with household expenditures on health greater than 25% of total household expenditure or income  ( SDG indicator 3.8.2) (%)
finprotection_cata_tot_25_level_million,measure,Total population with household expenditures on health greater than 25% of total household expenditure or income  ( SDG indicator 3.8.2) (millions)
finprotection_imp_np_190_level_sh,measure,Total population  pushed below the $1.90 a day  poverty line by household  health expenditures (%)
finprotection_imp_np_190_level_million,measure,Total population  pushed below the $1.90 a day  poverty line by household  health expenditures (millions)
finprotection_imp_np_310_level_sh,measure,Total population  pushed below the $3.10 a day  poverty line by household  health expenditures (%)
finprotection_imp_np_310_level_million,measure,Total population  pushed below the $3.10 a day  poverty line by household  health expenditures (millions)
gdo_q20,measure,Total number of published dementia research output
ghed_chegdp_sha2011,measure,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%)
ghed_che_pc_us_sha2011,measure,Current health expenditure (CHE) per capita in US$
ghed_che_pc_ppp_sha2011,measure,Current health expenditure (CHE) per capita in PPP int$
ghed_gghe-dche_sha2011,measure,Domestic general government health expenditure (GGHE-D) as percentage of current health expenditure (CHE) (%)
ghed_pvt-dche_sha2011,measure,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%)
ghed_extche_sha2011,measure,External health expenditure (EXT) as percentage of current health expenditure (CHE) (%)
ghed_gghe-dgge_sha2011,measure,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%)
ghed_gghe-dgdp_sha2011,measure,Domestic general government health expenditure (GGHE-D) as percentage of gross domestic product (GDP) (%)
ghed_ext-gext_sha2011,measure,External health expenditure channelled through government (EXT-G) as percentage of external health expenditure (EXT) (%)
ghed_gghe-d_pc_us_sha2011,measure,Domestic general government health expenditure (GGHE-D) per capita in US$
ghed_gghe-d_pc_ppp_sha2011,measure,Domestic general government health expenditure (GGHE-D) per capita in PPP int$
ghed_pvt-d_pc_us_sha2011,measure,Domestic private health expenditure (PVT-D) per capita in US$
ghed_pvt-d_pc_ppp_sha2011,measure,Domestic private health expenditure (PVT-D) per capita in PPP int$
ghed_ext_pc_us_sha2011,measure,External health expenditure (EXT) per capita in US$
ghed_ext_pc_ppp_sha2011,measure,External health expenditure (EXT) per capita in PPP int$
ghed_oopsche_sha2011,measure,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%)
ghed_oop_pc_us_sha2011,measure,Out-of-pocket expenditure (OOP) per capita in US$
ghed_oop_pc_ppp_sha2011,measure,Out-of-pocket expenditure (OOP) per capita in PPP int$
amrglass_coord01,measure,Functioning national AMR surveillance plan
amrglass_coord02,measure,Establishment of National Coordination Centre (NCC)
amrglass_coord03,measure,Nomination of National Focal Point (NFP)
amrglass_coord04,measure,Establishment of national reference laboratory (NRL)
amrglass_survl01,measure,Number of national surveillance sites in each country providing data to GLASS: hospital category
amrglass_survl02,measure,Number of National surveillance sites in each country providing data to GLASS: outpatient facility category
amrglass_survl03,measure,Number of local clinical laboratories in each country performing AST to support national AMR surveillance sites
amrglass_qa01,measure,EQA provided to the national reference laboratory (NRL)
amrglass_qa02,measure,EQA provided for bacterial identification and AST
amrglass_qa03,measure,EQA provided to local laboratories participating in GLASS
amrglass_qa04,measure,GLASS pathogens testing covered by EQA
amrglass_qa05,measure,Types of AST standards followed by countries
cci2030,measure,Composite coverage index (%)
fpsmo,measure,Demand for family planning satisfied - modern methods (%)
gdo_q35,measure,Estimated population-based prevalence of depression
sdghiv1524,measure,New HIV infections among adults 15-24 years old (per 1000 uninfected population)
sdgoda02,measure,"Official development assistance for medical research and basic health sectors as a percentage of GNI (%), by donor country"
sdgoda01,measure,"Total net official development assistance to medical research and basic health sectors per capita (US$), by recipient country"
sdghephbsagprv,measure,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%)
sdg_sh_dth_rncom,measure,"Number of deaths attributed to non-communicable diseases, by type of disease and sex"
sdg_sh_sta_sciden,measure,"Number of deaths attributed to suicide, total and by sex"
sa_0000001400_archived,measure,"Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol)"
nutrition_wh_3,measure,Children aged <5 years severely wasted <br> (% weight-for-height <-3 SD)
air_60,measure,Household and ambient air pollution attributable DALYs ('000)
air_61,measure,Household and ambient air pollution attributable DALYs (per 100 000 capita)
air_62,measure,"Household and ambient air pollution attributable DALYs (per 100 000 capita, age-standardized)"
air_63,measure,Household and ambient air pollution attributable DALYs in children under 5 years ('000)
ncd_ccs_targets,measure,Existence of a set of time-bound national targets based on WHO guidance
ncd_ccs_paaware,measure,Implementation of physical activity public awareness program
ncd_ccs_oralhealthplan,measure,Existence of operational policy/strategy/action plan for oral health
ncd_ccs_rheumreg,measure,Existence of a register of patients who had rheumatic fever and rheumatic heart disease
ncd_ccs_rheumfollowup,measure,Has systems for follow-up/recall to deliver long-term penicillin prophylaxis to patients with rheumatic fever and rheumatic heart disease
tb_e_inc_num_014,measure,Number of incident tuberculosis cases in children aged 0 - 14
m_est_tob_daily_crude,measure,"Daily tobacco smoking, crude adjusted"
m_est_cig_daily_crude,measure,"Daily cigarette smoking, crude adjusted"
m_est_tob_curr_crude,measure,"Current tobacco smoking, crude adjusted"
m_est_cig_curr_crude,measure,"Current cigarette smoking, crude adjusted"
air_39,measure,"Household air pollution attributable DALYs (per 100 000, age-standardized)"
sg_dmk_srcr_fn_zs,measure,"Proportion of women aged 15-49 years who make their own informed decisions regarding sexual relations, contraceptive use and reproductive health care (%)"
e14a_prod_tv_films,measure,Ban on appearance of tobacco products in TV and/or films
e19_indirect_ad_fines,measure,Law requires fines for violations of indirect advertising bans
e20_subnational_exists,measure,"Subnational laws or regulations exist banning some or all types of tobacco advertising, promotion and sponsorship"
e22_internet_sales_ban,measure,Ban on internet sales of tobacco products
e6b_ban_display_pt_of_sale,measure,Ban on display of tobacco products at points of sale
e8_direct_ad_fines,measure,Law requires fines for violations of direct advertising bans
name,string,Name
year,time,Year
country,entity_domain,Country
